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GENERAL INTRODUCTION 
Epidemiological studies have shown strong correlation of 
plasma cholesterol concentration and risk of coronary heart 
disease (Noruma et al., 1992). The incidence of coronary heart 
disease is rare in populations with plasma cholesterol lower 
than 5.2 mmol/1 and risks of coronary heart disease increase 
when plasma cholesterol is higher (Isles and Hole, 1992). 
Informed consumers worldwide prefer low-fat food, which should 
result in lower plasma cholesterol concentration and thus 
lower risk of coronary heart disease (Schroder and Baer, 
1990) . Cholesterol content of animal-derived foods is a 
primary public concern as there is considerable evidence that 
suggests that plasma cholesterol plays an important role in 
the development of atherosclerosis and coronary heart disease 
(Dehal et al., 1991). The fatty acid composition of adipose 
tissue reflects that of the diet and is an objective 
biochemical indicator of the kind of fats consumed for several 
years (Seidelin et al., 1992). The amount and type of fat in 
the diet affect blood lipid concentrations (Norum, 1992). 
Treatment of hypercholesterolemia by diet or by drugs 
decreased the incidence of coronary heart disease (Katan, 
1992) . Lipid-lowering drugs may pose adverse side effects to 
patients with hypercholesterolemia and there is need for 
development of technology for safer applicable methods of 
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treatment of hypercholesterolemic patients and to decrease the 
cholesterol content of foods. 
The hypothesis for these studies is that consumption of 
foods containing E. coprostanoligenes or ingestion of an 
effective dose of bacteria and colonization of the intestinal 
tract of by this cholesterol-reducing microbe will result in 
conversion of dietary and endogenous cholesterol to 
coprostanol, which is poorly absorbed from the intestinal 
tract of h\imans and animals. These investigations were 
conducted to determine the potential for the use of 
Eubacterium coprostanoligenes to decrease plasma cholesterol 
concentration in hypercholesterolemic rabbits as a model for 
human hypercholesterolemia and to decrease the cholesterol 
content of fermented meats as a model for decreasing the 
cholesterol content of foods. 
Dissertation Organization 
This dissertation consists of acknowledgements, a general 
introduction containing a review of literature, two separate 
papers, and general conclusions. The references cited in each 
paper are listed as REFERENCES at the end of each paper. 
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Literature Review 
It is hypothesized that there is a causal association 
between seriom cholesterol concentration, dietary fat, and 
coronary heart disease in humans, and it is believed that the 
risk of coronary heart disease should be decreased 
substantially when serxjm cholesterol concentration is lowered 
(Ravnskov, 1992). Incidence of coronary heart disease is rare 
in populations with plasma cholesterol lower than 5.2 mmol/1, 
and risks of coronary heart disease increase when plasma 
cholesterol is higher (Isles and Hole, 1992) . Epidemiological 
studies have indicated that there is a high correlation of 
plasma lipid concentrations, especially lipoprotein (LDL)-
cholesterol, with risk of coronary heart disease (Noruma et 
al, 1989; Noruma et al., 1992). 
Cholesterol content of animal-derived foods is a primary 
public concern as there is considerable evidence that suggests 
that plasma cholesterol plays an important role in the 
development of atherosclerosis and coronary heart disease. 
Cholesterol is required for several important biological 
functions in animals: precursor for biosynthesis of bile 
acids, corticosteroids and sex hormones; regulation of 
membrane activity and transport of lipid from the intestines 
to tissues; and proliferation of a variety of cells (Dehal et 
al., 1991). 
In a pig model on restricted intake, it was observed that 
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cholesterol-deprived pigs with similar caloric intake to 
cholesterol-fed pigs had a net weight loss, whereas 
cholesterol-fed animals had a net weight gain (Neu et al., 
1987). Studies conducted on the effect of soy versus beef 
diets on blood and tissue cholesterol and body composition of 
growing swine showed that no significant differences were 
observed in total plasma cholesterol or liver cholesterol 
concentrations. In soy-fed pigs, significantly greater 
cholesterol concentrations were found in the viscera excluding 
liver (p<.001), aorta (p<.04), carcass (p<.001) and whole body 
(liver + other viscera + carcass) (p<.001) (Walsh et al., 
1983). In hypercholesterolemic pigs fed a western type diet 
composed of baked beans {Phaseolus vulgaris) at 100, 200, and 
300 g/kg reduced plasma total cholesterol by 5.3, 20.2 and 
35.6%, respectively (Costa et al., 1993). In miniature pigs 
fed fish oil and corn oil, triacylglycerol and cholesterol in 
plasma and VLDL were significantly reduced (Huff et al., 
1993) . 
In studies conducted on the effect of a bean diet on 
biliary lipid secretion, serum cholesterol concentration and 
hepatic cholesterol metabolism in rats, the results showed 
increased output of biliary cholesterol and biliary 
phospholipid, whereas biliary flow and biliary salts output 
remained in the normal range. Total serum and very-low-density 
lipoprotein (VLDL) cholesterol concentrations decreased 
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significantly (27% and 50%), whereas hepatic cholesterogenesis 
increased 170% in the bean-fed animals. Newly synthesized 
cholesterol contribution to total biliary cholesterol 
increased by 200% and was preferentially channelled to the 
biliary cholesterol secreted in these rats (Rigotti et al., 
1989). Elucidation of intrahepatic determinants of biliary 
cholesterol output was done in rats by feeding 1% diosgenin 
for one week. The results showed that biliary cholesterol 
output and saturation increased by 400%, whereas bile flow, 
biliary bile salts, phospholipids and protein outputs 
remained in the normal range (Nervi et al., 1984). In a 
cholesterol model system study of cholesterol movements 
between plasma and organs in rats following a single injection 
of red cells containing free (unesterified) [^H] cholesterol, 
results showed that cholesterol movements between plasma and 
different organs occurred mainly through intense exchange of 
free cholesterol resulting in a low net flux (Magot et al., 
1987). 
Determination of the amount of LDL-cholesteryl ester 
converted to biliary steroids in rats after a single 
intravenous or pulse injection of LDL-[^H]cholesterol linoleyl 
ester, followed by constant infusion to maintain plasma 
radioactivity showed that although a substantial (53-61 ug/h) 
amount of cholesteryl esters were released into the liver 
during catabolism, only a small fraction (0.8-1.90 ug/h) was 
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found in biliary steroids (Bhattacharyya et al., 1986). 
Absorption studies of saturated analogues of cholesterol by 
rat small intestine showed that cholestanol was absorbable 
whereas coprostanol was unabsorbable because of differences in 
uptake and esterification (Bhattacharyya, 1986). 
In a study of the relationship between rates of hepatic 
sterol synthesis and rates of hepatic LDL uptake (clearance) 
in animals with high (rats), low (female hamsters) and very 
low (male hamsters) basal rates of hepatic sterol synthesis, 
it was found that in rats and female hamsters fed cholesterol 
or cholestyramine, rates of hepatic sterol synthesis varied 
over 110-fold range, whereas rates of hepatic LDL clearance 
and plasma LDL-cholesterol concentrations remained unchanged. 
In male hamsters, cholestyramine feeding increased rates of 
hepatic LDL uptake by 2.5-fold and was associated with a 50% 
reduction in plasma LDL-cholesterol concentrations (Spady et 
al., 1985). 
The classification of lipoproteins by lipidologists has 
been done by methods of separation with the assumption that 
the separation techniques were based on physicochemical 
properties and had physiological significance. The two methods 
were based on flotation in a prescribed density solution, 
very-low-density lipoproteins (VLDL), LDL and HDL, and in a 
charged prescribed buffer solution (pre-beta migrating 
lipoproteins, beta-migrating lipoproteins and alpha migrating 
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lipoproteins). The density of lipoproteins is dependent on the 
makeup of the lipoprotein particle and on the types of 
molecular components and it is sensitive to changes in 
triglyceride content when indexed by the remaining lipids. 
Lipids are transported in plasma by forming lipoprotein 
particles (Zech et al., 1986). 
In sheep, rabbit, guinea pig and wild boar, most of the 
cholesterol (70-76%) was in the beta-lipoprotein fraction, 
whereas in horse (60%), mink (60%), fox (65%), goat (70%) and 
cattle (73%) the HDL fraction was the main carrier of 
cholesterol (Vitic and Steveanovic, 1993). 
The three long-chain fatty acids most commonly found in 
neutral fats in the hioman body are similar to the major 
constituents of fats in foods; (a) stearic acid, which has 18-
carbon atoms and is fully saturated with hydrogen atoms, (b) 
oleic acid, which has 18-carbon atoms and one double bond in 
the middle of the chain, and (c) palmitic acid, which has 16-
carbon atoms and is fully saturated (Guyton, 1966). The fatty 
acid composition of adipose tissue reflects that of the diet 
and is an objective biochemical indicator of the kind of fats 
consumed for several years (Seidelin et al., 1992). 
The amount and type of fat in the diet can affect blood 
lipid concentrations. A recent study from Taiwan showed that 
large amounts of monounsaturated fat in the diet raised plasma 
lipids (Norum, 1992). The effects of saturated fats on plasma 
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cholesterol are seen only with saturated fats having chain 
lengths of 12, 14 and 16 carbons atoms, which show increase in 
total cholesterol mainly in the concentrations of LDL. Shorter 
chain fatty acids have little effect on plasma LDL (Norum, 
1992). Recent investigations have shown that stearic acid 
failed to increase LDL-cholesterol concentration in plasma, 
whereas oleic acid was as effective as linoleic acid in 
lowering plasma LDL-cholesterol when substituted for palmitic 
acid (Mattison and Grundy, 1985). 
The hypocholesterolemic effect of dietary polyunsaturated 
fat in guinea pigs may have resulted from redistribution of 
plasma cholesterol to body tissues by increased tissue LDL 
receptors (Minocha et al., 1988). In a study conducted in rats 
on the output of bile and biliary components {biliary salts, 
phospholipids and cholesterol), during the first hour after 
bile duct catheterization it was found that feeding a 
commercial diet or semi-purified diets containing 7% or 20% 
corn oil or 20% lard or mutton tallow, the output of 
cholesterol was augmented when the percentage of corn oil was 
increased from 7% to 20% (Bouquillon and Clement, 1979) . 
In studies relating to the effects of fat unsaturation and 
fatty acid composition on the development of experimental 
atherosclerosis in rabbits after feeding cholesterol or an 
atherogenic or cholesterol-free semipurified diet, it was 
found that the severity of atherosclerosis was inversely 
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related to the level of fat saturation. Cocoa butter was found 
to be less atherogenic than expected, whereas peanut oil, 
which is relatively unsaturated, was atherogenic for rats, 
rabbits and monkeys (Kritchevsky, 1991). 
Structures of Cholesterol and Related Sterols 
The structures of cholesterol and related sterols consist 
of a cyclopentanophenanthrene ring, which can be synthesized 
from a simple precursor such as acetate by most mammalian 
cells. Liver and small intestines are the most dominant in 
rate of cholesterol synthesis (Boyd, 1975) . Structures of 
sterols related to cholesterol are shown Figure 1 and 2 (Boyd, 
1975). A proposed model for metabolism of cholesterol by 
microorganisms and enzymes is shown in Figure 3 (Macdonald et 
al., 1985) . Figure 4 shows proposed mechanisms for the 
formation of coprostanol from cholesterol (Bjorkheim and 
Gustafsson, 1971). 
Metabolism and Distribution of Cholesterol 
Multicompartmental analysis of cholesterol metabolism in 
humans was studied in patients with total bile fistula; 
radiolabelled mevalonic acid and [^^C] cholesterol were 
administered simultaneously. The results indicated that newly 
synthesized hepatic cholesterol contributed 31% and 20% to 
bile acid and biliary cholesterol, whereas plasma free 
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No 
c 
Cholestanol 
r30' 
Zymosterol Desmosterol ui ^ i 
7-Dehydrocholesterol 
, r^PS *-< 
„,x:Q 
Cholesterol 
Coprostanol Epi-cholesterol 
Figure 1, Structures of cholesterol and related sterols which 
may be present in tissues (Boyd, 1975) 
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no-
Ergosterol Stigmasterol Sitosterol 
ilo 
Cholesterol 
,10-"---"^ =!^  110'^ ^^ '^  IK) 
Brassicasterol Fucosterol Campesterol 
Figure 2. Structures of cholesterol and related sterols which 
may be present in various plants and unicellular 
organisms (Boyd, 1975) 
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A-androstGne-3,17-diorie 
Cholesterol 
Chclesta-1,A-dien-3-one 4-choIesten-3-one 
MO 
>1 
1,4-androstadiene 5p-cholestan-3-one Coprostanol 
Figure 3, Model for metabolism of cholesterol by-
microorganisms and enzymes: 1) E. coli, Eubacterivm 
21408, cholesterol dehydrogenase; 2) Eubacteriim, 
Bacteroides, Clostridium, Bifidobacterium, 6^-NDH; 
3) Eubacteriim, 6^-NDH; E. coli, 4) 
Dehydrogenase; 5) hximan fecal flora E. coli, 
desmolase (Macdonald et al., 1983) 
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1 
Cholesterol 
MGcliniiisrn .II 
Moclinnistii 1 
V' V 
r -^< 
4-cholesten-3-one 
Coprostanol 
HO riy 
H 
1 \ 
no 
H 
Copros tanone 
Figure 4. Proposed mechanisms for the formation of 
coprostanol from cholesterol (Bjorkheim and 
Gustafsson, 1971) 
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cholesterol made a small contribution (11%) to bile acid 
(Schwartz et al., 1978). Elucidation of cholesterol dynamics 
in membranes is essential in the understanding of cellular 
cholesterol accumulation and loss. Cholesterol is not randomly-
distributed in model or biologic membranes, but appears to be 
organized in structural and kinetic cholesterol-rich and poor 
domains, which can be observed histochemically and can be 
physically isolated from epithelial cell surface membranes 
(Table 1) (Schroeder et al., 1991). 
Lipids make up a major fraction of each class of 
lipoproteins, which are transported in plasma. These 
macromolecular complexes are constructed so that the more 
polar constituents are on the lipoprotein surface (S) forming 
a boundary layer which interacts directly with the aqueous 
environment. The less polar moieties make up the core (C) 
which is relatively isolated from the bulk plasma. Hviman 
plasma lipoproteins are a polydisperse collection of 
macromolecular complexes ranging from 7 to 160 nm and contain 
the moieties shown in Table 2 (Zech et al., 1986). 
Results from an investigation on the effect of dietary fats 
on the fluidity of human HDL suggest that the percentages of 
triacylglycerol and oleic acid in phospholipids of HDL have a 
fluidifying effect on these lipoproteins (Sola et al., 1990). 
The investigation of the action of lecithin-cholesterol 
acyltransferase (LCAT, EC 2.3.1.43) on different pig 
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Table 1. Asymmetric distribution of cholesterol in cells 
Type 
Intracellular 
Plasma membrane>microsome>mitochondria 
Intramembrane-transbilayer 
Intramembrane-lateral 
Macroscopic domains 
Microscopic domains 
Schroeder et al., 1991. 
Table 2. Components of human plasma lipoproteins 
Moiety Location Polar 
Triglyceride C 
Cholesterol S + 
Cholesterol esters C 
Phospholipid S + 
Apolipoprotein® S + 
Sphingomyelin S + 
C = core 
S = surface 
- = less polar 
+ = more polar 
®(10 or more) 
Zech et al., 1986. 
lipoprotein classes showed that in the absence of active LCAT 
there was a substantial transfer of free cholesterol from LDL 
to HDL and a small transfer of cholesteryl esters in the 
opposite direction. The loss of free cholesterol was immediate 
in all three lipoproteins and the presence of LCAT was more 
prominent in LDL and was proportional to the newly synthesized 
cholesteryl esters incorporated in each fraction (Knipping et 
al., 1987). It is hypothesized that cholesteryl esters formed 
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in HDL by LCAT mediate the return of cholesterol from 
extrahepatic tissues to the liver for excretion and 
reutilization (Goldberg et al., 1991). 
The circulating concentrations of plasma HDL may be an 
important determinant of plasma cholesteryl ester transfer 
activity, through the function of HDL-deprived lipids transfer 
inhibitor protein (Tollefson et al., 1988). LCAT is the enzyme 
that catalyzes the esterification of free cholesterol in 
plasma lipoproteins (Bujo and Saito, 1993). Investigation of 
the mechanism for the regulation of cholesterol esterification 
by LCAT in pig plasma showed that reaction with 
phosphatidylcholine small unilamellar vesicles, cholesterol, 
water, diacylglycerol, and lysophosphatidylcholine were all 
potent acceptors of acyl group cleaved from the sn-2 position 
of egg phosphatidylcholine, generating cholesteryl ester, free 
fatty acid, triglyceride, and phosphatidylcholine, 
respectively (Czarneck and Yokoyama, 1993) . LCAT activity was 
positively correlated with plasma total cholesterol in the 
normocholesterolemic pigs, whereas it was negatively 
correlated in the hypercholesterolemic group (Lacko et al., 
1992) . 
In a rabbit model, dietary cholesterol downregulates 
hepatic LDL receptor and treatment with 3-hydroxy-3-
methylglutaryl coenzyme A (HMG CoA, 1.1.1.34) reductase 
inhibitors partly restored the expression (Roach et al.. 
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1993). The HMG CoA reductase reaction is a rate-limiting step 
in cholesterol biosynthesis (Black et al., 1988). Three 
components involved in cholesterol homeostasis, the B/E (LDL) 
receptor, HMG CoA reductase and acyl-coenzyme A: cholesterol 
acyltransferase activity (ACAT, EC 2.3.1.26) were 
characterized in the livers of hypercholesterolemia-resistant 
rabbits. Resistant rabbits manifested several quantitative 
differences in cholesterol metabolism and regulation (Loose-
Mitchell et al., 1991). 
In piglets fed sow milk or infant formula with or without 
addition of cholesterol, liver total cholesterol, cholesteryl 
esters, biliary bile acids, and phospholipid concentrations 
were higher and liver HMG CoA reductase activity and plasma 
lithosterol:cholesterol ratio were significantly lower in 
piglets fed the infant formula with cholesterol than in 
piglets fed the infant formula without cholesterol (Rioux and 
Innis, 1993) . 
In cholesterolemia-resistant rabbits, less dietary 
cholesterol was absorbed and it appeared that a major 
mechanism controlling plasma cholesterol concentrations 
involved the rate of cholesterol conversion to bile acids 
(Overturf et al., 1990). New Zealand White rabbits resistant 
to hypercholesterolemia excreted more lithocholic and 
deoxycholic acid than cholesterol-fed normal rabbits. A higher 
than normal 7 alpha-hydroxylase activity and cholesterol 7 
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alpha-hydroxylase mRNA was observed in livers from the 
resistant rabbits versus normal rabbits (Poorman et al., 
1993) . A decrease in the activity of 7 alpha-hydroxylase, the 
rate limiting enzyme in the catabolism of cholesterol to bile 
acids, resulted in increased biliary cholesterol concentration 
and supersaturation of bile. Ascorbic acid affects the rate-
limiting step in the catabolism of cholesterol in guinea pigs 
and many h\aman groups have the risk for cholesterol gallstones 
that are associated with decreased ascorbic levels (Simon, 
1993) . 
The description of a typical three pool system of 
cholesterol dynamics in mammals is shown in Figure 5. The 
system contains plasma, liver, small intestines and 
erythrocytes in pool 1 where rapid equilibration of 
cholesterol occurred between tissues after administration of 
isotopically labelled cholesterol (Boyd, 1975). In pool 2, 
slower equilibration of cholesterol than in pool 1 occurred 
between plasma and tissues such as cardiac and skeletal 
muscles. The slowest equilibration of cholesterol occurred in 
pool 3 which contains tissues such as brain and nerve and 
others (Boyd, 1975). 
The interrelationship between liver, small intestines, 
plasma and extrahepatic tissues regarding cholesterol 
exchanges is shown in Figure 6. Liver and small intestines 
have the ability to synthesize cholesterol from precursors 
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Pool 2 Pool 1 Pool 3 
Plasma 
ay 
Liver 
Diet KFecal 
Excretion 
Figure 5. Three pool system of cholesterol dynamics in 
mammals: pool 1, plasma, liver, small intestine, 
erythrocytes; pool 2, cardiac and skeletal muscles; 
pool 3, brain and nerves; 1 = rate of synthesis 
in liver; 2 = rate of synthesis in small intestine; 
3 = rate of transference from liver to plasma; 4 = 
rate of transference from plasma to liver; 5 = rate 
of transference from liver to small intestine via 
bile duct; 6 = rate of conversion to bile acids in 
liver; 7 = rate of addition from the diet; 8 = rate 
of absorption from diet; 9 = faecal excretion; 10 = 
rate of transference into pool 1; 11 = rate of 
synthesis from acetate in pool 2; 12 = rate of 
transference from pool 2 to plasma; 13 = rate of 
transference from plasma to pool 3; 14 = rate of 
synthesis of cholesterol in pool 3; 15 = rate of 
transference from pool 3 to plasma (Boyd, 1975). 
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Figure 6. Interrelationship between liver, small intestine, 
plasma and extrahepatic tissues regarding 
cholesterol exchanges. MVA = Mevalonic acid, HMG 
CoA = 3-hydroxy-3-methylglutaryl coenzyme A, VLDL = 
very-low-density lipoprotein, LDL = low-density 
lipoprotein, high-density lipoprotein (Boyd, 1975) 
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such as acetate. Liver is the only known source of enzymes 
involved in the conversion of cholesterol to bile acids (Boyd, 
1975) . 
Hypercholesterolemia and Atherosclerosis 
Cholesterol feeding in rabbits leads to increased 
cholesterol and phospholipid in plasma and erythrocytes 
resulting in an increased cholesterol to phospholipid ratio 
(Kanakaraj and Singh, 1989). Hypercholesterolemia was induced 
by feeding guinea pigs a purified diet containing 15% lard and 
enriched with 0.5% cholesterol (O'Brien and Corrigan, 1988; 
Hadcock et al., 1991), whereas hypercholesterolemia was 
inhibited significantly in pigs consuming baked beans, peas 
and butter beans (Kingman et al., 1993). Hypercholesterolemia 
(mean plasma cholesterol: 15 mM) was induced in rabbits fed a 
chow diet enriched with a low amount (0.25%, w/w) of 
cholesterol (Gross et al., 1991). Hypercholesterolemia 
increased both free and esterified cholesterol in the entire 
aorta of pigs fed a hypercholesterolemic diet (Sassen et al., 
1993) . 
In pigs, hypercholesterolemia was associated with increased 
transport rates of LDL-cholesteryl ester (CE) (165 mumol/h/L) 
and HDL-CE (78 mumol/h/1) and with an increased flux of HDL-CE 
to LDL (78 mumol/h/L) (Terpstra et al., 1993). 
Hypertriglyceridemia and enhanced hypercholesterolemia in 
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rabbits fed coconut oil resulted primarily from increased 
hepatic secretion of VLDL and a modest decrease in VLDL 
triglyceride clearance capacity (Van Heek and Zilversmit, 
1991). Hypercholesterolemia resulted in elevation of plasma 
and tissue endothelin immunoreactivity and abnormal 
acetylcholine-evoked coronary vasoconstriction in 
hypercholesterolemic animals was associated with further 
elevation of plasma endothelin. Endothelin was an early 
participant and marker for endothelivun dysfunction in 
hypercholesterolemia and atherogenesis (Lerman et al., 1993). 
Hyperlipidemia can potentiate the cardiovascular responses 
to adrenergic stimulation and may have some relevance to the 
possible role of mechanism of interaction of hyperlipidemia 
and hypertension in atherogenesis (Kuwahara et al., 1992). In 
rabbits fed a high cholesterol diet, plasma cholesterol 
concentration elevated significantly without macroscopic 
evidence of atherosclerosis after 4 weeks, whereas after 8 
weeks significant development of atherosclerotic lesions was 
present in the thoracic and abdominal aorta (Du and Woodman, 
1992) . High dietary cholesterol caused increased aortic 
intimal-plus-medial thickness (Ludwig et al., 1992). Low-level 
cholesterol-enriched diet (0.1%) was atherogenic, with 
macroscopically detectable lesions of atherosclerosis apparent 
at 12 weeks (Teixeria et al., 1991). 
Combination of feeding a cholesterol/fat dietary regimen 
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and chronic mild endothelial injury in rabbits resulted in a 
diet-induced hypercholesterolemia with LDL as the predominant 
lipoprotein; and lesion within the iliac-femoral artery 
comparable in histologic and chemical composition to h\iman 
fatty streak (Bocan et al., 1991). Short-term diet-induced 
hypercholesterolemia increased the size of myocardial infarcts 
in awake dogs (Sakamoto et al., 1991). 
Atherosclerosis is a complex-multifactorial disease which 
results when there is formation of calcified plaque with 
intermediate events of intimal cell injury, smooth muscle cell 
proliferation and migration, macrophage infiltration, lipid 
accumulation and excess formation of ground substance (Nayler, 
1992) . Atherosclerosis is not merely a disease, but a process 
that is the principal contributor to the pathogenesis of 
myocardial and cerebral infarction, gangrene and loss of 
function of the extremities (Ross, 1993). 
Several calcium-dependent processes are involved in 
atherosclerotic lesion formation; platelet aggregation, 
monocyte adhesion, release of growth factors, cell 
proliferation and migration, protein and collagen secretion 
and synthesis and endothelial necrosis (Nayler and 
Panagiotopoulos, 1993). Macrophage/smooth muscle interactions 
play a role in atherogenesis and foreign body reactions to 
biomaterials (Lam et al., 1992). Diabetes mellitus (plasma 
glucose greater than 16 mM) is a major risk factor for 
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atherosclerosis. In alloxan-induced diabetes in normally fed 
rabbits, endothelial alterations consistent with injury, 
included adhesion of white blood cells, platelets and fibrin­
like material to endothelial surface of aortas after 2 weeks 
(Hadcock et al., 1991). Loss of endothelivim relaxation is one 
of the early steps in atherogenesis (Becker et al., 1991). 
Endothelial cell damage is considered to be the primary event 
in atherogenesis; cholesterol levels have correlated 
significantly with endothelial damage of coronary arteries 
(Pesonen et al., 1987). Selective endothelial dysfunction 
giving rise to abnoonmal coronary artery reactivity preceded 
the onset of coronary artery atherosclerosis during 
hypercholesterolemia (Cohen et al., 1988). 
Lipolytic remnants of triglyceride-rich lipoproteins may 
play an important role in the development of atherosclerosis 
by decreasing the barrier function of vascular endothelivmi 
(Henning et al., 1992). Cholesterol oxidation products 
(oxysterols), cholesten-3-beta, 5 alpha,6 beta-triol (Triol), 
may be atherogenic by altering the barrier function of 
vascular endothelium (Ramasamy et al., 1992). 
Progression of atherosclerotic lesions in coronary arteries 
and abdominal aortas in swine fed hyperlipidemic diet showed 
lesions mainly in the intima cell masses. Lipid-rich calcific 
necrotic debris occupied about 25% of the lesion and lesions 
increased 3-fold in size and cell numbers (Kim et al., 1988). 
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Cholesterol accxunulation in the tunica intima of arteries is a 
characteristic of atherosclerosis. Activation of the 
complement system by cholesterol producing chemotactic 
products for monocytes may provide a mechanism for lipid 
accumulation in arteries (Seifert et al., 1989). Observations 
in animals showed that fatty streaks precede the development 
of intermediate lesions (Ross, 1993). In a rabbit surgical 
model, higher cholesteryl ester influx led to cholesterol 
accumulation in arteries (Hjelms and Stender, 1992) . Positive 
association existed between permeability and accumulation of 
cholesterol in the aortic segment of cholesterol-fed rabbits 
(Nielsen et al., 1992). Enhanced rate of development of 
coronary atherosclerotic during hypercholesterolemia is more 
critically modulated by genetic factors than by absolute 
plasma cholesterol concentration (Sprecher et al., 1987). 
Lesion development in the aorta of cholesterol-lard fed swine 
correlated with foam cell accumulation (Cupp et al., 1987). 
Atherosclerotic lesions comparable in composition to human 
fatty streaks were induced in the iliac-femoral artery of 
hypercholesterolemic New Zealand White rabbits by chronic 
endothelial denudation (Bocan et al., 1991). Watanabe 
heritable hyperlipidemic (WHHL) rabbits have elevated 
concentrations of plasma cholesterol and develop progressive 
atherosclerosis (Wines et al., 1989). Lipoprotein changes seen 
in male WHHL heterozygous (WHHL-Hh) rabbits during aging were 
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similar to those observed in hviman subjects. Pregnancy in 
WHHL-Hh rabbits, like in humans, may induce hyperlipidemia, 
which is opposite to effects observed in normal or homozygous 
WHHL rabbits (Esper et al., 1993). Atherosclerotic lesion 
development may be altered indirectly by the regulation of 
plasma cholesterol or indirectly by inhibition of acyl-CoA 
cholesterol 0-acyltransferase within arterial cells (Bocan et 
al., 1993). Evidence suggests that atheroma formed in a short 
period in rabbits fed a cholesterol diet were caused mainly by 
increased LDLl, of large molecular size and foam cells formed 
in humans atheromas were caused by the production of modified 
LDL with peroxidized cholesteryl ester (Kanazawa et al., 
1993) . 
In cholesterol-fed rabbits receiving dietary antioxidants, 
results suggest that abnormalities in endothelium-dependent 
control of vascular tone developed early in atherosclerosis 
and may result from oxidative modification of LDL (Keaney et 
al., 1993). Low-density lipoprotein oxidation and macrophage 
accumulation are both involved in atherogenesis (Aviram and 
Eias, 1993; Kita et al., 1992; Kita et al., 1990). Oxidative 
modification of LDL may represent an initiating event in the 
formation of monocyte-macrophage foam cells, a major cell type 
in fatty streaks and atherosclerotic fibrous plaques (Bocan et 
al., 1992). Oxidation of LDL in atherosclerotic may be involve 
in converting macrophages into cholesterol-laden foam cells 
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(Morgan et al., 1993) . 
Postsecretory modifications of lipoprotein appear to 
influence atherogenesis, and pro- and antioxidative conditions 
can modulate these processes (Mol et al., 1993; Mao et al., 
1991) . Platelet-derived serotonin may contribute to 
thromboembolic complications of atherosclerosis (Weber et al., 
1993). High fat-cholesterol intake could play a causative role 
in matrix dysfunction by altering the synthesis of 
glycoprotein during atherogenesis (Sharma et al., 1993). 
Susceptibility studies of animals to atherosclerosis showed 
that animals with high polyunsaturated to saturated fatty acid 
ratio (mice, 13.0, tree shrews, 9.0, rats, 9.0) were resistant 
to atherosclerosis, whereas animals with low polyunsaturated 
to saturated fatty acid ratio (rabbits, 2.9) were susceptible. 
Polyunsaturated to saturated fatty acid ratio of 4.9 in men, 
pigs, 4.2 and monkeys, 3.7, were between those of the 
resistant and susceptible animals (Chen and Li, 1993). Hepatic 
lipase plays a key role in turnover of atherogenic remnants 
and distribution of HDL particle size subclasses. Rabbits fed 
a cholesterol-enriched diet accumulated potentially 
atherogenic chylomicron remnants and VLDL (Ebert et al., 
1993) . Lipoprotein remnants play an important causal role in 
atherosclerosis under conditions where plasma lipoproteins 
levels are elevated (Nordestgaard and Lewis, 1991). 
Treatment of hypercholesterolemia by diet or by drugs 
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decreased the incidence of coronary heart disease (Katan, 
1992) . Supplementation of swine diet with vitamin D3 increased 
plasma cholesterol levels but decreased arterial damage (Ito 
et al., 1987). Dietary supplementation with evening primrose 
oil in New Zealand White rabbits may be effective in the 
prevention of atherosclerosis (Fragoso and Skinner, 1992) . 
Supplementation of standard rabbit diet with olive oil or 
margarine has led to lower plasma cholesterol acciamulation in 
the thoracic aorta (Hodis et al., 1992). Dietary magnesium 
prevented development of atherosclerosis in cholesterol-fed 
rabbits by inhibiting lipid acciimulation in aortic wall (Ouchi 
et al., 1990). Intervenous injection of polyene 
phosphatidylcholine in rabbits decreased plasma cholesterol 
and increased HDL-cholesterol concentrations and decreased the 
extent of aorta damage (Tarkhovskaia et al., 1992). 
Thermofiltration lowering of plasma cholesterol levels 
resulted in slowing the progression of atherosclerosis (Noruma 
et al., 1989). 
LDL from normal rabbits has acted as antiatherogenic 
lipoprotein (Kanzawa et al., 1991). The antiatherogenic 
properties of HDL are thought to reside in their involvement 
in the reverse cholesterol transport pathway (De Cromp et al,, 
1992) . Skim milk has slowed down the process of cholesterol-
induced atherogenesis (Aggarwal and Kansal, 1992) . Human 
monocyte colony-stimulating factor enhanced excretion of 
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cholesterol from target cells (cholesterol-laden macrophages) 
in arterial walls, reducing the rate of atherogenesis (Yamada 
et al., 1992). Dietary fish oils has exacerbated LDL 
hypercholesterolemia, but not the atherosclerotic process in 
casein-fed rabbit model for atherosclerosis (Adelstein et al., 
1992). Fish oils have attenuated atherosclerosis in 
cholesterol-fed rats, quails, rabbits, pigs and monkeys (Zhu 
and Parmlet, 1990). Dietary fish oils decreased aortic lipid 
deposition in WHHL rabbits, possibly by decreasing plasma 
triglyceride and cholesterol, platelet count and aggregability 
and systolic blood pressure (Lichtenstein and Chobanian, 
1990). In male Yorkshire pigs fed a 2% high-cholesterol diet, 
cod-liver oil delayed the impairment of endothelium-dependent 
relaxations in hypercholesterolemia and atherosclerosis 
(Shimokawa and Vanhoutte, 1988). Dietary grapefruit pectin 
supplementation inhibited hypercholesterolemia and appeared to 
be protective against atherosclerosis (Baekey et al., 1988). 
Unmodified estrogens decreased atherosclerosis without 
damaging the rabbit liver (Skjaerlund, 1992). Moderate 
pharmacological doses of estrogen given to cholesterol-fed 
rabbit for 12 weeks drastically retarded the development of 
arterial lesions (Henriksson et al., 1989). The antioxidant 
action of ferulic acid in gamma-oryzanol in 
hypercholesterolemic New Zealand White rabbits decreased the 
incorporation of oleate into cholesteryl ester by macrophages 
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(Hiramatsu et al., 1990). ACAT inhibitor C-976 in the absence 
of plasma cholesterol lowering drugs has resulted in 
inhibition of atherosclerosis lesion progression and can 
enhance regression (Bocan et al., 1991). Probucol has lowered 
plasma cholesterol in humans and animals. It reduced 
progression of atherosclerosis in LDL receptor-deficient 
Watanabe rabbits (Mao et al., 1991). Probucol slowed the 
progression of atherosclerosis, especially foam cell-rich 
fatty steak lesions (Kita et al., 1991). Probucol has 
decreased oxidative modification of LDL and diminish its 
uptake by macrophages (Faulkner et al., 1993). 
Panax notoginseng saponins may have prevented 
atherosclerosis and inhibited progression of atherosclerotic 
lesions by interfering with proliferation of arterial smooth 
muscle cells (Lin et al., 1993). Abana administration in 
hypercholesterolemic rabbits showed pronounced reduction in 
atherosclerotic involvement of coronary artery (Tiwari et al., 
1993). Regression of plaque was a function of dynamic balance 
among initiation, progression, stabilization and removal of 
plaque constituents (Schwartz et al., 1992). 
Modifications of Cholesterol By Cholesterol Lowering 
Modalities 
Studies have shown that the type of dietary protein can 
influence cholesterol metabolism. Rcibbits fed casein and soy 
protein showed different responses. Rabbits readily developed 
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hypercholesterolemia when fed a casein diet, and substitution 
of the casein diet with a soy protein diet decreased serum 
cholesterol concentration (Terpstra, 1983). Injection of [26-
cholesterol to rabbits fed casein or a soy protein showed 
that the decay in plasma cholesterol specific radioactivity 
decreased much more rapidly in rabbits fed the soy protein 
diet than in rabbits fed the casein diet. Increased fecal 
steroid excretion, increased oxidation of cholesterol in the 
liver and decreased secretion of cholesterol pointed to the 
mechanism responsible for the hypocholesterolemic effect in 
rabbits and rats fed soy protein compared with casein (Sugano, 
1983). In cholesterol-fed rats, soybean protein diet decreased 
plasma cholesterol when compared with a casein diet (Chizuko 
et al., 1983) . 
Lipid-lowering drugs may have affected the kinetics and 
transport of cholesterol. Reverse cholesterol transport which 
includes transport to the liver, represents the movement of 
cholesterol out of cells and regulating flux of sterol through 
membranes. Probucol is believed to act in lowering cholesterol 
as a primary antioxidant, whereas neomycin is thought of as 
complexing bile acid in the gut similar to cholestyramine 
(Schroeder et al., 1991). In rabbits fed a 0.5% cholesterol-
rich diet supplemented with 1% probucol, an inhibitor of LDL 
oxidation, prevented increase in lipid peroxides (Simon et 
al., 1993). Intravenous administration of cyclodextrins to 
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rats decreased plasma cholesterol level in a dose-dependent 
manner (Frijlink et al., 1991). Lifibrol modified lipid 
metabolism in atherosclerotic aortae from swine and WHHL 
rabbits during incubation has implications to extend its 
ability beyond its confirmed plasma cholesterol-lowering 
activity (Bell, 1993). Etofibrate treatment of rabbits fed a 
0.1% cholesterol diet markedly decreased total cholesterol and 
LDL-cholesterol and decreased copper-induced lipid peroxide 
formation (Wulfroth et al., 1992). 
In cholesterol-fed rabbits, lovastatin, a HMG CoA reductase 
inhibitor, the observed hypocholesterolemic effect was 
associated with decreased cholesterol absorption from the 
intestinal tract (Nielsen et al., 1993). In New Zealand White 
rabbits fed a cholesterol diet with pravastatin and 
simvastatin, plasma cholesterol decreased by 55%, liver 
membrane cholesterol by 29% and bile cholesterol saturation by 
23%, liver and mononuclear cell LDL receptor activities 
increased by 120% and 77%, respectively in pravastatin-treated 
rabbits. In the simvastatin-treated rabbits, plasma 
cholesterol decreased by 74%, liver membrane cholesterol by 
24% and bile cholesterol saturation by 38%, liver and 
mononuclear cell LDL receptor activities increased by 80% and 
62%, respectively (Roach et al., 1993). 
In normocholesterolemic rabbits fed food supplemented with 
20 mg/kg body weight of pravastain, lovastatin, simvastatin 
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and fluvastatin for two weeks showed no modification in rabbit 
plasma cholesterol concentrations (Soma et al., 1993). 
Lovastatin and simvastatin lowered levels of plasma 
cholesterol in rats, dogs and rabbits by inhibition of 
cholesterol synthesis and induction of LDL receptor in liver 
cells (Choa et al., 1991). Administration of CS-514, an 
inhibitor of HMG CoA reductase, with and without 
cholestyramine to heterozygous WHHL rabbits, showed that CS-
514 alone lowered plasma LDL cholesterol by 50%, and in 
combination with cholestyramine, lowered plasma LDL by 80% 
(Kume et al., 1989). 
In testosterone-treated, cholesterol-fed, castrated male 
rabbits, aortic cholesterol content was lower than in the 
placebo group (Larsen et al., 1993). Intravenous injections of 
recombinant human monocyte colony-stimulating factor (rh-MCSF) 
in LDL receptor-deficient WHHL rabbits showed decreased plasma 
total cholesterol levels with decreased lipoproteins 
containing apo B 100, VLDL, intermediate-density lipoprotein 
(IDL), and LDL (Shimano et al., 1990). Acarbose, a complex 
oligosaccharide of microbial origin, added to an atherogenic 
diet and fed to New Zealand White rabbits decreased plasma 
cholesterol, IDL, and LDL (Kritchevsky et al., 1990). 
Ethylenediamine tetraacetic acid (EDTA) supplemented at 3 
g/day to a 0.1% cholesterol diet fed to New Zealand White 
rabbits lowered hepatic cholesterol concentrations (Uhl et 
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al., 1992). Saponins inhibited cholesterol absorption and 
decreased plasma cholesterol levels in experimental animals 
(Long et al., 1993). In hypercholesterolemic rabbits 
extracorporeal circuits containing enzymes modified 
lipoproteins and decreased plasma cholesterol concentration 
(Shefer et al., 1993; Labeque et al., 1993). 
Cholesterol and its esters are associated with milk fat 
globules (Long et al., 1990), and have been found in free fat, 
bound to lipoprotein of fat globules and in cholesterol esters 
(Lacroix et al., 1973). Cholesterol in milk may be derived 
from blood or from de novo synthesis from acetate in the 
mammary gland (Long et al., 1990). The effect of dietary 
cholesterol on cardiovascular disease and atherosclerosis is 
still a great health concern and probably has contributed to 
the reduction in milkfat consvunption (Xiansheng et al., 1990). 
Food with significant levels of lipid oxidation or lipid 
degradation products can be defined as 'problem food'. 
Research on food analysis, absorption by humans and toxicology 
is needed (Addis and Warner, 1992). Investigators have been 
concerned about the conditions that oxidize cholesterol and 
the effect that the oxidized products have on diet and health 
(Cleveland and Harris, 1987). Informed consumers prefer low 
fat products (Schroder and Baer, 1990; Xiansheng et al., 
1990), and product manufacturers need more applicable 
inexpensive methods to decrease excess cholesterol and fat in 
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foods. 
Numerous chemical and physical methods have been employed 
to reduce or eliminate cholesterol in milk. The use of organic 
solvents results in residues in the final product. 
Supercritical fluid extraction, vacuum steam distillation, 
short path distillation, and complexing with cyclodextrins and 
saponins are used also (Kosikowski, 1990; Schroder and Baer, 
1990; Xiansheng et al., 1990; Micich, 1991; Smith et al., 
1991). Enzyme-based processes have been employed in the food 
industry (Gross, 1991; Kosikowski, 1988). 
The chemical/physical methods used to reduce or eliminate 
cholesterol from foods are expensive and non-selective 
removing flavor and nutrient components along with cholesterol 
(Smith et al., 1991). Enzymatic processes have major selective 
advantages: highly selective, operation near room temperature, 
reduce by-product formation and potentially minimize 
regulatory hurdles (Gross, 1991; Smith et al., 1991). 
Studies have suggested that unsaturated dietary sterols 
were hydrogenated by riimen microflora; this was confirmed when 
cholesterol was hydrogenated to coprostanol during anaerobic 
incubation with rumen fluid. Microorganisms capable of 
reducing cholesterol in the intestinal tract are of the genera 
Bifidobacterium, Clostridium and Bacteriodes. Microorganisms 
that hydrogenate cholesterol to coprostanol have been isolated 
from rat ceca, hioman and baboon feces. They are small, gram-
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positive, strictly anaerobic and are assigned tentatively to 
the genus Eubacterium (Dehal et al., 1991). Lactobacillus 
acidophilus RP32 significantly inhibited increase in seriom 
cholesterol levels in pigs fed a high-cholesterol diet 
(Gilliland et al., 1984). Eubacterium 21,408 reduced the 4,5 
double band of allocholesterol to coprostanol (Eyssen et al., 
1973). Hydrogenation of cholesterol by anaerobic incubation 
with rxamen fluid for 20 hours resulted in coprostanol as the 
principal product (Ashes et al., 1978). Results of catalytic 
hydrogenation of cholesterol indicated that coprostanol was 
one of the by-products (Hershberg et al., 1951). 
Streptococcus faecalis KAMI decreased serum cholesterol 
levels in humans with hyperlipidemia as a result of decreased 
LDL-cholesterol. The mechanism of serum lipid reduction in 
rabbits and rats showed that serum cholesterol level was 
decreased by oral administration of Streptococcus faecalis 
KAWI (Suegara et al., 1985). Escherichia coli in human feces 
was found to degrade cholesterol under aerobic and anaerobic 
conditions to form neutral products, cholest-4 en-3-one, 
cholesta-1,4-dien-3-one, androst-4-ene-3,17-dione, and 
androsta-1,4-diene-3,17-dione. Cholesta-1,4-dien-3-one and 
androsta-1,4-diene-3,17-dione were also produced under 
anaerobic condition (Owen et al., 1978). Degradation of 
cholesterol by Pseudomonas species NCIB 10590 showed that the 
major products included cholest-5-en-3-one, cholest-4-en-3-
37 
one, 26-hydroxycholest-4-en-3-one, androst-1,4-dien-3,17-
dione, cholest-4-en-3-one-26-oic acid, chol-4-en-3-one-24-oic 
acid, pregn-4-en-3-one-20-carboxylic acid and pregna-1,4-dien-
3-one-20 carboxylic acid (Owen et al., 1983). Microbial 
hydrogenation of cholesterol to coprostanol may occur by the 
intermediates 4-cholesten-3-one and coprostanone (Eyssen et 
al., 1973). Microbial transformation of cholesterol by cecal 
contents from rats showed that at least 50% of the cholesterol 
converted to coprostanol by means of the intermediate 4-
cholestenone (Bjorkhem and Gustafsson, 1971). In the human 
gut, cholesterol is partially degraded to coprostanol and 
coprostanone and determination of metabolites is complicated 
by the degradation of products from plant sterols (Macdonald 
et al., 1983). Mycobacterium species were magnetically 
immobilized and used for side chain degradation of cholesterol 
into androsta-1,4-dien-3,17-dione (Flygare and Larsson, 1978). 
Demonstrations have shown that bacteria as well as plants 
can metabolize steroids by transformation of their side chains 
and nucleus to produce pharmaceutically active compounds. 
Dehal et al. (1988) showed that cytosolic preparations from 
cucumber leaves contained cholesterol reductase activity 
(Dehal et al., 1989). Further demonstrations showed that 
cholesterol reductase activity was present in alfalfa and 
garden pea leaves (Dehal et al., 1991). Fluorometric assay of 
cholesterol reductase activity in peas leaves {Pisum satiwm) 
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showed when cholesterol is catalytically reduced by 
cholesterol reductase oxidation of NADH occurred (Yang and 
Beitz, 1992) . Results suggested that fluorometric method was 
useful for the accurate determination of cholesterol reductase 
activity in biological specimens. 
Freier (1991) successfully isolated a pure culture of 
Eubacterium coprostanoligenes and it was characterized as a 
small, gram positive, non-spore forming, coccobacillus, and 
cholesterol-reducing anaerobe. Lecithin was required for 
growth, whereas cholesterol was not. Coprostanol is not 
produced when lecithin is replaced by phosphatidylinositol or 
phosphatidylglycerol. E. coprostanoligenes possesses 
phospholipase activity and does not reduce nitrate or produce 
indole. Esculin was hydrolyzed, but starch and gelatin were 
not. E. coprostanoligenes produced much acid by fermentation 
of amygdalin, lactose and salicin (acetic, formic and 
succinic), whereas arabinose, cellobiose, fructose, glucose, 
mannose and melibiose were poorly fermented. Volumes of gases 
produced in the head space of fermentation apparatus showed 
that and CO2 percentages ranged from 4.5 to 7.2 and 0.9 and 
1.8, respectively. The evaluation of the effects of pH on 
coprostanol production by E. coprostanoligenes showed that the 
greatest amounts of coprostanol was formed in media with pH 
values 7.5, 7.2 and 7.0. After incubation, the pH values of 
the media used were 6.4, 6.3, and 6.2, respectively (Freier et 
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al., 1994). 
Fermentation of radiolabelled [4-^H, 4-^^C]-cholesterol with 
E. coprostanoligenes resulted in 90% conversion of cholesterol 
to coprostanol in 5 days. Coprostanol formation by E. 
coprostanoligenes involved the transfer of a hydrogen from C4 
to C5 position. E. coprostanoligenes reduction of radioactive 
coprostanone to coprostanol tend to favor the theory of the 
indirect pathway with the isomerization of a double bond at 
the 4-5 position (Ren, 1991). 
Oral administration of E. coprostanoligenes to New Zealand 
White rabbits fed a 0.05% cholesterol-enriched diet resulted 
in lower (P < 0.001) plasma cholesterol concentration in 
rabbits fed the live bacteria for 10 days when compared with 
rabbits fed the boiled bacteria. Coprostanol/cholesterol 
ratios in the contents of the digestive tracts of rabbits fed 
the live bacteria were greater than those of rabbits fed the 
boiled bacteria (Li et al., 1995) 
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Abstract 
The use of milk to deliver Eubacterium 
coprostanoligenes, a cholesterol-reducing bacteria, to 
decrease plasma cholesterol concentration was investigated in 
hypercholesterolemic rabbits. Eighteen adult male New Zealand 
White rabbits were randomly divided into three groups and fed 
a no cholesterol diet (control) , control diet supplemented 
with 0.1% cholesterol and boiled E. coprostanoligenes in 2% 
minimal fat homogenized milk diet or control diet supplemented 
with 0.1% cholesterol and E. coprostanoligenes in 2% fat 
homogenized milk for 21 days. 
No clinical signs or symptoms of bacterial intoxication 
were observed in any rabbit. There were no significant 
differences in rabbit mean body weight during the different 
feeding periods. There were no significant differences between 
total plasma cholesterol concentration in rabbits fed the 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% fat 
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homogenized milk diet, and a 0.1% cholesterol + E. 
coprostanoligenes in 2% fat homogenized milk. However, changes 
in total plasma cholesterol concentration from day 0-77 in 
rabbits fed the 0.1% cholesterol + E. coprostanoligenes in 2% 
fat homogenized milk diet were significantly lower (P < 0.01) 
than plasma cholesterol concentration in rabbits fed the 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% fat 
homogenized milk diet. Liver enzymes activities and major 
metabolites in plasma were not influenced by the bacterial 
treatments. 
Fecal excretion of cholesterol, coprostanol, sitosterol and 
bile acid in rabbits fed the 0.1% cholesterol + E. 
coprostanoligenes in 2% fat homogenized milk diet were greater 
at day 77 compared with that excreted by rabbits fed the 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% fat 
homogenized milk diet. Fecal bile acid excretion was 1.9 times 
greater (P < 0.05) in rabbits fed the 0.1% cholesterol + live 
E. coprostanoligenes in 2% fat homogenized milk diet. 
Fecal coprostanol/cholesterol ratio of rabbits fed the 0.1% 
cholesterol + live E. coprostanoligenes in 2% fat homogenized 
milk diet at day 77 was greater 1.7 times greater than that of 
rabbits fed the 0.1% cholesterol + boiled E. coprostanoligenes 
in 2% fat homogenized milk diet. In s\immary oral 
administration of E. coprostanoligenes via milk decreased 
plasma cholesterol conversion of intestinal cholesterol to 
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coprostanol and increased excretion of cholesterol, 
coprostanol and bile acids. Therefore, milk may be used as 
food to deliver a hypocholesterolemic microbe to people. 
(Supported in part by Anderson Erickson Dairy Company, Iowa 
Dairy Products Association, and the Center for Redesigning 
Foods to Improve Nutrition) . 
INTRODUCTION 
Studies have demonstrated a causal association between 
seriom cholesterol concentration, dietary fat, and coronary 
heart disease, and it is believed that the risk of coronary 
heart disease should be reduced substantially when serum 
cholesterol concentration is lowered (1). Cholesterol content 
of animal-derived foods is a primary piiblic concern as there 
is considerable amount of evidence that suggest that plasma 
cholesterol plays an important role in the development of 
atherosclerosis and coronary heart disease. 
Cholesterol is required for several important biological 
functions in animals, including humans; precursor for 
biosynthesis of bile acids, corticosteroids, sex hoinnones and 
structure and function of membranes (2). 
Recent investigations have shown that stearic acid failed 
to increase LDL-cholesterol concentration in plasma, whereas 
oleic acid was as effective as linoleic acid in lowering 
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plasma LDL-cholesterol when substituted for palmitic acid (3). 
In a study conducted on the output of bile and biliary 
components (biliary salts, phospholipids and cholesterol) 
during the first hour after bile duct catheterization in rats, 
it was found that feeding a commercial diet or semi-purified 
diets containing 7 or 20 parts/100 of corn oil or 20 parts/100 
of lard or mutton tallow, the output of cholesterol was 
augmented when the percentage of corn oil was increased from 7 
to 20 parts/100 (4). 
In studies conducted on the effect of a bean diet on 
biliary lipid secretion, serum cholesterol concentration, and 
hepatic cholesterol metabolism in rats, the results showed 
increased output of biliary cholesterol and biliary 
phospholipid, whereas biliary flow and biliary salts output 
remained in the normal range. Total serum and very-low-density 
lipoprotein (VLDL) cholesterol concentrations decreased 
significantly (27% and 50%), whereas hepatic cholesterogenesis 
increased 170% in the bean fed animals. Newly synthesized 
cholesterol contribution to total biliary cholesterol 
increased by 200% and was preferentially channelled to the 
biliary cholesterol secretion in these rats (5). 
Lipid lowering drugs may affect the kinetics and transport 
of cholesterol. Probucol is concluded to act in lowering 
cholesterol as a primary antioxidant, whereas neomycin is 
thought to complex bile acids in the gut in a manner similar 
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to cholestyramine (6) In a study of the relationship between 
rates of hepatic sterol synthesis and rates of hepatic low-
density lipoprotein (LDL) uptake (clearance) in animals with 
high (rats), low (female hamsters) and very low (male 
hamsters) basal rates of hepatic sterol synthesis, it was 
found that in rats and female hamsters fed cholesterol or 
cholestyramine, rates of hepatic sterol synthesis varied over 
110-fold range, whereas rates of hepatic LDL clearance and 
plasma LDL-cholesterol concentrations remained unchanged. In 
male hamsters cholestyramine feeding increased rates of 
hepatic LDL uptake by 2.5-fold and was associated with a 50% 
reduction in plasma LDL-cholesterol concentrations (7). 
Swine have been used as model in several research studies 
related to human problems (diseases) because of their 
similarities to hiiman in cardiac and vascular anatomy, 
ventricular performance, electrophysiology and coronary artery 
distribution which should result in transition from research 
to clinical application (8). The nutrient requirements of the 
pig resembles that of human more than any other nonprimate 
mammalian species due the physiological and anatomical 
similarity of their digestive tract which provide the basis 
for use in human nutritional studies (9). 
In swine fed soy and beef diets, although there was no 
significant difference in plasma cholesterol concentrations, 
there was increased proportion of fat in carcass and increased 
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cholesterol deposition in tissue (10) . In hypercholesterolemic 
pig fed baked beans at 300 g/kg diet, plasma cholesterol 
decreased by 36.5%, whereas low-density-lipoprotein-
cholesterol decreased by 48% (11) . 
In rviminants, several studies suggested that unsaturated 
dietary sterols were hydrogenated by r\amen microflora. This 
suggestion was confirmed when cholesterol was hydrogenated to 
coprostanol during anaerobic incubation with sheep rumen fluid 
for 20 hours (12). Several studies have suggested that dietary 
administered microorganisms influenced plasma cholesterol 
concentration. Lactobacillus acidophilus RP32 significantly 
inhibited increase in serum cholesterol in pigs fed high-
cholesterol diet (13). 
Demonstrations have shown that bacteria as well as plants 
can metabolize steroids by transformation of their side chains 
and steroid nuclei to produce pharmaceutically active steroid 
compounds. Dehal et al. (1988) showed that cytosolic 
preparations from cucumber leaves contained cholesterol 
reductase activity (1). Further demonstrations showed that 
cholesterol reductase activity was also present in alfalfa and 
in garden pea leaves (17). 
Eubacterium 21,408 reduced the 4,5 double band of 
allocholesterol to coprostanol (14). It was found that 
Streptococcus faecalis KAWI decreased serum cholesterol levels 
in human with hyperlipidemia and serum cholesterol levels in 
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rabbits and rats by oral administration (15). Microbial 
transformation of cholesterol by cecal contents from rats 
showed that at least 50% of the cholesterol was converted to 
coprostanol (16). The conversion of cholesterol to coprostanol 
was observed also in rats after intervenous injections of an 
alfalfa cholesterol reductase (1). 
Freier (1991) successfully isolated a pure culture of E. 
coprostanoligenes and it was characterized as a small, gram 
positive, nonspore foinning, coccobacillus and cholesterol-
reducing anaerobe. Lecithin is required for growth, whereas 
cholesterol is not. Coprostanol is not produced when lecithin 
is replaced by phosphatidylinositol or phosphatidylglycerol. 
E. coprostanoligenes possesses phospholipase activity and does 
not reduce nitrate or produce indole. Esculin is hydrolyzed, 
but starch and gelatin is not. E. coprostanoligenes produces 
acids (acetic, formic and succinic) by fermentation of 
amygdalin, lactose and salicin, whereas arabinose, cellobiose, 
fructose, glucose, mannose and melibiose are poorly fermented. 
Percentages of H2 and CO2 in the head space during growth 
ranged from 4.5 to 7.2 and 0.9 to 1.8, respectively. 
Evaluation of the effects of pH on coprostanol production by 
E. coprostanoligenes showed that greater amounts of 
coprostanol were formed in media with pH values of 7.5, 7.2, 
and 7.0. After fermentation pH values of the media used were 
6.4, 6.3, and 6.2, respectively (18,19). 
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Fermentation of radiolabelled [4-^H, 4-"c]-cholesterol with 
E. coprostanoligenes resulted in 90% conversion of cholesterol 
to coprostanol in 5 days. Coprostanol formation by E. 
coprostanoligenes involved the transfer of a hydrogen from C4 
to C5 position. E. coprostanoligenes reduction of radioactive 
coprostanone to coprostanol tend to favor the theory of the 
indirect pathway with the isomerization of a double bond at 
the 4-5 position (20). 
Oral administration of E. coprostanoligenes to New Zealand 
White rabbits fed a 0.05% cholesterol-enriched diet resulted 
in lower (P < 0.001) plasma cholesterol concentration in 
rabbits fed the live bacteria for 10 days when compared with 
rabbits fed the boiled bacteria. Coprostanol/cholesterol 
ratios in the contents of the digestive tracts of rabbits fed 
the live bacteria were greater than those of rabbits fed the 
boiled bacteria (21). 
The study was undertaken to investigate the ability of E. 
coprostanoligenes to decrease plasma cholesterol concentration 
in hypercholesterolemic rabbit as a model for human 
hypercholesterolemia. The hypothesis of the study is that 
orally administered E. coprostanoligenes will convert dietary 
and endogenous cholesterol in the small intestine to 
coprostanol which is a poorly absorbed sterol (2), and 
increased excretion of total fecal steroids. It is further 
hypothesized that increased excretion of fecal steroids will 
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decrease plasma cholesterol concentrations. 
The specific objectives of the study were; to feed a 
cholesterol-enriched diet to make the rabbits 
hypercholesterolemic and to evaluate the effects of dietary 
administered Eubacterium coprostanoligenes on (a) rabbit 
plasma cholesterol concentration (b) rabbit health and c) 
fecal coprostanol to cholesterol ratios. 
MATERIALS AND METHODS 
Animals and diets 
Eighteen (12 weeks old, 3 kg body weight) New Zealand White 
male adult rabbits (Laboratory Animal Resources, College of 
Veterinary Medicine, Iowa State University) were used in this 
experiment. The rabbits were housed and fed separately. 
Fourteen rabbits were randomly selected and fed a commercial 
chow with cholesterol (Sigma Chemical Co., St. Louis, MO) 
added at 0.1% on dry-matter basis. The remaining 4 rabbits 
were fed the commercial chow without cholesterol (control: 
Group 1). Plasma cholesterol was monitored weekly in the 
cholesterol-fed rabbits until hypercholesterolemia was 
maintained. The rabbits were then randomly assigned to two 
treatment groups as follows: Group 2 = Cholesterol + boiled E. 
coprostanoligenes in 2% fat milk, N = 6 and group 3 = 
Cholesterol + E. coprostanoligenes in 2% fat milk, N = 8. 
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Rabbits were maintained on the commercial chow or on the 0.1% 
cholesterol-enriched diet for 21 days before feeding the E. 
coprostanoligenes-containing diets. 
Preparation of bacterial culture 
E. coprostanoligenes ATCC 5122 was grown anaerobicaliy in 
liquid media composed of 0.2% cholesterol, 0.1% lecithin, 0.5% 
sodium thioglycollate (Sigma Chemical Co., St. Louis, MO), 1% 
casitone, 1% yeast extract (Difco Laboratories, Detroit, MI), 
and 0.1% calciiim chloride (Fisher Scientific, Fair Lawn, NJ) . 
Resazurin was added at 0.4% as an indicator for the presence 
of oxygen. The components were blended and the pH of the media 
adjusted to 7.2. The media were transferred to 400 ml boiling 
flasks and boiled for 30 minutes under a steady stream of 
argon gas until the color changed to yellow. The flasks were 
cooled to room temperature in an ice-bath, stoppered, then 
autoclaved at 121° C for 45 minutes. 
Each flask was inoculated with a 4 ml aliquot of a 48 hour 
anaerobically-grown stock bacterial culture by using the 
Hungate technique (22) and incubated at 37° C for 48 hours. A 
1 ml aliquot of each culture was removed from each flask for 
bacterial protein determination by using the Bradford method 
(23). The bacterial pellets then were harvested in preweighed 
200 ml centrifuge bottles in a Sorvall^ RC2-B refrigerated 
centrifuge at 7,500 rpm for 10 minutes. The weights of the 
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bacterial pellets were calculated for the experimental 
feeding. A 2% homogenized lowfat milk (Anderson Erickson Dairy 
Co.) was used to deliver a 5 ml dose containing of 1.64 g of 
Eubacterium coprostanoligenes to the rabbits once daily. Water 
was provided ad libitum. 
Experimental protocol 
The test diets were fed for 21 days. Blood, fecal samples 
and body weights were taken weekly. Bacterial feeding was 
initiated on day 28 and ended on day 49. Feeding of the 0.1% 
cholesterol-enriched diet was continued without the bacteria 
for 28 days to observe if there was any carryover effect of 
feeding the bacteria. The regular commercial chow was then fed 
for 31 days followed by the 0.1% cholesterol-enriched diet for 
an additional 29 days. The rabbits were examined daily for 
clinical signs and symptoms of bacterial intoxication, 
including anorexia, lethargy and diarrhea. The feeding regimen 
used in the experiment is shown in Table 1. 
Analysis of blood samples 
Blood samples were collected (using 6 ml syringes via the 
central ear artery) into polystyrene tubes containing EDTA as 
anticoagulant. All samples were centrifuged in a Sorvall^ RC2-
B refrigerated centrifuge at 1,500 rpm for 10 minutes. Plasma 
was transferred using individual pasteur pipet to individual 2 
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Table 1. Diets fed to each group of rabbits during different 
feeding periods of the experiment 
Diets 
Periods 
(days) Group 1 Group 2 Group 3 
0-28 No cholesterol 0.1% cholesterol 0.1% cholesterol 
28-49 No cholesterol 0.1% cholesterol 
+ boiled bacteria 
in 2% fat milk 
0.1% cholesterol 
live bacteria 
in 2% fat milk 
49-77 No cholesterol 0.1% cholesterol 0.1% cholesterol 
77-108 No cholesterol No cholesterol No cholesterol 
108-137 No cholesterol 0.1% cholesterol 0.1% cholesterol 
ml tubes and stored at -20° C until analysis of cholesterol 
concentrations, liver enzyme activities and major metabolite 
concentrations. Plasma cholesterol was quantified by an 
enzymatic method (Cholesterol 100, Sigma Chemical Co., St. 
Louis, MO). Enzyme activities (glutamic oxaloacetic 
transaminase (GOT), gamma pyruvic transaminase (GPT), lactic 
dehydrogenase (LDH) and alkaline phosphatase (ALP)) and major 
metabolites (bilirubin, uric acid and total protein) 
concentrations were determined (Roche Chemicals, Kansas, MO). 
Analysis of fecal cholesterol, coprostanol and bile acids 
Fecal samples collected at the time of blood collection 
were frozen at -80° C until analysis of excretory 
coprostanol/cholesterol concentration ratios. Each fecal 
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sample was crushed with mortar and pestle then homogenized. 
Duplicate 0.5 grams of each sample were weighed into 
corresponding labelled 20 ml extraction tubes. Extraction of 
cholesterol and coprostanol from each sample was performed by 
the addition of 2 ml of methanol-benzene (4:1, v/v) and 200 |il 
of acetylchloride to each sample tube and capped tightly. All 
tubes were then placed on a heatblock set at 100° C +/- 3® C 
for 1 hour, then tubes were removed from the heatblock and 
allowed to cool to room temperature. Five ml of a 6% K2CO3 
solution and 2 ml of benzene were added to each sample tube 
which then was vortexed at for 60 seconds. All tubes were 
centrifuged at 2,000 rpm for 20 minutes. The top (benzene) 
layer of each sample extract was transferred quantitatively 
with individual pasteur pipet to a silanized vial (24). All 
samples were concentrated to dryness under a stream of 
nitrogen gas in a heated block at set at 65® C. All samples 
were flushed with nitrogen gas, capped and stored at -20° C 
until gas chromatographic (GC) analysis was performed. 
Each sample extract was dissolved in 200 Hi of chloroform 
and vortexed for 30 seconds. Twenty |il of each sample extract 
was transferred to a new silanized vial and 1 |ig of cholestane 
added as internal standard to one of the duplicates of each 
sample extract. Then, all samples were concentrated to dryness 
in a pre-heated block at 65° C under nitrogen gas. A standard 
mixture of 1.0 |ig of cholestane, coprostanol, cholesterol and 
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4-cholesten-3-one in chloroform, and another mixture of S-
sitosterol, stigmasterol, cholic acid, lithocholic acid, 
deoxycholic acid and chenodeoxycholic acid were prepared with 
and without 20 |J,1 of a control rabbit sample extract. 
Each sample was derivatized to trimethylsilyl ethers by the 
addition of 100 p,l of 1,3 bis-trimethylsilyl trifluroacetamide 
in 1% trimethylchlorosilane and 100 ^il of silylation grade 
acetonitrile (Pierce, Rockford, IL) and vortexed for 15 
seconds. All capped vials were return to the pre-heated block 
at 65° C and allowed to derivatize for 1 hour. Each sample 
extract was transferred quantitatively to 200 jil inserts in 
vials for GC analysis (25,26,27). Each derivatized sample was 
in 200 |il volume and an aliquot of 10 |il of each sample 
extract was injected into the GC for analysis of 
concentrations of cholesterol and metabolites. 
Analysis of cholesterol, coprostanol and bile acid 
concentrations in the fecal samples was done on a Hewlett-
Packard 583OA gas chromatograph equipped with a flame 
ionization detector. Col\unn temperature was set at 280° C, 
injector at 290° C, detector at 290° C and maximal oven 
temperature at 300° C. Separation of cholesterol and 
coprostanol and bile acid as trimethylsilyl ether derivatives 
occurred on a 0.9 M, 0.64 mm ID glass column packed with 3% 
SP-2250 on 100/120 Supelcoport (Supelco®^, Bellfonte, PA) . 
Carrier gas was nitrogen with flow rate at 60 ml/min, air at 
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240 ml/min and hydrogen at 60 ml/min. The detector was 
equipped with an integrator and slope sensitivity was set 0.5 
and paper speed at 0.7 cm/min. 
Quantitation of cholesterol, coprostanol and bile acid was 
done by calculating the peak area of each metabolite in each 
sample extract corresponding to the retention time of each 
standard in the control sample extract and comparing the ratio 
of peak area of each metabolite in each sample to the 
respective standards in the control sample. 
Statistical analysis 
The data were analyzed by using the SAS System software 
with application of the Repeated Measures Analysis and 
utilizing Analysis of Variance and General Linear Model 
procedures. Means showing significant differences were 
indicated by using Duncan's Multiple Range Test. Significance 
was based on probability value at P< 0.05. Body weights were 
analyzed at different periods of the experiment corresponding 
to the feeding regimen. Plasma data were analyzed for total 
plasma and change in plasma cholesterol concentrations at 
different periods and days of the experiment. Plasma liver 
enzyme activities and major metabolites and fecal cholesterol, 
coprostanol, bile acids and fi-sitosterol concentrations were 
analyzed at specific days of the experiment. 
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RESULTS AND DISCUSSION 
All rabbits were fed first with a commercial chow at 140 
g/day before the start of the feeding of the 0.1% cholesterol-
enriched diet. Each treated rabbit received an oral daily 5 ml 
volxime dose of 2% homogenized lowfat milk with 1.64 g 
bacterial pellet containing 154.99 mg bacterial protein/ml. 
There were no clinical signs or symptoms suggestive of effects 
of the cholesterol-reducing bacteria observed in any rabbit 
during the experiment. 
No significant differences were observed in mean body 
weight in rabbits at the start of the experiment (P< 0.05) as 
all animals received the same commercial chow ration prior to 
the start of the study. Results of body weight observed in 
rabbits during the different feeding periods of the experiment 
are shown in Table 2. Rabbits in the group 1 fed the no 
cholesterol diet (control) had higher mean body weight than 
the rabbits in the group 2 fed the 0.1% cholesterol + boiled 
E. coprostanoligenes and group 3 0.1% cholesterol + live E. 
coprostanoligenes diets, but no significant differences were 
observed in rabbit mean body weight for any period during 
experiment (P> 0.05). Mean body weight in control rabbits 
between days 108-137 was higher than that of the treated 
rabbits fed the 0.1% cholesterol-enriched diet but were not 
significantly different (P< 0.05)(Table 2). 
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Table 2. Body weight of rabbits fed a commercial chow 
followed by a 0.1% cholesterol-enriched diet and 
Eubacterimi coprostanoligenes in 2% fat milk for 
21 days. 
Body Weight® (kg) 
Periods of Experiment (days) 
Groups 0-28 28-49 49-77 108-137 
1 3.9'' 
±.3 
4.0" 
±.3 
4.0" 
±.3 
4.2" 
±.3 
2 3.8'' 
±.2 
3.9" 
±.2 
3.8" 
±.3 
3.7= 
±.3 
3 3.8'' 
±.2 
3.8" 
±.2 
3.8" 
±.3 
3.8= 
±.2 
Significance 
Level 
TRT .458 .264 .355 .069 
DAY .247 .006 .005 .0001 
TRT*DAY .0003 .525 .625 .568 
^Values represent means and standard errors of body weight per 
group of rabbits corresponding to days of experiment. 
°"°Means in the same column with the same superscript are not 
significantly different (P < 0.05) 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched diet was 
continued until day 77. Regular chow was fed from day 78 to 
day 108, which was then followed by 0.1% cholesterol diet from 
day 108 to day 137. 
Groups: 1 = No cholesterol (control), N = 4; 2 = 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% fat milk, N = 
6; 3 = 0.1% cholesterol + E. coprostanoligenes in 2% fat milk, 
N = 8. 
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The results of analysis of total plasma cholesterol 
concentrations are shown in Table 3. The mean total plasma 
cholesterol concentration of rabbits in group 3 fed the live 
bacteria (130.0 ± 11 SE mg/dl) was similar to that of rabbits 
in group 2 fed the boiled bacteria (130.9 ± 13 SE mg/dl) at 
the beginning of the bacterial feeding (day 28) . Lower total 
plasma cholesterol concentrations were observed in rabbits in 
group 3 fed the live E. coprostanoligenes (158.5 ± 13.9 SE 
mg/dl) at day 35 (7 days after initiation of the feeding) when 
compared with that in rabbits in group 3 fed the boiled E. 
coprostanoligenes (171.3 ± 12.5 SE mg/dl) (Table 3) (Figure 1), 
but were not different (P < 0.05). 
Changes in plasma cholesterol concentrations at day 7 of 
the bacterial feeding in rabbits were different at P< 0.13 
(Table 4). The greatest differences in plasma cholesterol 
concentrations were observed at days 49 and 56 and day 77 
(Table 3). Differences in total plasma cholesterol 
concentrations were observed through out the bacterial feeding 
(day 28-49) but were not statistically significant (P< 0.05) 
(Table 3). No significant differences (P< 0.05) were observed 
in total plasma and changes in plasma cholesterol 
concentration in rabbits group 3 fed the live E. 
coprostanoligenes in the 2% fat milk and in rabbits in group 2 
fed the boiled E. coprostanoligenes in the 2% fat milk during 
periods days 0-28, 35-49, 56-77 (Table 3 and Table 4). 
250 — Pretreat Fed Bacteria Fed No Bacteria Fed No Cholesterol 
Fed Cholesterol 
»200 
100 No cho esterol (control) 
Choles erol + Eubacterium 
in 2% rhilk 
Cholesterol + Boiled 
Eubacterium in 2% milk 
m o> 
Time of Experiment (days) 
CO (O CO in CO o 00 in CO 
Figure 1. Effects of orally acSministrated Eubactsrium coprostanoligenes on plasma 
cholesterol concentrations in hypercholesterolemic rabbits. All rabbits 
except control received a 0.1% cholesterol-enriched diet before being 
assigned to each group at day 0. A 2% fat milk (5 ml) was used to deliver 
the bacteria. Each data point represents the group average of triplicate 
assays of plasma samples from each rabbit; Group 1 = No cholesterol 
(control), N = 4; group 2 = Cholesterol + boiled Eubacterium in 2% milk, N = 
6; group 3 = Cholesterol + Eubacterium in 2% milk, N = 8. Eubacterium was 
fed from day 28-49. The 0.1% cholesterol-enriched diet was fed until day 77, 
regular chow, day 78-108, and 0.1% cholesterol-enriched diet, day 109-137. 
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Table 3. Plasma cholesterol concentrations of rabbits fed a 
commercial chow followed by a 0.1% cholesterol-
enriched diet and Euhacterium coprostanoligenes in 
2% fat milk for 21 days 
Total Plasma Cholesterol Concentrations® (mg/lOO ml) 
Days of Experiment 
Groups 0 7 14 28 35 42 49 56 63 70 77 
1 20^ 21^ 17b le'' IS'' 17b 15b le'' 19b 18^ I7I 
±2 ±2 ±1 ±2 ±1 ±.7 ±1 ±. 6 ±2 ±1 ±1 
2 98= 128= 110= 130= 171= 179= 205= 205= 187= 180= 205' 
±8 + 11 ±8 ±13 ±11 ±13 ±16 ±17 ±14 ±13 ±16 
3 143= 142= 133= 130= 158= 167= 188= 168= 170" 164= 175' 
±14 ±13 ±13 ±11 ±13 ±12 ±14 ±13 ±13 ±12 ±14 
Significance 
Level 
TRT - - - .08 .03 .02 .02 .03 .03 .03 .03 
^Values represent means and standard errors of plasma 
cholesterol concentrations of rabbits corresponding to days of 
experiment. 
''""Means in the same column with the same superscript are not 
significantly different (P < 0.05). 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched diet 
continued until day 77. Groups; 1 = No cholesterol (control), 
N = 4; 2 = 0.1% cholesterol + boiled E. coprostanoligenes in 
2% fat milk, N = 6; 3 = 0.1% cholesterol + E. 
coprostanoligenes in 2% fat milk, N = 8. 
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Table 4. Changes in plasma cholesterol concentrations from 
day 28 of rabbits fed a commercial chow followed by 
a 0.1% cholesterol-enriched diet and Eubacterium 
coprostanoligenes in 2% fat milk for 21 days 
Changes in Plasma Cholesterol Concentrations^ (mg/100 ml) 
Days of E3{periment 
Groups 35 42 49 56 63 70 77 
1  l.O'' 0.5^ -1.7" 1.6" 2.7" -0.6" -1.4" 
2 
u
 o 7 .5^ 26.9" -l.l" -17.8" 1 •
 cr
 
25 .3" 
3 28.8^= 7.7" 21.8" -20.1" 1.7" -5.9" 11.5" 
Significance 
Level 
TRT . 13 .78 .23 .26 .89 .03 .19 
^Values represent mean changes from day 28 in plasma 
cholesterol concentrations of rabbits corresponding to days of 
experiment. 
"^'^ Means in the same column with the same superscript are not 
significantly different (P < 0.05)). 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched diet 
continued until day 77. Groups: 1 = No cholesterol (control), 
N = 4; 2 = 0.1% cholesterol + boiled E. coprostanoligenes in 
2% fat milk, N = 6; 3 = 0.1% cholesterol + E. 
coprostanoligenes in 2% fat milk, N = 8. 
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Total plasma cholesterol concentration in rabbits in group 
3 fed the 0.1% cholesterol + E. coprostanoligenes on days 0-77 
and days 28-77 were not significantly different (P < 0.05) 
from that of group 2 fed the 0.1% cholesterol + boiled E. 
coprostanoligenes (Table 5). Changes in plasma cholesterol 
concentrations for days 0-77 were statistically significant 
(P< 0.01) and changes in plasma cholesterol for days 28-77 
were different at P< 0.14 (Table 6)(Figure 2). 
Differences in plasma cholesterol concentrations were 
observed in rabbits in groups 2 and 3 after feeding the 
regular commercial chow followed by the 0.1% cholesterol-
enriched diet. Plasma cholesterol concentrations decreased in 
all groups when fed the commercial chow (days 77 to 108). 
Total plasma cholesterol concentrations in treated rabbits 
increased when the 0.1% cholesterol-enriched diet was fed 
(days 108 to 137) (Figure 1). Total plasma cholesterol 
concentration in rabbits in group 3 fed the 0.1% cholesterol + 
E. coprostanoligenes remained lower than those in the group 2 
fed the 0.1% cholesterol + boiled E. coprostanoligenes, but 
the differences were not statistically significant (P< 0.05) 
(Table 6). 
Results of analysis of plasma biochemical parameters 
evaluated are shown in Table 7. No significant changes (P< 
0.05) were observed in plasma GOT, GPT, LDH and ALP activities 
and bilirubin and uric acid concentrations during the 
bacterial feeding period in rabbits group 3 fed the live or 
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Table 5. Plasma cholesterol concentrations of rabbits fed a 
commercial chow followed by a 0.1% cholesterol-
enriched diet and Eubacterium coprostanoligenes in 
2% fat milk for 21 days 
Total Plasma Cholesterol Concentrations® (mg/100 ml) 
Periods of Experiment (days) 
Groups 0-28 35-49 56-•77 to
 
00
 
-77 0-77 108-137 
1 17.9^ 15 .8^ 17 .7^ 16 .8^ 17.4^ to
 
o
 
U)
 tr 
2 135.3® 185 .3= 194 .0^= 190 .2° 163.4= 140.3= 
3 122.6= 170 .9= 169 .0= 169 .9= 158.0= 115.2= 
Significance 
Level 
TRT .083 .022 028 .14 .035 .144 
DAY .235 .0016 102 .002 .0001 .001 
TRT*DAY .487 .279 
• 
39 .38 .0003 .749 
^Values represent means of plasma cholesterol concentrations 
of rabbits corresponding to days of experiment. 
^"°Means in the same column with the same superscript are not 
significantly different (P < 0.05). 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched continued 
until day 77. Groups: 1 = No cholesterol (control), N = 4; 2 = 
0.1% cholesterol + boiled E. coprostanoligenes in 2% fat milk, 
N = 6; 3 = 0.1% cholesterol + E. coprostanoligenes in 2% fat 
milk, N = 8. 
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Table 6. Changes in plasma cholesterol concentrations during 
different periods of rabbits fed a commercial chow 
followed by a 0.1% cholesterol-enriched diet and 
Eubacterium coprostanoligenes in 2% fat milk for 21 
days 
Changes in Plasma Cholesterol Concentrations® (mg/100 ml) 
Periods of Experiment (Days) 
Groups 0-28 35-49 56-77 28-77 0-77 108-137 
1 -1.6^ 0.1^ 0.6^ 0.3^ -.28'' 9.6^ 
2 11.0^ 24.9^= -.2^ 10.6= 10.69= 5.2^ 
3 4.2'' 19.3^ -3.2^ 6.9^= 3.27^ 1.6^^ 
Significance 
Level 
TRT .09 
DAY .04 
TRT*DAY .22 
.15 
.009 
.43 
.325 
-.07 
-.31 
.14 
.0001 
.204 
.011 
.0001 
.172 
.560 
.003 
.223 
^Values represent mean changes of plasma cholesterol 
concentrations of rabbits corresponding to periods of 
experiment. 
'^ ""Means in the same column with the same superscript are not 
significantly different (P < 0.05). 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched diet 
continued until day 77. Groups: 1 = No cholesterol (control), 
N = 4; 2 = 0.1% cholesterol + boiled E. coprostanoligenes in 
2% fat milk, N = 6; 3 = 0.1% cholesterol + E. 
coprostanoligenes in 2% fat milk, N = 8. 
No cholesterol (control) 
Cholesterol + Boiled 
Eubacterium in 2% milk 
Cholesterol + 
Eubacterium in 2% milk 
120 - Pretreat iFed Bacteria 
'Fed No Bacteria Fed No 
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100 -
•o 
ra 
s: 
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o 
a 
g 60 --
o 
u 
S 40 --
£ 
o 
o 20 -a 
£ 10 
a 
CL 
fO CO 
CO 
CO 
CO 
-20 -
Time of Experiment (days) 
Figure 2. Total changes in plasma cholesterol concentrations observed in 
hypercholesterolemic rabbits after daily orally administrated Eubacterium 
coprostanoligenes. All rabbits except control received a 0.1% cholesterol-
enriched before being assigned to the experimental groups at day 0. 
5 ml of a 2% fat milk was used to deliver the bacteria to the rabbits. Each 
data point represents the group average change of triplicate assays of 
plasma samples from each rabbit. Eubacterium was fed from day 28-49. Feeding 
of the 0.1% cholesterol-enriched diet was continued through day 77). Regular 
chow was fed from day 78 to day 108, then followed by 0.1% cholesterol-
enriched diet from day 109 to day 137. 
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group 2 fed the boiled bacteria when compared with those 
parameters of control rabbits in group 1. GOT activities 
showed small differences between treated rabbits and controls 
on day 42 (P< 0.10), but no significant differences were 
observed at day 56 (P< 0.05). 
Total plasma protein concentrations remained constant 
throughout the experiment (Table 7). Significant differences 
(P< 0.002) were observed in bilirubin concentrations in 
rabbits in group 2 fed the fed 0.1% cholesterol-enriched diet 
+ boiled Eubacterium coprostanoligenes when compared with 
those rabbits in group 3 fed the live bacteria and control 
rabbits in group 1 at the initiation of bacterial feeding. 
Fourteen days after initiation (day 42) of bacterial 
feeding, bilirubin concentration in rabbits in group 3 fed the 
live bacteria was significantly higher (P< 0.001) than that in 
rabbits in group 2 fed the boiled bacteria and in the control 
rabbits, but the value was the same as that recorded for group 
3 at the beginning of the experiment (Table 7) . 
No significant differences (P< 0.05) were observed in 
bilirubin concentration between treatment groups one week 
after termination of bacterial feeding. Uric acid 
concentration was significantly higher (P< 0.04) in rabbits 
group 3 fed the live bacteria when compared with that of 
rabbits in group 3 fed the boiled bacteria and with that of 
rabbits in the control group, but the value was lower than 
that recorded for group 3 at the initiation of bacterial 
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Table 7. Plasma enzyme activities and metabolite 
concentrations® of rabbits fed a commercial chow 
followed by a 0.1% cholesterol-enriched diet and 
Eubacterium coprostanoligenes in 2% fat milk for 21 
days 
Day 28 - initiation of bacterial feeding 
Total 
GOT GPT LDH ALP Protein Bilirubin Uric acid 
Groups (lU/L) (g/100 ml) (mg/100 ml) 
1 1211'' 2714" 236±34'' 0 5±.3^  0.101.03" 0.551.03'' 
2 141.8'' 3011'' 2051 6" 31.3" 61.3" 3.511= 0.451.3" 
3 141.9'' 211.1" 2151 7" 81.9" 61.l" 0.201.1" 2.501.4" 
Day 42 - 14 after initiation of bacterial feeding 
1 911" 3014" 123137" 0 51.l" O.lOlO" 0.151.1" 
2 1711® 291.5" 2461 9" 31.7" 61.l" O.lOl.l" 0.55l.l"= 
3 131.4"® 231.5" 238116" 313" 61.l" 0.201.01" 0.781.04= 
Day 56-7 days after cessation of bacterial feeding 
1 1312" 2917" 29414" 0 .31. lb 51, .1" 0, .101, .03" 0 .101, .03" 
2 2012" 2512" 244123" 3 .01. 2" 61 .1" 0 .201 .02" 0 .401 .1" 
3 1112" 1412" 34615" 0 • CO
 
H- 3" 61 .1" 0 .601 O
 tr
 
0 .201 .1" 
®Values represent means and standard errors of plasma enzyme 
activities and metabolite concentrations per group of rabbits 
corresponding to days of experiment 
""=Means in the same column within the same period with common 
superscript are not significantly different (P < 0.05) 
Groups: 1 = No cholesterol (control), N = 4; 2 = 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% fat milk, N = 
6; 3 = 0.1% cholesterol + E. coprostanoligenes in 2% fat milk, 
N = 8. 
GOT = glutamic oxaloacetic transaminase; GPT = glutamic 
pyruvic transaminase; LDH = lactic dehydrogenase; ALP = 
alkaline phosphatase. 
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feeding. No significant differences (P< 0.05) were observed 
between treatment groups one week after termination of 
bacterial feeding (Table 7). Overall, the results suggest that 
the bacteria did not cause any detectable changes in liver 
function or damage. 
Liver damage usually results in elevated plasma GOT, GPT, 
LDH and ALP activities and decreased plasma total protein 
concentrations. Hepatic excretory dysfunction usually shows 
increased ALP activities and small elevations in bilirubin 
concentrations (28,29). Increased GOT activities and uric acid 
concentrations and hypoproteinemia are suggestive of 
nephrotoxic manifestations. GOT activities and uric acid 
concentration at day 42 were not different from those at day 
28 and were not accompanied by changes in total protein which 
remained constant through the experiment. 
Susceptibility of the rabbits to the effects of the 
bacteria should depend not only on the nutritional status 
of the rabbits but also on the amount of bacteria 
incorporated into the diet, the ability of the bacteria to 
colonized the intestinal tract and to produce metabolites 
that are toxic to the rabbits and the rate of detoxification 
of any toxic metabolites. 
The results of the evaluation of biochemical and 
hematological parameters further suggest that these bacteria 
are non-toxic and non-pathogenic. It may be possible to 
incorporate E. coprostanoligenes into foods commonly consumed 
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by htunans without changing their nutritional, aesthetic and 
palatable qualities. This possibility could result in 
development of technology to use cholesterol reductase 
produced by Ei coprostanoligenes to decrease the cholesterol 
content of foods and the possibility for treatment of 
hypercholesterolemia in humans. 
The major sterols detected in feces of rabbits fed live and 
dead E. coprostanoligenes were cholesterol and coprostanol 
(Table 8) and fi-sitosterol, whereas the major bile acid was 
deoxycholic acid (Table 9). Rabbits in the group 2 fed the 
live bacteria excreted the highest fecal cholesterol 
concentration at 21 days before bacterial feeding when 
compared with that of rabbits in the other groups, but no 
coprostanol was detected in feces of rabbits from the other 
two groups. There were no significant differences (P < 0.05) 
in cholesterol concentration in excreta of rabbits at the 
start of the bacterial feeding (Table 8). 
Fecal cholesterol concentrations increased at two weeks of 
bacterial feeding in rabbits fed both the live and dead 
bacteria, whereas cholesterol concentration decreased in the 
control rabbits. Cholesterol concentrations in excreta of 
rabbits in group 2 fed the dead bacteria increased 1.95 times 
compared with 1.67 times in rabbits in group 3 fed the live 
bacteria at 2 weeks (day 42) of bacterial feeding when 
compared with concentrations at the initiation of bacterial 
feeding. The differences in cholesterol concentration were not 
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Table 8. Fecal cholesterol and coprostanol concentrations® 
and weight ratios of rabbits 
Groups N Cholesterol(Choi) N Coprostanol(Cop) Cop/Choi 
(ug/g) 
Day 0- 21 days before bacterial feeding 
1 3 15.1±4.5'' 4 
2 5 27.3 ± 0.4 ^  6 
3 8 33.6 ± 2.5 ^  2 6.5 ± 1.7 0.19 
Day 28 - Initiation of bacterial feeding 
1 4 138.2 ± 8^ 4 127.1 ± 17.2^ 0.92 
2 6 246.4 ± 19.8^ 6 160.9 ± 11.1^ 0.65 
3 8 232.9 ± 11.7^ 8 119.6 ± 9.6^ 0.33 
Day 42- 14 days of bacterial feeding 
1 4 104.3 ± 7.7® 2 59.4 ± 8.4^ 0.57 
2 6 480.6 ± 28.7° 6 127.2 ± 12.6" 0.26 
3 8 388.2 ± 20.9= 5 61.7 ± 5.7^ 0.16 
Day 56- 7 days after cessation of bacterial feeding 
1 4 117.2 ± 6.7" 4 128.5 ± 17.0" 1.10 
2 6 167.9 ± 16.7" 6 122.7 ± 7.9" 0.73 
3 8 139.0 ± 8.7" 8 58.8 ± 3.1° 0.42 
Day 77- 28 days after cessation of bacterial feeding 
1 4 58.0 ± 13.7" 3 24.7 ± 3.2" 0.42 
2 6 82.1 ± 4.9" 5 35.6 ± 4.5" 0.43 
3 8 172.5 ± 17.7" 8 123.7 ± 20.6" 0.72 
Day 132- 24 days of refeeding of 0.1% cholesterol diet 
1 3 61.9 ± 31.1" 2 35.6 ± 15" 0.57 
2 6 225.4 ± 9.8° 6 147.8 ± 20.9" 0.66 
3 8 191.2 ± 11.8° 8 60.5 ± 4" 0.32 
Day 137- 29 days of refeeding of 0.1% cholesterol diet 
1 2 76.4 ± 9.6" 2 62.9 ± 22.4" 0.82 
2 6 156.2 ± 22.5" 6 140.3 ± 26.6" 0.92 
3 8 116.3 ± 7.2" 6 58.5 ± 6.2" 0.50 
^Values represent means and standard errors of fecal 
cholesterol and coprostanol concentrations from rabbits. 
""°Means in the same colxomn within the same time period with 
same superscript are not significantly different (P < 0.05) . 
Groups: 1 = No cholesterol (control); 2 = 0.1% cholesterol + 
boiled E. coprostanoligenes in 2% fat milk; 3 = 0.1% 
cholesterol + E. coprostanoligenes in 2% fat milk 
= No detectable amount 
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Table 9. Fecal fi-sitosterol and deoxycholic acid 
concentrations^ in feces of rabbits 
Groups N S-Sitosterol N Deoxycholic acid 
(ug/g) 
Day 0- 21 days before bacterial feeding 
1 3 33.6 ± 18.5^ 4 39.0 ± 3.0^ 
2 4 99.9 ± 38.0^ 6 31.1 ± 2.1^ 
3 6 45.8 ± 8.7^ 8 47.5 ± 3.6^ 
Day 28 - Initiation of bacterial feeding 
1 4 1073.2 ± 311.8^ 4 223.5 ± 61.6^ 
2 6 1369.7 ± 211.2^^ 6 222.8 ± 21.3^ 
3 8 1495.1 ± 107.4^ 8 260.1 ± 17.2^' 
Day 42- 14 days of bacterial feeding 
1 4 1688.7 ± 129.7^ 4 233.6 ± 10.l'' 
2 6 2280.9 ± 129.4'' 6 258.4 ± 12.3^ 
3 8 1765.3 ± 81.4^ 8 268.1 ± 12. 6^' 
Day 56- 7 days after cessation of bacterial feeding 
1 4 2044.1 ± 55.7^ 4 278.8 ± 6.6^ 
2 5 1759.9 ± 123.7^ 5 214.9 ± 14.0^® 
3 8 1381.2 + 84.0^ 8 171.6 ± 9.2^ 
Day 77- 28 days after cessation of bacterial feeding 
1 4 1776.4 ± 283.1^ 4 243.1 ± 26.3^^ 
2 6 1559.2 ± 76.0^ 6 223.0 ± 12.6^ 
3 8 2829.1 ± 183.0^ 8 413.4 ± 23.7° 
Day 132- 24 days of refeeding of 0.1% cholesterol diet 
1 3 265.3 ± 127.5^ 4 198.7 ± 59.6'' 
2 4 692.9 ± 27.1^= 6 393.8 ± 11.9^ 
3 6 818.1 ± 62.5® 8 479.5 ± 31.7^ 
Day 137- 29 days of refeeding of 0.1% cholesterol diet 
1 4 1702.4 ± 60.0'' 4 384.1 ± 46.5'' 
2 6 1120.1 ± 698.9'' 6 315.3 ± 31.1" 
3 8 1055.7 ± 81.2" 8 405.5 ± 24.7" 
^Values represent means and standard errors of fecal bile acid 
concentrations from rabbits. 
"•°Means in the same coliimn within the same time period with 
same superscript are not significantly different (P < 0.05). 
Groups: 1 = No cholesterol (control); 2 = 0.1% cholesterol + 
boiled E. coprostanoligenes in 2% fat milk; 3 = 0.1% 
cholesterol + E. coprostanoligenes in 2% fat milk. 
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statistically significant (P< 0.05)(Table 8). 
On day 77 (4 weeks after bacterial feeding), rabbits in 
group 3 fed the live bacteria excreted feces with greater 
concentrations of cholesterol than rabbits fed boiled bacteria 
(P< 0.14). No significant differences (P< 0.05) were observed 
in cholesterol excreted in feces of rabbits fed the live 
bacteria and rabbits fed the boiled bacteria on days 132 and 
137 (Table 8). Investigation of oral administration of 
Streptococcus feacalis KAWI powder to rats fed a 0.5% 
cholesterol diet increased cholesterol excreted in feces by 
65% and 39% after 2 and 4 weeks, respectively (15). 
Coprostanol concentration was significantly lower (P< 0.02) 
at day 56 in rabbits in group 3 fed the live E. 
coprostanoligenes bacteria when compared with rabbits in group 
2 fed the boiled E. coprostanoligenes bacteria (Table 8). 
Rabbits fed the live bacteria had 2.1 times higher cholesterol 
and 4.1 times higher coprostanol concentrations excreted in 
feces at 4 weeks after bacterial feeding (day 77) when 
compared with rabbits fed the boiled bacteria (Table 8). 
During the bacterial feeding period coprostanol, 
concentrations and coprostanol/cholesterol concentration 
ratios decreased in all groups of rabbits. The coprostanol/ 
cholesterol concentration ratio in rabbits fed the live 
bacteria at day 77 was 1.7 times greater in rabbits fed the 
live bacteria when compared with rabbits fed the boiled 
bacteria (Table 8). 
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The excretion of sitosterol and bile acids increased in all 
groups of rabbits at 2 weeks of bacterial feeding and 4 weeks 
after bacterial feeding when compared with the fecal 
concentrations at the initiation of bacterial feeding (Table 
8). Rabbits fed the dead bacteria excreted 1.29 times more 
sitosterol and 0.98 times more bile acids than rabbits fed the 
dead bacteria at 2 weeks after bacterial feeding. Bile acid 
excretion was significantly lower (P< 0.05) in rabbits fed the 
live bacteria on day 56 when compared with rabbits fed the 
boiled bacteria (Table 9). Rabbits fed the live bacteria 
excreted significantly higher (P< 0.05) concentrations of bile 
acid than rabbits fed the boiled bacteria at day 77. At day 
132 and 137 rabbits fed the live bacteria excreted higher bile 
acid than rabbits fed the boiled bacteria, but differences 
were not statistically significant (P< 0.05) (Table 9). 
Studies of sterol and bile acid excretion in 
hypercholesterolemia-resistant rabbits showed that resistant 
rabbits when compared to normoresponsive rabbits excreted 
significantly larger amounts of fecal bile acids. Preliminary 
tissue distribution studies 24 hours after consumption of 
cholesterol-supplemented diet containing [4-^^C]cholesterol 
bile aspirated from gallbladder at necropsy contained an 
average of 2.2 times more radioactivity than specimens 
obtained from normoresponsive rabbits (22). 
Rabbits fed the live bacteria excreted 1.81 times more 
sitosterol and 1.85 times more bile acid than rabbits fed the 
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boiled bacteria at 4 weeks after termination of bacterial 
feeding. Sitosterol excreted by rabbits fed the live bacteria 
was greater at day 77 when compared with that excreted by 
rabbits fed the boiled bacteria, but the differences were not 
significantly different (P< 0.05)(Table 9). 
CONCLUSIONS 
Oral administration of E. coprostanoligenes, a cholesterol-
reducing bacteria, in 2% fat milk decreased cholesterol 
concentrations in New Zealand White adult male rabbits 
receiving a 0.1% cholesterol-enriched diet. No clinical 
signs or symptoms of bacterial intoxication were observed in 
any rabbit. Feeding of the bacteria did not affect rabbit 
mean body weight. Changes in plasma cholesterol concentration 
from days 0-77 in rabbits fed the 0.1% cholesterol + live E. 
coprostanoligenes in 2% milk diet were lower (P < 0.01) than 
plasma cholesterol concentration in rabbits fed the 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% milk diet. 
Incorporation of E. coprostanoligenes in milk and feeding 
to New Zealand White adult male rabbits receiving a 0.1% 
cholesterol-enriched has been shown to be non-toxic and non­
pathogenic to rabbits because no changes were observed in 
plasma enzymes (GOT, GPT, LDH and ALP) activities and major 
metabolites (bilirubin, uric acid and total protein) 
concentrations during the bacterial feeding when compared with 
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corresponding activities and concentrations at the initiation 
of the bacterial feeding. 
The results suggest that E. coprostanoligenes is non-toxic 
and non-pathogenic in rabbits and may be safe for human 
consumption. Results further suggest that milk may be used as 
a medium to deliver a cholesterol-reducing microbe to decrease 
plasma cholesterol concentration in hvimans. Therefore, the 
decrease in plasma cholesterol concentrations observed in 
hypercholesterolemic rabbits fed E. coprostanoligenes may have 
important positive impacts on human health and welfare. 
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Abstract 
Three preliminary investigations of the potential use 
of Eubacterium coprostanoligenes, a cholesterol-reducing 
bacteria, with or without commercially available Lactobacillus 
starter culture in the production of fermented pork and mutton 
sausages were conducted. Meat samples were assigned to the 
following treatment groups; uninoculated (control), 
Lactobacillus commercial starter culture, various combinations 
of Lactobacillus + E. coprostanoligenes and E. 
coprostanoligenes. All treatments were allowed to undergo the 
normal fermentation process at 37° C for 12-15 hours, then the 
sausages were cooked at 68° C in conventional oven. The 
viability of E. coprostanoligenes after fermentation was 
assessed by culturing samples of meat from each treatment. All 
sausages were evaluated for cholesterol and coprostanol 
concentrations, moisture, total lipid and pH before and after 
fermentation. After fermentation pH decreased in sausages 
inoculated with Lactobacillus and the various combinations of 
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Lactobacillus + E. coprostanoligenes, were significantly lower 
(P < 0.05) than that of control and the other treatments. 
Moisture, total lipid and cholesterol content in fermented 
sausages were not consistently affected by the bacterial 
treatments. 
Coprostanol was detected only in cultures from fermented 
sausages inoculated with the 0.5 g of E. coprostanoligenes 
pellet in experiment 2. In experiment 3, coprostanol was 
detected in all treatments after fermentation except 
uninoculated (control) pork sausages. Significantly greater (P 
< 0.05) concentrations of coprostanol were detected in 
fermented sausages and cultures from feinnented sausages 
inoculated with the 2.0 g of E. coprostanoligenes. Detection 
of coprostanol in fermented sausages and in cultures from 
fermented sausages confirmed that E. coprostanoligenes 
remained viable during fermentation while converting 
cholesterol to coprostanol and maintained its ability to 
reduce cholesterol to coprostanol when added to media 
containing 0.2% cholesterol. 
INTRODUCTION 
Consumers worldwide have become more concerned the 
composition of their diets and how changes in life styles can 
result in lower blood cholesterol concentration and thus lower 
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risk of coronary heart disease. Studies have demonstrated that 
there is a causal association between serum cholesterol 
concentration, dietary fat, and coronary heart disease, and it 
is hypothesized that the risk of heart disease should be 
reduced substantially when sertim cholesterol is lowered 
(Ravnskov, 1992). Cholesterol content of animal-derived foods 
is a primary public concern as there is considerable evidence 
to suggest that plasma cholesterol plays an important role in 
the development of atherosclerosis and coronary heart disease. 
Cholesterol is required for several biological functions in 
animals, including hiimans; precursor for biosynthesis of bile 
acids, corticosteroids and sex hormones; regulation of 
membrane activity and transport of lipids from the intestines 
to other tissues; and proliferation of a variety of cells 
(Dehal et al., 1991). The greatest challenge to meat scientist 
is to lower the palmitic acid content, the major fatty acid in 
meat and meat products, which is associated with increase in 
plasma cholesterol concentration in humans (Grundy, 1986). 
Consumers prefer foods with low lipid content and producers 
have need for application of inexpensive methods to reduce 
excess fat and cholesterol in various meat and meat-products 
without changing the nutritional, aesthetic and palatability 
qualities. 
In studies conducted with starter cultures on quality of 
fermented mutton sausages, starter cultures did not affect 
98 
water activity, ash or protein content, fatty acid 
composition, cholesterol or retention of moisture, protein 
fat, ash or fatty acids (Long et al., 1990). Production of 
Manchego cheese with fast acid producing bacteria may cause 
bitterness during ripening (Nunez et al., 1982). Starter 
cultures prepared with nonbitter strains may be used to 
minimize bitterness in cheese when acid production is not 
necessary for cheese production (Wu et al., 1991). Starter 
cultures that produce antimicrobial compounds may be 
beneficial for both consumer safety and shelf life of product 
(Nunez et al., 1982). 
Numerous chemical, physical and biological methods have 
been employed to decrease or eliminate fat and cholesterol in 
milk because of the perceived association of dairy products 
with cardiovascular disease (Chavarri et al., 1988). Physical 
and chemical methods tend to be nonselective and usually 
remove the nutritional components with cholesterol (Deeth, 
1983). The use of organic solvents results in residues in the 
final product. Supercritical fluid extraction, vacuum steam 
distillation, short path distillation, and complexing with 
cyclodextrins and saponins have been used also (Deeth, 1983; 
Smith et al., 1991). Bacterial and enzyme methods offer 
potential cost and selectivity advantages (Deeth, 1983) . 
Degradation and reactivity of cholesterol in milk have been 
studied at different temperatures using bacterial cholesterol 
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oxidases (Deeth, 1983; Smith et al., 1991). 
Demonstrations have shown that bacteria as well as plants 
can metabolize steroids by transformation of their side chains 
and steroid nuclei to produce pharmaceutically active steroid 
compounds (Dehal et al., 1991). Lactobacillus acidophilus RP32 
significantly inhibited increase in serum cholesterol 
concentrations in pigs fed high-cholesterol diet (Xiansheng et 
al., 1990). Hydrogenation of cholesterol by anaerobic 
incubation with r\amen fluid for 20 hours resulted in 
coprostanol as the principal product (Eyssen et al., 1973). 
Results of catalytic hydrogenation of cholesterol indicated 
that coprostanol was one of the by-products (Ashes et al., 
1978). 
Escherichia coli in human feces was found to degrade 
cholesterol under aerobic and anaerobic conditions to form 
neutral products, cholest-4 en-3-one, cholesta-1,4-dien-3-one, 
androst-4-ene-3,17-dione and androsta-1,4-diene-3,17-dione. 
Cholesta-1,4-dien-3-one and androsta-1,4-diene-3,17-dione were 
also produced under anaerobic condition (Hershberg et al., 
1951). Degradation of cholesterol by Pseudomonas species NCIB 
10590 showed that the major products included cholest-5-en-3-
one, cholest-4-en-3-one, 26-hydroxycholest-4-en-3-one, 
androst-1,4-dien-3,17-dione, cholest-4-en-3-one-26-oic acid, 
chol-4-en-3-one-24-oic acid, pregn-4-en-3-one-20-carboxylic 
acid and pregna-1,4-dien-3-one-20 carboxylic acid (Owen et 
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al., 1978). 
Microbial hydrogenation of cholesterol to coprostanol may 
occur by the intermediates 4-cholesten-3-one and coprostanone 
(Owen et al., 1983). Microbial transformation of cholesterol 
by cecal contents from rats showed that at least 50% of the 
cholesterol converted to coprostanol by means of the 
intermediate 4-cholestenone (Bjorkhem and Gustafsson, 1971). 
In the human gut, cholesterol was partially degraded to 
coprostanol and coprostanone and determination of metabolites 
is complicated by the degradation of products from plant 
sterols (Macdonald et al., 1983). Mycobacterium species were 
magnetically immobilized and used for side chain degradation 
of cholesterol into androsta-1,4-dien-3,17-dione (Flygare and 
Larsson, 1987) . 
Eubacterium can anaerobically reduce cholesterol to 
coprostanol, which is absorbed poorly by the human 
gastrointestinal tract (Gilliland et al., 1984). Eubacteriim 
21,408 reduced the 4,5 double band of allocholesterol to 
coprostanol (Gilliland et al., 1984). 
Freier, (1991) successfully isolated a pure culture of 
Eubacterium coprostanoligenes and it was characterized as a 
small, gram positive, nonspore forming, coccobacillus, 
cholesterol-reducing anaerobe. Lecithin is required for 
growth, whereas cholesterol is not. Coprostanol is not 
produced when lecithin is replaced by phosphatidylinositol or 
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phosphatidylglycerol. E. coprostanoligenes possesses 
phospholipase activity and does not reduce nitrate or produce 
indole. Esculin was hydrolyzed, but starch and gelatin were 
not. E. coprostanoligenes produced much acid by fermentation 
of amygdalin, lactose and salicin (acetic, formic and 
succinic), whereas arabinose, cellobiose, fructose, glucose, 
mannose and melibiose were poorly fermented. Volumes of gases 
produced in the head space showed that H2 and CO2 percentages 
ranged from 4.5 to 7.2 and 0.9 and 1.8, respectively (Frier, 
1991, Frier et al., 1994). Fermentation of radiolabelled [4-
%, 4-^^C]-cholesterol with E. coprostanoligenes resulted in 
90% conversion of cholesterol to coprostanol in 5 days. 
Coprostanol formation by E. coprostanoligenes involved the 
transfer of a hydrogen from C4 to C5 position. E. 
coprostanoligenes reduction of radioactive coprostanone to 
coprostanol tend to favor the theory of the indirect pathway 
with the isomerization of a double bond at the 4-5 position 
(Ren, 1991) . 
Oral administration of E. coprostanoligenes to New Zealand 
White rabbits fed a 0.05% cholesterol-enriched diet resulted 
in lower (P < 0.001) plasma cholesterol concentration in 
rabbits fed the live bacteria for 10 days when compared with 
rabbits fed the boiled bacteria. Coprostanol/cholesterol 
ratios in the contents of the digestive tracts of rabbits fed 
the live bacteria were greater than those of rabbits fed the 
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boiled bacteria (Li et al., 1995). 
The hypothesis of this study was that Eubacterium 
coprostanoligenes could grow in meats during sausage 
production and would decrease the cholesterol content of 
meats. The studies were undertaken to investigate the 
feasibility of using a cholesterol-reducing bacteria in the 
production of pork and mutton sausages. We evaluated the 
viability of E. coprostanoligenes in the fermented pork and 
mutton sausages and the concentrations of cholesterol and 
coprostanol, total lipids, moisture and pH at different stages 
of production and storage of the sausages. 
MATERIALS AND METHODS 
Preparation of starter culture 
Eubacterium coprostanoligenes ATCC 51222 was maintained in 
10 ml cultures grown anaerobically in liquid media composed of 
0.1% lecithin (Sigma Chemical Co. St. Louis, MO), 1% casitone, 
1% yeast extract (Difco Laboratories, Detroit, MI), 0.5% 
sodixam thioglycollate and 0.1% calcium chloride (Fisher 
Scientific, Fair Lawn, NJ). Resazurin added at 0.4% as an 
indicator for the presence of oxygen. Lacto-Bacto plates 
prepared from media containing 1% Bacto-Tryptone, 0.5% Bacto-
Yeast, 1% sodium chloride and 1.5% Bacto-Agar (Difco 
Laboratories, Detroit, MI) were used to monitor purity of 
103 
cultures. A 4 ml aliquot of Eubacterium coprostanoligenes 
stock culture was used to inoculate 400 ml flasks of media 
similar to the maintenance as indicated above by using the 
Hungate technique (Holdeman et al., 1977). Each flask was 
sealed with a rubber stopper and incubated at 37° C for 48 
hours for growth of the bacteria used to inoculate meat 
samples. The Lactobacillus commercial starter culture used was 
Lactacel^ 115 (Microlite Technics, Sarasota, FL). 
Preparation of ground pork and mutton 
Fresh ground pork was used in experiment one and two and 
ground pork and mutton were used in experiment three 
representing the normal consumer choice. The pork and mutton 
were ground through a 0.32 cm plate and mixed thoroughly to 
homogenize. Duplicate or triplicate samples were taken for 
analysis of pH, moisture, total lipids, cholesterol and 
coprostanol content before seasoning. The bulk meats were 
seasoned (3% sodivim chloride, 0.75% dextrose, 0.015% sodium 
nitrate, 0.38% pepper), and vacuxam-mixed. Duplicate or 
triplicate samples were taken from each meat for analysis of 
pH, moisture, total lipids, cholesterol and coprostanol 
content after seasoning (before fermentation), after 
fermentation, after cooking and after 1 month of storage after 
cooking. 
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Experiment one 
Triplicate 100 g samples of each meat were weighed into 
autoelaved 400 ml or 600 ml beakers and randomly assigned to 
each of following treatments in Table 1. Triplicate 100 g 
ground pork samples were inoculated with 1 ml, 2 ml and 10 ml 
aliquots of liquid E. coprostanoligenes culture. The remaining 
bacteria were harvested by centrifuging the 48 hour bacterial 
culture in pre-weighed bottles in a Sorvall^ RC2-B 
refrigerated centrifuge at 750 rpm for 20 minutes and the 
weight of the bacterial pellet was calculated and treatment 
doses determined. Bacterial pellet of E. coprostanoligenes was 
weighed in triplicate amounts of 0.05 g and 0.1 g and 
duplicate 0.2 g. Each amount of bacterial pellet was suspended 
in 1 ml volume of sterile phosphate-buffered saline (0.01 M 
Na2HPO4.7H20 + 0.15 M NaCl, pH 7.5)(PBS) and used to inoculate 
a 100 g sample of ground pork. Triplicate ground pork samples 
were inoculated also with 0.05 g of Lactobacillus pellet and 
the combination 0.05 g of Lactobacillus + 0.05 g of E. 
coprostanoligenes pellets; uninoculated pork samples were used 
as controls. All samples were placed in jars and were 
incubated at 37° C for 12 hours. Treatments 3 and 4 were 
incubated under anaerobic conditions to facilitate the growth 
of E. coprostanoligenes by using gas jars charged with BBL®^ 
GasPak Plus™ system (Becton Dickinson, MD). 
After fermentation, duplicate 0.5 g samples from sausages 
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Table 1. Assignment of meat samples 
Treatments Total Replicates 
1. Uninoculated (control) 
Pork 3 
2. Lactobacillus (0.05 g) 
Pellet - Pork 
3 
3. Lactobacillus + 
E. coprostanoligenes 
(0.05 of each) 
Pellet - Pork 3 
4. E. coprostanoligenes 
Pork 
liquid media, 1, 2, 10 ml 
pellet 0.05, 0.10, 0.2 g 
9 
9 
from each treatment were suspended in a 1 ml volvime of sterile 
PBS and each was used to inoculate a 9 ml voliame culture 
containing the components of the media used to maintain the 
bacteria with cholesterol added at 0.2% for the evaluation of 
the viability of E. coprostanoligenes. All cultures from 
fermented sausages were incubated at 37° C for 96 hours. A 1 
ml aliquot of each culture was taken for analysis of pH and a 
1 ml aliquot was taken for analysis of cholesterol and 
coprostanol. A 1 g sample was taken from each pork sausage and 
used to determine pH and a 1 g sample was taken from each pork 
sausage to determine moisture content. A 0.5 g sample was 
taken from each pork sausage for analysis of total lipids, 
cholesterol and coprostanol concentrations. 
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Experiment two 
The design of the experiment was similar to that in 
experiment 1 (Table 1). Triplicate 100 g ground pork samples 
were inoculated with 1 ml, 2 ml and 10 ml aliquot of bacterial 
culture. The remaining bacteria were harvested by centrifuging 
the 48 hour bacterial culture in pre-weighed bottles in a 
Sorvall^ RC2-B refrigerated centrifuge at 7,500 rpm for 20 
minutes and the weight of the bacterial pellet was calculated 
and treatment loads determined. Bacterial pellet was weighed 
in triplicate amounts of 0.05 g, 0.1 g and duplicate 0.5 g. 
Each amount of bacterial pellet was suspended in a 1 ml volume 
of sterile PBS and used to inoculate a 100 g sample of ground 
pork. Triplicate ground pork samples were inoculated also with 
0.05 g of Lactobacillus pellet and the combination of 0.05 g 
Lactobacillus + 0.05 g of B. coprostanoligenes pellets; 
uninoculated pork samples were used as controls. All samples 
were placed in jars and were incubated at 37° C for 15 hours. 
Treatments 3 and 4 were incubated under anaerobic conditions 
to facilitate the growth of E. coprostanoligenes by using gas 
jars charged with BBL^ GasPak Plus™ system (Becton Dickinson, 
MD) . 
After fermentation, a 0.5 g of each pork sausage was 
suspended in a 1 ml volume of sterile PBS and each was used to 
inoculate a 9 ml volume culture containing the components of 
the media used to maintain the bacteria with cholesterol added 
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at 0.2% for the evaluation of the viability of E. 
coprostanoligenes. All cultures from the fermented sausages 
were incubated at 37° C for 96 hours. A 1 ml aliquot of each 
culture was taken for analysis of pH and a 1 ml aliquot was 
taken for analysis of cholesterol and coprostanol. A 1 g 
sample was taken from each pork sausage and used to determine 
pH and a 1 g sample was taken to determine moisture content. A 
0.5 g of each sausage was taken for analysis of total lipids, 
cholesterol and coprostanol concentrations. 
All sausages were cooked at 68° C for 25 minutes then 
stored in freezer. A 1 g sample was taken from each pork 
sausage and used to determine pH and a 1 g sample was taken to 
determine moisture content. A 0.5 g of each sausage was taken 
for analysis of total lipid, cholesterol and coprostanol 
concentrations. All sausages were vacuumed-packaged and held 
at typical retail display case temperature (approx. 25° C to 
simulate the current demand for shelf stable fermented 
products) and sampled after 1 month of storage after cooking 
for performing the above mentioned analyses. 
Experiment three 
The design of this experiment was a modification of the 
first 2 experiments (Table 1) with both ground pork and 
mutton. Based on the results obtained in experiment 2, only 
bacterial pellets were used to inoculate the ground pork and 
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mutton samples. The bacteria were harvested by centrifuging in 
pre-weighed bottles in a refrigerated Sorvall^ RC2-B 
centrifuge at 750 rpm for 20 minutes and weight of the 
bacterial pellet was calculated and treatment loads 
determined. Bacterial pellet was weighed in triplicate amounts 
of 0.25 g and 0.5 g and duplicate amounts of 2 g bacterial 
pellet for inoculation of pork samples and triplicate 0.5 g 
and 1 g amounts for inoculation of mutton samples. 
Each amount of bacterial pellet was suspended in a 1.5 ml 
volime of sterile PBS and used to inoculate a 100 g sample of 
ground pork or mutton. Triplicate ground pork samples were 
inoculated also with 0.05 g of Lactobacillus pellet and the 
combinations of 0.1 g, 0.25 g and 0.5 g of E. 
coprostanoligenes + 0.05 g Lactobacillus pellets; uninoculated 
pork and mutton sausages were used as control. All samples 
were placed in jars and were incubated at 37° C for 15 hours. 
Treatments 3 and 4 were incubated under anaerobic conditions 
to facilitate the growth of E. coprostanoligenes by using gas 
jars charged with BBL^ GasPak Plus™ system (Becton Dickinson, 
MD) . 
After fermentation, a 0.5 g of each pork or mutton sausage 
was suspended in a 1 ml volume of sterile PBS and each was 
used to inoculate a 9 ml volume culture containing the 
components of the media used to maintain the bacteria with 
cholesterol added at 0.2% for the evaluation of the viability 
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of E. coprostanoligenes. All cultures from fermented sausages 
were incubated at 37° C for 96 hours. A 1 ml aliquot of each 
culture was taken for analysis of pH and a 1 ml aliquot was 
taken for analysis of cholesterol and metabolites. A 1 g 
sample was taken from each pork or mutton sausage and used to 
determine pH and a 1 g sample was taken to determine moisture 
content. A 0.5 g sample of each pork or mutton sausage was 
taken for analysis of total lipids, cholesterol and 
coprostanol concentrations. All sausages were cooked at 68° C 
for 25 minutes then stored in freezer. A 1 g sample was taken 
from each meat sample and used to determine pH and a 1 g 
sample was taken to determine moisture content. A 0.5 g of 
each pork or mutton sausage was taken for analysis of total 
lipids, cholesterol and coprostanol concentrations. All 
sausages were vacuumed-packaged and held at typical retail 
display case temperature and at room temperature (approx. 25° 
C to simulate the current demand for shelf stable fermented 
products) and sampled after 1 month of storage after cooking 
for analysis of pH, moisture, total lipids and cholesterol and 
coprostanol concentrations. 
Sample preparation and analytical procedures 
Duplicate or triplicate 1 g samples were taken from the 
fresh ground raw pork or mutton, ground pork and mutton after 
seasoning (before fermentation) and from each pork or mutton 
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sausage after fermentation for the determination of pH and 
moisture content and a 0.5 g of each meat sample was taken for 
analysis of total lipid content and cholesterol and 
coprostanol concentrations. Each 1 g of sample for pH 
determination was suspended in a 10 ml aliquot of deionized 
water, vortexed for 15 seconds and pH of each suspension was 
measured with a model 701A digital ionalyzer pH meter (Orion 
Research^) . A 1 g sample of each meat sample was placed in a 
pre-weighed crucible and placed in oven at 100° C over night. 
Each crucible was removed from the oven and placed in 
desiccator and weighed for moisture determination (AOAC, 
1980) . 
Extraction of cholesterol and coprostanol in each 1 ml 
sample of each culture from fermented pork or mutton sausages 
was performed by the addition of 5 ml of chloroform:methanol 
(2:1, v/v) (AOAC, 1990) to each 20 ml screw-cap test tube. 
Each sample was vortexed for 60 seconds, then centrifuged at 
2,000 rpm for 20 minutes. The bottom (chloroform) layer was 
transferred quantitatively to a 2 dram vial that had been 
treated with a solution of 10% dimethylchlorosilane in toluene 
(silanized) (Nawrocki, 1985), then concentrated to dryness in 
a heated block set at 65° C under nitrogen gas. 
Analyses of total lipid, cholesterol, coprostanol 
concentrations in fresh ground raw before seasoning and ground 
pork or mutton after seasoning (before fermentation), 
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fermented, cooked fermented and fermented cooked pork and 
mutton sausages after 1 month of storage were performed by 
removal of triplicate or duplicate 0.5 g sample of each 
treatment and each placed in a 30 ml extraction tube. 
Extraction of total lipids in each meat sample was performed 
by the addition of 18.5 ml of methanol:water (2.5:1, v/v) to 
each 30 ml extraction tube (Bligh and Dyer, 1959). Each sample 
was vortexed for 10 seconds, then 6.5 ml of chloroform was 
added to each sample and each sample vortexed for 1 minute. 
Each sample was shaken on a Burrell wrist-action shaker 
overnight, then 7.5 ml of chloroform and 7.5 ml of aqueous 
0.37% potassium chloride (KCl) solution were added to each 
sample. Each extraction tube was inverted and centrifuged at 
2,000 rpm for 25 minutes. The top aqueous layer was removed by 
aspirating and discarded. Ten ml of aqueous 0.37% KCl solution 
was added to each extraction tube and each tube inverted then 
centrifuged at 2,000 rpm for 25 minutes. The top aqueous layer 
was removed by aspirating and the procedure repeated with the 
10 ml of aqueous 0.37% KCl solution. The top aqueous layer of 
each sample was removed by aspirating and each sample was 
filtered in a pre-weighed scintillation vial by using a 4.5 cm 
glass micro-fiber filter paper (Whatman^) , a Buchner funnel 
and a suction flask. Each meat residue was washed with two 
four ml volumes of chloroform into the scintillation vial and 
each chloroform extract was concentrated to dryness in a 
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Brinkman®^ SC/48R sample concentrator at 50° C under nitrogen 
gas. The scintillation vials were allowed to cool at room 
temperature. Each vial containing each lipid extract was 
weighed and lipid weight of each sample calculated and 
expressed as percentages on wet and dry matter basis. 
Each lipid extract was dissolved in 1 ml of chloroform, 
vortexed and transferred to a 20 ml extraction tube. 
Extraction of cholesterol and coprostanol was performed by the 
addition of 2 ml of methanol:benzene (4:1, v/v) and 200 |xl of 
acetyl chloride to each sample tube and capped tightly. All 
tubes were placed on a heatblock set at 100 ± 3° C for 1 hour, 
then the tubes were removed from the heatblock and allowed to 
cool to room temperature. Five ml of 6% K2CO3 solution and 2 ml 
of benzene were added to each sample and each vortexed at high 
speed for 1 minute. All samples were centrifuged in a lEC 
model centrifuge (International Equipment Company, Neeham, 
Mass) at 2,000 rpm for 20 minutes. The top (benzene) layer of 
each sample extract was transferred quantitatively with 
individual pasteur pipet to individual silanized vial 
(Nawrocki, 1985). All samples were concentrated to dryness 
under nitrogen gas in a pre-heated block set at 65° C. 
In experiment 1 and 2, each meat or culture sample extract 
was dissolved in 200 |il of chloroform . Forty p,l of each meat 
sample extract or 100 |il of each culture sample extract was 
transferred to a new silanized vial (Nawrocki, 1985) and 20 jig 
113 
of cholestane standard was added to one replicate of each 
sample as internal standard. Mixtures of 0.125 |Xg, 0.25 |ig, 
0.5 |j,g and 1.0 |j,g of cholestane, cholesterol, coprostanol and 
cholest-4 en-3-one standards were used for gas chromatography 
(GC) analysis of the various sterols. Each sample extract and 
each standard mixture was concentrated to dryness under 
nitrogen gas, then derivatized with 100 (il of silylation grade 
acetonitrile and 100 |il of 1,3 bis (trimethylsilyl) 
trifluoroacetamide with 1% trimethyl chlorosilane (Pierce, 
Rockford, IL). Each derivatized sample was quantitatively 
transferred to 200 |i,l inserts for GC analysis as 
trimethylsilyl ethers (Overturf et al., 1990; Martin et al., 
1972; Subbiah et al., 1972). 
Analyses of cholesterol and coprostanol concentrations in 
were done on a Hewlett-Packard 5830A gas chromatograph 
equipped with a flame ionization detector. Column temperature 
was set at 280° C, injector at 290° C, detector 290° C and 
maximvim oven temperature at 300° C. Separation of cholesterol 
and coprostanol occurred on a 0.9 M, 0.64 mm ID glass column 
packed with 3% SP-2250 on 100/200 Supelcoport (Supelco^, 
Beliefonte, PA), carrier gas was nitrogen at 60 ml/min, air at 
240 ml/min and hydrogen at 60 ml/min. The detector was 
equipped with an integrator set at slope sensitivity of 1.5 
and paper speed of 0.7 cm/min. Quantitation of trimethylsilyl 
ether derivatives was by standard curve and the concentration 
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of each sterol in each extract was calculated by using 
cholestane concentrations as internal standard. 
In experiment 3, 40 ml of each meat sample or culture 
sample extract was transferred to silanized vial and each was 
concentrated to dryness under nitrogen gas in a pre-heated 
heatblock set at 65® C. Two |Xg of cholestane standard was 
added to one replicate of each sample. Mixtures of 0.01 |ig, 
0.02 |ig, 0.04 |ig, 0.08 Jig and 0.16 |ig of cholestane, 
cholesterol, coprostanol and cholest-4 en-3-one standards were 
used for GC analysis of the various sterols. Each sample 
extract or standard mixture was derivatized with 100 |J.l of 
silylation grade acetonitrile and 100 (il of 1,3 
bis(trimethylsilyl) trifluoroacetamide with 1% trimethyl 
chlorosilane (Pierce, Rockford, IL) . 
Each derivatized sample extract was concentrated to dryness 
under nitrogen gas. Each sample extract was then redissolved 
in 20 Hi of hexane, vortexed and 1.5 jil of each extract was 
used for GC analysis as trimethylsilyl ethers (Overturf et 
al., 1990; Martin et al., 1972; Subbiah et al., 1972). 
Analyses of cholesterol and coprostanol concentrations were 
done on a Tracor 540 gas chromatograph equipped with a flame 
ionization detector and split injection system, column 
temperature was set at 290® C, injector at 290° C, detector at 
300® C. Separation of cholesterol and coprostanol occurred on 
a DB™-5, (30 M x 0.25 |im ID x 0.25 |im film thickness) nonpolar 
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bonded phase (5% phenyl)-diphenyl-dimethylpolysolaxne 
capillary coliunn (J & W Scientific, Folsom, CA), carrier gas 
was helium with flow rate at 60 ml/min, air at 400 itil/min and 
hydrogen at 30 ml/min. The detector was equipped with a 
Shimadzu Chromatopac^ C-R3A integrator with slope sensitivity 
set at 0 and paper speed of 0.7 cm/min. Quantitation of 
trimethylsilyl ether derivatives was done by comparing the 
area of each meatabolite in each sample extract to the area of 
a known concentration of each sterol standard in each control 
extract and by using cholestane as internal standard; 
|ig/g of each sterol in each sample = (Ai/Ax) X (Bi/Bx) X 
(Ci/Cx) where Ai = peak area of each sterol in each sample; Ax 
= peak area of each sterol standard in control; Bi = peak area 
of cholestane standard in control; Bx = peak area of 
cholestane in each sample; Ci = amount of each sterol standard 
in control; and Cx = amount of each sample used for analysis 
(AOAC, 1990) . The relative amounts of each sterol in each meat 
sample were expressed on dry or wet matter basis, whereas each 
sterol in each culture from each meat sample was expressed as 
|i,g/ml of each culture. 
Statistical analysis 
The data were analyzed by using the SAS software system 
package utilizing the Analysis of Variance and Least 
Significant Differences Procedures. Differences between means 
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were tested at P < 0.05. 
Flow chart of procedures used for the assessment of the 
viability of E. coprostanoligenes in fermented meat samples 
0.5 g of each uninoculated or inoculated pork or mutton 
sausage was used to make a suspension in 1-1.5 ml PBS 
A 1 ml aliquot of suspension from each pork or 
mutton sausages was used to inoculate a 9 ml volume 
of media containing 0.2% cholesterol 
i 
All cultures were incubated at 37° C for 96 hours 
i 
All tubes were removed and examined for growth 
then vortexed for 15 seconds. 
4 
A 1 ml aliquot of each culture was removed, extracted and 
analyzed for cholesterol and coprostanol concentrations 
Viability of E. coprostanoligenes in inoculated fermented pork 
or mutton sausages was assessed based on the presence of 
coprostanol concentration in culture from each fermented 
sausage when compared with controls 
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RESULTS AND DISCUSSION 
The fresh raw ground pork and mutton samples were analyzed 
before and after the addition of the condiments and sausages 
were analyzed after fermentation for pH and moisture, total 
lipids, cholesterol and coprostanol content. The fermented 
pork samples were cooked; then samples were taken for analysis 
of pH and moisture, total lipids, cholesterol and coprostanol 
content. The cooked fermented pork samples then were vacuum-
packed and stored at normal display temperature and after 1 
month of storage samples were taken for analyses as mentioned 
above. 
pH. The pH values of raw ground pork before and after 
seasoning (before fermentation) and pork sausage after 
fermentation for experiments 1 and 2 are shown in Table 2. 
The pH values of the raw ground pork before and after 
seasoning (before fermentation) in experiment 1 were not 
different from each other (P > 0.05), but differed from those 
of the other treatments (P< 0.05) (Table 2). The pH values of 
fermented pork sausages inoculated with the combination of 
0.05 g of E. coprostanoligenes and Lactobacillus pellet in 
both experiments 1 and 2 were lower than those of the other 
treatments (P<0.05) (Table 2). 
The pH values of pork sausages after cooking in experiment 
2 and of cultures of suspensions from fermented pork sausages 
from experiments 1 and 2 are shown in Table 3. The pH values 
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Table 2. pH of raw ground pork before and after seasoning 
(before fermentation) and of pork sausages after 12 
hours of fermentation at 37° C 
pH Values® 
Treatments Esqperiment 1 Experiment 2 
Before seasoning 
Raw ground pork 5 .57±. Ol'' 5 .78^ 
Before fermentation 
Raw ground pork 5 . 60±. 02^= 5 .91= 
After fermentation 
Uninoculated pork 
(control) 
5 .80±. 10° 5 .51±. ,08"^ 
Lactobacillus 
Pellet (0.05 g) 
5 .18±. 79'i 4 .96±, ,13® 
Lactobacillus + 
E. coprostanoligenes 
Pellet (0.05 g of 
4 
each) 
.44±. 02® 4 . 66±. ,13^ 
E. coprostanoligenes 
Pellet 
0.05 g 
0.10 g 
0.20 or 0.5 g 
5 
5 
5 
. 86±. 
.87±. 
.87±. 
03 = 
03= 
01= 
5 
5 
5 
.44±, 
.55±, 
.72±, 
,10^ 
.06^ 
.01^ 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
5 
5 
5 
.78±. 
.82+. 
.78±. 
00= 
04= 
00= 
5 
5 
5 
.71±, 
. 56± 
.56± 
.02^ 
.04^ 
.12^ 
^Values represent means and standard errors of triplicate or 
duplicate samples of each treatment. Treatments were not 
replicated. 
^"^Means in the same column with the same superscript are not 
different (P > 0.05). 
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Table 3. pH of sausages after cooking in experiment 2 and 
of cultures from fermented pork sausages after 96 
hours incubation at 37° C in experiments 1 and 2 
pH Values® 
After cooking Cultures 
Treatments Expt. 2 Expt. 1 Expt . 2 
Uninoculated pork 6.12±. 07'' 6 .44±. 14b 6 .72±. 04" 
(control) 
Lactobacillus 5.10±. 16= 6 .33±. 17c 6 .69±. 24" 
Pellet (0.05 g) 
Lactobacillus + 
E. coprostanoligenes 4.77±. 07= 6 .27±3 .17^ 6 .72+. 08" 
Pellet (0.05 g each) 
E. coprostanoligenes 
Pellet 
07"^ 0.05 g 5.98+. 6 . 50±. 01® 6 .72±. 04" 
0.10 g 5.99±0 1 d 6 . 38±. 01'" 6 .75±. 17" 
0.20 or 0.50 g 6.00±. 06"^ 6 .46±. 14b 6 .78±. 11" 
Liquid culture 
04'' 1. 0 ml 6.01±. 6 .44±. 08" 6 .77+. 07" 
2.0 ml 5.63±. 57® 6 .41±. 02" 6 .83±. 09" 
10.0 ml 6.02±. 04'' 6 .57±. 06^ 6 .78±. 06" 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 0.5 g E. 
coprostanoligenes in duplicate. Treatments were not 
rwlicated. 
''"^eans in the same column with the same superscript are not 
different (P < 0.05). 
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after cooking in experiment 2 of sausages inoculated with the 
combination of 0.05 g of Lactobacillus and E. 
coprostanoligenes pellet and with 0.05 g of Lactobacillus 
pellet were lower than the pH values of the uninoculated 
(control) sausages and those of the other treatments (P < 
0.05)(Table 3). The pH values of cultures from sausages in 
experiment 1 inoculated with the combination of 0.05 g of 
Lactobacillus and 0.05 g E. coprostanoligenes pellet and from 
sausages inoculated with 0.05 of Lactobacillus were lower than 
those of the other treatments (P < 0.05). No differences (P > 
0.05) were observed for pH values of cultures from fermented 
sausages in experiment 2. 
The pH values of raw ground pork and mutton before and 
after seasoning (before fermentation) and sausages after 
fermentation, after cooking and after 1 month of storage after 
cooking in experiment 3 are shown in Table 4. Pork sausages 
inoculated with the combinations of 0.1 g, 0.25 g and 0.5 g of 
E. coprostanoligenes + 0.05 g of Lactobacillus pellet and with 
0.05 g of Lactobacillus pellet pH values were lower than those 
of the other treatments (P < 0.05)(Table 4). The pH of 
cultures from uninoculated (control) pork sausages was lower 
than those of the other treatments (P < 0.05). The differences 
observed in pH occurred because no specific endpoint for pH 
was used in the experiment (Wu et al., 1991). 
Lactobacillus and E. coprostanoligenes caused pH to 
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Table 4. pH values® of raw ground pork and mutton before and 
after seasoning and of pork and mutton sausages 
after 15 hours of fermentation at 37° C, after 1 
month of storage and in cultures from sausages -
Experiment three 
Before and After After After 
Treatments Fermentation Cooking Storage Cultures 
Before seasoning 
Raw ground 
Pork 5.80±.01^ 
Mutton 5.95±.00° 
Before fermentation 
Raw ground 
Pork 5.92±.01^ 
Mutton 5.83±.0l'' 
After fermentation 
Uninoculated (control) 
Pork 6.091.00® 
Mutton 6.111.00^ 
Lactobacillus 5.07±.10® 
Pellet (0.05 g) - Pork 
6.35±.05^ 6.37±0^ 6.56±.04^ 
6.24±.01'= 6.22±.01® 6.73±.002= 
5.lit.01^ 4.97±.03^ 6.74±.03= 
Lactobacillus (0.05 g) + E. coprostanoligenes 
Pellet - Pork 
0.10 g 4.74±.01^ 4.84±.01® 4.85±.02® 6.84±.02'^ 
0.25 g 4.92±.03^ 5.05±.02^ 4.91±.02^ 6.89±.01^ 
0.50 g 4.74±.05^ 4.991.029 4.85±.039 6.87±.01® 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 6.10±.02^ 6.30±.02^ 6.32±.03'' 6.72±.05® 
0.50 g 6.12±.01^ 6.25±.02^ 6.26±.00^ 6.841.02^^ 
2.00 g 6.24±.013 6.29±.02^ 6.29±.00^ 6.87±.04'^ 
Pellet - Mutton 
0.5 g 6.04±.00'^ 6.22±.01= 6.15±.0l'' 6.99±.09^ 
1.0 g 6.09±.00'' 6.23±.03® 6.20±.03^ 6.76±.01® 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 2.0 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. 
•'"•'Means in the same column with the same superscript are not 
different (P< 0.05). 
= Not evaluated 
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decrease, but when combinations of both bacteria were used the 
decrease was greater. The greater decrease in pH resulted 
because of the acid produced by E. coprostanoligenes (Freier 
et al., 1994). The pH of fresh mutton sausages stored at 2-4° 
C for 120 days did not differ (P > 0.05), but pH increased in 
sausages stored at 20-22° C for 120 days (Wu et al., 1991). 
The pH values observed in cultures from fermented pork 
sausages were more variable, which may have been caused by the 
amo\mt of inoculum added to each culture tube. 
Moisture content. Moisture content of raw ground pork before 
and after seasoning (before fermentation) and fermented pork 
sausages in experiments 1 and 2 are shown in Table 5. The 
moisture percentages in raw ground pork before and after 
seasoning in experiments 1 and 2 were not different from each 
other (P > 0.05). The moisture percentages of uninoculated 
(control) sausages after fermentation, sausages inoculated 
with 0.05 g of Lactobacillus pellet and with 0.5 g of E. 
coprostanoligenes pellet in experiment 1 were lower (P < 0.05) 
than the other treatments. No differences were observed 
between moisture percentages in experiment 1 in sausages 
inoculated with 0.1 and 0.2 g of E. coprostanoligenes pellet 
and 1 ml and 2 ml aliquots of liquid culture of E. 
coprostanoligenes and sausages inoculated with combination of 
0.05 g of Lactobacillus and E. coprostanoligenes pellet (P > 
0.05)(Table 5). In experiment 2, moisture percentages of the 
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Table 5. Moisture content of raw ground pork before and after 
seasoning (before fermentation) and of pork sausages 
after 12 hours of fermentation at 37° C 
Moisture Percentages® 
Treatments Experiment 1 Experiment 2 
Before Seasoning 
Raw ground pork 67.56*' 
Before fermentation 
Raw ground pork 67.6±.08^ 
After fermentation 
Uninoculated pork 61.7±1.2° 
(control) 
Lactobacillus 61.7±1.2° 
Pellet (0.05 g) 
Lactobacillus + 
E. coprastanoligenes 65.0±l'' 
Pellet (0.05 g of each) 
E. coprostanoligenes 
Pellet 
0.05 g 61.7±1.2° 
0.10 g 65.7±1.7'' 
0.20 or 0.5 g 63.5±0.5^ 
Liquid culture 
1.0 ml 66.0±1^ 
2.0 ml 67.0±1^ 
10.0 ml 68.011.7"^ 
6 6 . 0 6 ^  
66.40^ 
64.7±1.1= 
63.5±1.2= 
62.9±1.2= 
65.1±.36= 
65.0±1.6= 
64.8±.75= 
63.4±1.2= 
65.3±.3^ 
68.2±1.6^ 
®^Values represent means and standard errors of triplicate or 
duplicate samples of each treatment. Treatments were not 
r^licated. 
'^ "'%eans in the same column with the same superscript are not 
different (P > 0.05). 
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uninoculated (control) pork sausages and pork sausages treated 
with bacterial pellets and with 1.0 ml aliquot liquid of E. 
coprostanoligenes were lower than those of the other 
treatments (P < 0.05). Moisture percentage of sausages 
inoculated with 10 ml aliquot of liquid E. coprostanoligenes 
culture in experiments 1 and 2 were higher than those of the 
other treatments (P< 0.05) (Table 5). 
Moisture content of raw ground pork and mutton before and 
after seasoning (before fermentation) and pork and mutton 
sausages after fermentation, after cooking and after 1 month 
of storage after cooking in experiment 3 are shown in Table 6. 
Moisture percentage of the raw ground pork before seasoning 
was higher than those of the other treatments (P < 0.05). 
Moisture percentages of uninoculated (control) pork and mutton 
sausages after fermentation and mutton sausages inoculated 
with 0.5 g and 1.0 g of E. coprostanoligenes pellets were 
lower than those the other treatments (P < 0.05)(Table 6). 
Moisture percentage observed of pork sausages inoculated with 
0.25 g and 0.5 g of E. coprostanoligenes pellet after cooking 
and after 1 month of storage were higher than those of the 
other treatments (P < 0.05). 
Moisture percentage was not consistently affected by the 
treatments and the variability may be as a result of the size 
of the ground meat and the type of starter culture used in the 
sausage production. Mutton sausage products made with Lactacel 
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Table 6. Moisture content of raw ground pork and mutton 
before and after seasoning (before fermentation) and 
of pork and mutton sausages after 15 hours of 
fermentation at 37® C, after cooking and after 1 
month of storage after cooking - Experiment three 
Moisture Percentages® 
Before and After After After 
Treatments Fermentation Cooking Storage 
Before seasoning - Raw ground 
Pork 69.74±.72^ 
Mutton 61.93±.12° 
Before fermentation - Raw ground 
Pork 64.55±.55*^ 
Mutton 63.24±.23'^ 
After fermentation 
Uninoculated (control) 
Pork 62.8±.92® 
Mutton 60.1±.32® 
Lactobacillus 63.22±.54^ 
Pellet (0.05 g) - Pork 
Lactobacillus (0.05 g) + 
E. coprostanoligenes 
Pellet - Pork 
0.10 g 
0.25 g 
0.50 g 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 
0.50 g 
2.00 g 
Pellet - Mutton 
0.5 g 
1.0 g 
64.24±.04^ 
63.34±.28® 
63.04±.46"^ 
65.28±.53^ 
63.60±.39^ 
64.35±.25"^ 
62.55±.17° 
60.40±.52^ 
56.60± .52^ 
54.9011.3= 
56.07±1.6'= 
56.49i.22'' 
54.51i.66'' 
58.39i.37= 
59.20il.l'^ 
59.19i.48^ 
57.79i.66^ 
56.77i.79^ 
57.37i.63'' 
58.2+.09^^ 
56.5i.08° 
57.lil.12'' 
57.61.3"^ 
52.li.46® 
57.11.42" 
59.7±.65^ 
61.8i.863 
58.51.10"^ 
56.3i.29= 
56.1i.61= 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 2.0 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. 
''•^Means in the same column with the same superscript are not 
different (P > 0.05). = Not evaluated 
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75 starter culture had more (P < 0.05) moisture than sausage 
products made with L. plantarium 27 (Wu et al., 1991). 
Lipid content. Total lipid content of raw ground pork 
before and after seasoning (before fermentation) and fermented 
pork sausages in experiments 1 and 2 are shown in Table 7. 
Lipid percentages on both dry and wet matter basis observed in 
uninoculated (control) sausages (after fermentation) in 
experiment 1 were lower than those of the other treatments in 
both experiments (P < 0.05)(Table 7). Lipid percentages on 
both dry and wet matter basis in raw ground pork before and 
after seasoning in experiment 2 were not different from each 
other (P > 0.05), but were lower than those of uninoculated 
(control) fermented sausages and sausages inoculated with the 
bacterial pellets (P < 0.05)(Table 7). 
Total lipid content of raw pork sausages after cooking and 
after 1 month of storage after cooking on wet matter basis in 
experiment 2 are shown in Table 8. Lipid percentages of 
uninoculated (control) sausages were not different (P > 0.05). 
Lipid percentages observed in sausages inoculated with 10 ml 
aliquot of liquid E. coprostanoligenes culture in both 
experiments were lower than those of the other treatments (P < 
0.05)(Table 8). 
Total lipid content of raw ground pork and mutton before 
and after seasoning (before fermentation) and pork and mutton 
sausages after fermentation and after cooking in experiment 3 
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Table 7. Total lipid content of raw ground pork before and 
after seasoning (before fermentation) and of pork 
sausages after 12 hours of fermentation at 37° C 
Lipid Percentages® on Dry and Wet Matter Basis 
Treatments 
Before Seasoning 
Raw ground pork 
Before fermentation 
Raw ground pork 
After fermentation 
Uninoculated pork 
(control) 
Lactobacillus 
Pellet (0.05 g) 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
Ejcperiment 1 
Dry Wet 
NE^ NE 
32.97±4.3= 10.7±1.0® 
22.06±4.3'^ 7.7±1.3'^ 
30.14±4.8= 10.611.4= 
35.5± 3.2® 12.111.2= 
37.6±12.8® 12.3±1.0^ 
25.8± 4.3= 8.211.53 
Experiment 2 
Dry Wet 
31.5015.4^ 10.7+1.8^ 
32.7418.1^ 11.012.8^ 
35.1018.4= 12.512.4= 
35.2014.4= 12.911.1= 
34.4011.8= 12.811.2= 
40.71 6.5= 14.212.4"^ 
45.3111.3^ 15.813.6® 
39.4114.8= 14.613.7<^ 
30.31 6.5'=' 11.011.9^ 
29.11 1.7^ 10.110.5^ 
35.21 3.8= 11.212.0^ 
Lactobacillus + 
E. coprostanoligenes 37.7112.0® 13.314.7® 
Pellet 
(0.05 g of each) 
E. coprostanoligenes 
Pellet 
0.05 g 31.21 3.7= 11.911.7= 
0.10 g 35.71 8.1® 12.313.0^ 
0.20 or 0.5 g 26.91 1.2= 9.810.2= 
^Values represent means and standard errors of triplicate or 
duplicate samples of each treatment. Treatments were not 
replicated. 
= not evaluated 
="®Means in the same column with the same superscript are not 
different (P > 0.05). 
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Table 8. Total lipid content of fermented pork sausages 
after cooking and after 1 month of storage after 
cooking - Experiment two 
Lipid Percentages® on Wet Matter Basis 
Treatments After cooking After storage 
Uninoculated pork 
(control) 
13 .3±1 .9^ 13 .9±2^ 
Lactobacillus 
Pellet (0.05 g) 
16 .2±2 .7= 15 .5±1.4= 
Lactobacillus + 
E. coprostanoligenes 
Pellet (0.05 g each) 
16 .8±3 .2= 15 .9±4.1'= 
E. coprostanoligenes 
Pellet 
0.05 g 
0.10 g 
0.50 g 
14 
15 
13 
.2±1 
.5± 
.3±2 
.2^ 
.8^ 
.1^ 
16 
13 
14 
.7± .4= 
.7±2.3^ 
.7±1.5^ 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
13 
12 
11 
.7±1 
.2±1 
.6±1 
.5^ 
.8® 
.8^ 
13 
14 
11 
.7±2^ 
.5± .1^ 
.8± .6"^ 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 0.5 g E. 
coprostanoligenes in duplicate. Treatments were not 
r^licated. 
^"%eans in the same column with the same superscript are not 
different (P > 0.05). 
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are shovm in Table 9. Lipid percentages of raw ground mutton 
and uninoculated (control) and treated mutton sausages on dry-
matter basis were higher than those of raw ground pork and 
pork sausages (P < 0.05). Lipid percentages in raw ground pork 
and mutton and sausages on wet matter basis and on both dry 
and wet matter basis after cooking were variable. After 
cooking, lipid percentages of uninoculated (control) pork 
sausages and pork sausages inoculated with 0.1 g of E. 
coprostanoligenes pellet on dry and wet matter basis were 
lower than those of the other treatments (P < 0.05)(Table 9). 
Total lipid content of fermented pork and mutton sausages 
after 1 month of storage after cooking in experiment 3 are 
shown in Table 10. Lipid percentage of pork sausages 
inoculated with 0.1 g of E. coprostanoligenes pellet were 
lower than those of the other treatments on both dry and wet 
matter basis (P < 0.05) (Table 10). Lipid percentage of mutton 
sausages inoculated with 1.0 g E. coprostanoligenes pellet 
were higher than those of the other treatments on both dry and 
wet matter basis (P < 0.05)(Table 10). 
The variability of lipid percentages in meat samples may 
have resulted from the conditions under which the sausages 
were processed, the size of the inoculum used and the 
interaction of the bacteria with the meat. Microorganisms can 
degrade meat fat by hydrolysis via a lipase and/or oxidation 
by oxidases (Bacus, 1984). E. coprostanoligenes possesses 
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Table 9. Total lipid content of raw ground pork and 
mutton before and after seasoning and of pork and 
mutton sausages after 15 hours of fermentation at 
37® C and after cooking - Experiment three 
Lipid Percentages® on Wet and Dry Matter Basis 
Before and After After 
Fermentation Cooking 
Treatments Dry Wet Dry Wet 
Before seasoning - Raw ground 
Pork 40.90±1.4'= 12.58±.29^ 
Mutton 54.4312.3® 20.71±.81= 
Before fermentation - Raw ground 
Pork 35.58±3.5^ 12.51±1.1^ 
Mutton 37.9211.5® 13.541.45'' 
After fermentation 
Uninoculated (control) 
Pork 35.6811.6'^ 13.181.37^' 27.6516.6^ 12.0311.3^ 
Mutton 47.5512.3^ 19.021.96"^ 41.4612.5° 18.791.66= 
Lactobacillus 37.2211.3® 13.651.31^ 31.7212.1= 13.851.80^ 
Pellet (0.05 g) - Pork 
Lactobacillus (0.05 g) + 
E. coprostanoligenes 
Pellet - Pork 
0.10 g 39.0013.6^ 13.9511.3^ 28.1111.9^ 12.231.82'' 
0.25 g 36.0811.3^ 13.221.44'' 33.8413.0= 15.23+1.3^ 
0.50 g 37.8411.1® 13.971.31^ 35.7111.6= 14.831.55"^ 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 33.8811.0*^ 11.751.36® 40.8715.3= 16.6912.1'^ 
0.50 g 35.4211.2*^ 12.921.56'' 34.7511.2= 14.161.38"^ 
2.00 g 33.411.58^ 11.911.08® 44.9412.8^ 19.0312.1= 
Pellet - Mutton 
0.5 g 41.6211.5'' 15.581.51^ 45.1713.7"^ 19.4611.5® 
1.0 g 45.8211.3® 18.141.539 42.2011.5"^ 17.991.68= 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 2.0 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. = Not evaluated 
''"^ Means in the same coltunn with the same superscript are not 
different (P > 0.05). 
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Table 10. Total lipid content of fermented pork and 
mutton after 1 month of storage after cooking -
Experiment three 
Lipid Percentages® 
Treatments Dry Wet 
Uninoculated (control) 
Pork 
Mutton 
33 
37 
.45± 
.74±1 
.55^ 
.64'= 
13 
16 
.98±.24^ 
.60±.64= 
Lactobacillus 
Pellet (0.05 g - Pork 
30 .57± .48<^ 13 .15±.52'^ 
Lactobacillus (0.05 g) + 
E. coprostanoligenes 
Pellet - Pork 
0.10 g 
0.25 g 
0.50 g 
27 
35 
37 
.33±1 
.28±1 
.52±1 
.72® 
.28^ 
.22"= 
11 
17 
16 
.62±.74® 
.02±.73= 
.08±.51^ 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 
0.50 g 
2.00 g 
31 
36 
34 
.44± 
.78±1 
.77± 
.69® 
.17^ 
.99^ 
13 
14 
14 
.10±.17<^ 
.10±.70® 
.41±.379 
Pellet - Mutton 
0.50 g 
1.00 g 
35 
39 
.48±5 
.12± 
.2^ 
.27^ 
15 
17 
.50±2.08^ 
.17± .30^ 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 1.0 g 
and 2.0 g E. coprostanoligenes in mutton and in pork which 
were in duplicate. Treatments were not replicated. 
"^^ 'Means in the same column with the same superscript are not 
different (P > 0.05). 
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phospholipase activity and requires lecithin for growth 
(Freier, 1991). 
Cholesterol emd coprostanol content. Cholesterol and 
coprostanol concentrations on dry and wet matter basis in raw 
ground pork after seasoning (before fermentation) and 
fermented pork sausages in experiment 1 are shown in Table 11. 
Cholesterol concentrations in raw ground pork before seasoning 
on dry and wet matter basis were lower than those of the other 
treatments (P < 0.05). Sausages inoculated with 0.1 g of E. 
coprostanoligenes pellet contained higher concentration of 
cholesterol on dry matter basis than those in the uninoculated 
(control) sausages and those of the other treatments (P < 
0.05) . 
Cholesterol concentration on wet matter basis in sausages 
inoculated with 0.05 g and 0.1 g of E. coprostanol igenes 
pellet and with 0.05 g Lactobacillus pellet were not different 
from each other (P > 0.05), but contained higher cholesterol 
than those in the uninoculated (control) sausages and the 
other treatments (P < 0.05) (Table 11). No detectable amount 
of coprostanol was observed in any raw ground pork or 
fermented pork sausage samples. 
Cholesterol and coprostanol concentrations in raw ground 
pork before and after seasoning (before fermentation) and pork 
sausages after fermentation on dry and wet matter basis in 
experiment 2 are shown in Table 12. Cholesterol concentration 
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Table 11. Cholesterol and coprostanol concentrations® in raw 
ground pork before and after seasoning 
(before fermentation) and of pork sausages after 12 
hours of fermentation at 37° C - Experiment one 
Dry basis(^g/g) Wet basis (|Xg/g) 
Treatments Chol^. Cop®^ Choi. Cop. 
Before fermentation 
Raw ground pork 
After fermentation 
Uninoculated pork 
(control) 
Lactobacillus 
Pellet (0.05 g) 
Lactobacillus + 
E. coprostanoligenes 
Pellet (0.05 g of each) 
E. coprostanoligenes 
Pellet 
0.05 g 
0.10 g 
0.20 g 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
NDA^ 
NDA 
329.1±46.3® 
685.3±32.1^ 
890.4±25.0® NDA 
727.8±33.5^ NDA 
904.6±37.4® NDA 
968.4±21.3^ NDA 
592.3116.6^ NDA 
944.2±32.0'^ NDA 
846.1±23.4^ NDA 
746.3± 9.4^ NDA 
124.2±24.8® NDA 
259.4±10.0^ NDA 
349.6± 8.0^ NDA 
256.2111.8^ NDA 
352.8114.0® NDA 
337.01 7.4® NDA 
214,01 6.0^ NDA 
324.8111.0^ NDA 
282.61 7.8^ NDA 
238.81 3.0^ NDA 
®Values represent means and standard errors of triplicate or 
duplicate samples of each treatment. Treatments were not 
replicated. 
^Chol = cholesterol 
®Cop = coprostanol 
"^ NDA = no detectable amount 
®"^Means in the same column with the same superscript are not 
different (P > 0.05). 
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on dry matter basis in raw ground pork before ^ seasoning was 
higher than those in the other treatments (P < 0.05). 
Cholesterol concentrations on wet matter basis in raw ground 
pork before seasoning and sausages inoculated with 0.5 g of E. 
coprostanoligenes pellet were not different from each other (P 
> 0.05), but were higher than those in the other treatments (P 
< 0.05) (Table 12). No detectable amount coprostanol was 
observed in any raw ground pork or fermented pork sausage 
samples. 
Cholesterol and coprostanol concentrations detected in 
fermented pork sausages after cooking and after 1 month of 
storage in experiment 2 are shown in Table 13. The cholesterol 
concentrations observed after cooking on wet matter basis in 
sausages inoculated with the combination of 0.05 g of 
Lactobacillus and E. coprostanoligenes pellet was higher than 
those in the uninoculated (control) sausages and other 
treatments (P < 0.05) (Table 13). No detectable amount of 
coprostanol was observed in any uninoculated (control) or 
inoculated pork sausage. 
After 1 month of storage after cooking, no differences were 
observed between cholesterol concentrations in the sausages 
(P > 0.05) (Table 13). No detectable amount of coprostanol was 
observed in any sausage scimple. 
Cholesterol and coprostanol concentration in cultures of 
suspensions from fermented pork sausages in experiments 1 and 
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Table 12. Cholesterol and coprostanol concentrations® in pork 
samples before and after 12 hours of fermentation 
at 37° C - Experiment two 
Dry basis (|Llg/g) Wet basis (jig/g) 
Treatments Chol^. Cop°. Choi. Cop. 
Before seasoning 
Raw ground pork 
Before Fermentation 
Raw ground pork 
After fermentation 
Uninoculated pork 
(control) 
Lactobacillus 
Pellet (0.05 g) 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
1188.20±150.0® NDA"^ 
847.06± 50.0^ NDA 
928.30± 13.99 NDA 
867.80± 26.79 NDA 
936.71 40.69 NDA 
959.4± 14.1^ NDA 
959.41 22.5® NDA 
404.01 5.0® NDA 
288.6117.0^ NDA 
334.21 5.0® NDA 
312.41 9.69 NDA 
298.0111.6^ NDA 
356.8113.29 NDA 
311.41 5.89 
382.0122.8® NDA 
337.2114.69 NDA 
326.21 4.89 NDA 
307.01 7.2^ NDA 
Lactobacillus + 
E. coprostanoligenes 784.201 30.5® NDA 
Pellet (0.05 g each) 
E. coprostanoligenes 
Pellet 
0.05 g 991.11 36.7^ NDA 
0.10 g 915.91 17.19 NDA 
0.50 g 1061.11 63.3^ NDA 
^Values represent means and standard errors of triplicate 
scimples of each treatment except seunples treated with 0.5 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. 
^Chol = cholesterol 
°Cop = coprostanol 
"^ NDA = no detectable amount 
®"'^ Means in the same column with the same superscript are not 
different (P > 0.05). 
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Table 13. Cholesterol and coprostanol concentrations^ in 
fermented pork sausages after cooking and after 1 
month of storage after cooking - Experiment two 
After cooking After Storage 
Treatments Chol^. Cop." 
Uninoculated pork 
(control) 
Lactobacillus 
Pellet (0.05 g) 
Lactobacillus + 
E. coprostanoligenes 
Pellet (0.05 g each) 
E. coprostanoligenes 
Pellet 
0.05 g 
0.10 g 
0.50 g 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
318. 8± 5.8® NDA' 
326.0± 7.8® NDA 
396.0±28.4^ NDA 
293.0± 3.4® 
278.6±18.29 
381.8± 3.4® 
290.4±16.8® 
320.2±13.6® 
282.4± 3.8® 
NDA 
NDA 
NDA 
NDA 
NDA 
NDA 
Choi. 
•Wet basis (^ig/g)-
C QS TVTnAQ 
Cop. 
448±17® NDA 
431±26.4® NDA 
431.55.8® NDA 
372±12.4® NDA 
363±10.6® NDA 
400± 3.6® NDA 
391± 2® 
293.28.6® 
395± 8.2® 
NDA 
NDA 
NDA 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 0.5 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. 
''Choi = cholesterol 
''Cop = coprostanol 
^NDA = no detectable amount 
®"®Means in the same colvunn with the same superscript are not 
different (P > 0.05) 
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2 are shown in Table 14. Cholesterol concentrations in 
cultures from uninoculated (control) sausages in experiment 1 
was higher than those of the other treatments (P < 0.05). 
Cholesterol concentration observed in cultures from sausages 
inoculated with the combination of 0.05 g Lactobacillus and E. 
coprostanoligenes pellets and with 1.0 ml aliquot of liquid E. 
coprostanoligenes culture in experiment 2 were higher than 
those in the other treatments in both experiments (P < 
0.05)(Table 14). 
No detectable amount of coprostanol was observed in any 
cultures from any of the fermented pork sausages experiment 1. 
Coprostanol was detected only in cultures from sausages 
inoculated with 0.5 g of E. coprostanoligenes pellet in 
experiment 2. The detection of coprostanol in cultures from 
sausages inoculated with the 0.5 g of bacterial pellet showed 
that E. coprostanoligenes remain viable and maintained its 
ability to reduce cholesterol to coprostanol after 
fermentation. 
Cholesterol and coprostanol concentrations in raw ground 
pork and mutton before seasoning, after seasoning (before 
fermentation) and pork and mutton sausages after fermentation 
in experiment 3 are shown in Table 15. Cholesterol 
concentrations observed in raw ground pork before and after 
seasoning (before fermentation), uninoculated (control) pork 
sausages after fermentation, pork sausages inoculated with 
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Table 14. Cholesterol and coprostanol concentrations® in 
cultures from pork sausages after fermentation - 96 
hours of incubation at 37® C 
Experiment 1 Experiment 2 
Treatments 
Uninoculated pork 
(control) 
Lactobacillus 
Pellet (0.05 g) 
Lactobacillus + 
E. coprostanoligenes 
Pellet (0.05 g each) 
E. coprostanoligenes 
Pellet 
0.05 g 
0.10 g 
0.20 or 0.5 g 
Choi''. Cop®. Choi. 
(fig/ml)-
Cop. 
438.2±44.0® NDA"^ 721.3±33.9® NDA"^ 
226.3±20.4^ NDA 729.3+17.2® NDA 
231.0±15.0^ NDA 828.0±90.5^ NDA 
244.0± 6.43 NDA 717.3±11.1® NDA 
378.9±50.6® NDA 544.0+75.4® NDA 
429.5±54.0^ NDA 570.0±.93^ 18.5±4.9 
Liquid culture 
1.0 ml 
2.0 ml 
10.0 ml 
230.2±11.9^ NDA 
215.9±10.5^ NDA 
286.8± 4.2® NDA 
824.01±30.2^ NDA 
773.32±40.6® NDA 
761.28±19.3® NDA 
^Values represent means and standard errors of duplicate 
samples of each treatment. Treatments were not replicated. 
^Chol = cholesterol 
®Cop = coprostanol 
*^NDA = no detectable amount 
®'®Means in the same column with the same superscript are not 
different (P > 0.05). 
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Table 15. Cholesterol and coprostanol concentrations® in 
pork and mutton before and after 15 hours of 
fermentation at 37° C - Experiment three 
Treatments 
Dry basis (|ig/g) 
Chol^. Cop°. 
Wet basis(^g/g) 
Choi. Cop. 
Before seasoning 
Raw ground 
Pork 
Mutton 
734.2±51.4'^ 
1671.0±33.7® 
3.5"^* 222.8±10.8^ 1.0"^* 
1.8±.8^** 638.3± 9.5® .71.3"^* 
Before fermentation 
Raw ground 
Pork 
Mutton 
518.1±20.9'^ 
1933.3±47.3^ 
1.3±.l^** 203.3± 9.1^ .5±.0®* 
2.0±.l'^** 687.8+20.3® .7±.0<^* 
After fermentation 
Uninoculated (control) 
Pork 542.1± 27.0"^ NDA"" 
Mutton 2157.1±549.3® 3.6"^* 
Lactobacillus 844.3± 15.3^ 1.7"^* 
Pellet (0.05 g) - Pork 
198.4± 9.8^ NDA" 
868.4±210.1^ 1.4"^* 
366.9± 23.5^ rd* 
Lactobacillus (0.05 g) + 
E. coprostanoligenes 
Pellet - Pork 
0.10 g 504.6±26.89 
0.25 g 463.6±38.8® 
0.50 g 492.1122.1® 
.9"^* 180.0± 9.3^ .3"^* 
1.7±.2'^***170.8±12.7^ .6±.l®** 
3.3±.6'^*"181.4± 5.6^ 1.2±.2'^** 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 
0.50 g 
2.00 g 
Pellet - Mutton 
0.50 g 
1.00 g 
591.9±25.2<^ 
708.4±61.2'^ 
1272.11 .2^ 11.8±.4® 
2.51.1'^** 203.9± 7.7^ .81.0"^* 
3.11.6"^" 226.4±27.4"^ 1.1±.3^* 
449.4± 1.9^ 4.1±.2^* 
1414.1±27.6^ 
1535.0±75.0^ 
1.3±.5^** 532.1+12.7^" .7±.3^* 
3.4±.2'^***609.2±23.3^ 1.31.1"^** 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 2.0 g B 
coprostanoligenes in duplicate. Treatments were not 
replicated. %hol = cholesterol, °Cop = coprostanol. 
•^"^Means in the same column with the same superscript are not 
different^jP< 0.05). * = 1 positive, ** = 2 
positive,** = 3 positive, "toA = no detectable amount. 
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0.25 g and 0.5 g of E. coprostanoligenes pellet on dry matter 
basis were not different (P > 0.05). Sausages inoculated with 
the combinations of 0.1 g, 0.25 g and 0.5 g of E. 
coprostanoligenes and 0.05 g of Lactobacillus pellets were not 
different from each other, but were lower than those of the 
other treatments (P < 0.05)(Table 15). Cholesterol 
concentrations observed in raw ground mutton and mutton 
sausages on dry and wet matter basis were higher than those of 
raw ground pork and pork sausages (P < 0.05) . 
Cholesterol concentrations on wet matter basis in raw 
ground pork, uninoculated (control) pork sausages, pork 
sausages inoculated with the combinations of 0.1 g, 0.25 g and 
0.5 g of E. coprostanoligenes + 0.05 g of Lactobacillus pellet 
and with 0.25 g of E. coprostanoligenes pellet were not 
different from each other (P > 0.05), but they were lower than 
those of the other treatments (P < 0.05) (Table 15) (Figure 1) . 
Small amounts of coprostanol were detected in raw ground 
pork and mutton on dry and wet matter basis. No coprostanol 
was detected in the uninoculated (control) pork sausage after 
fermentation. The concentration of coprostanol observed on dry 
and wet matter basis in pork sausages inoculated with 2.0 g E. 
coprostanoligenes pellet were higher than the coprostanol 
concentrations detected in all other meat samples (P < 0.05) 
(Table 15). No differences were observed between coprostanol 
concentrations detected in the other meat samples (P > 0.05) 
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Treatments 
Cholesterol concentrations in meat samples before and after 15 hours of 
fermentation at 37° C, P = pork, M = mutton. Farm = fermentation, Lact = 
Lactobacillus, E = Eubacterixm, Season = seasoning. Values are expressed 
as treatment means ± SEM 
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(Table 15)(Figure 2). 
Cholesterol and coprostanol concentrations in fermented 
pork and mutton sausages after cooking in experiment 3 are 
shown in Table 16. No differences were observed between 
cholesterol concentrations detected on dry and wet matter 
basis in the uninoculated (control) pork sausages and any of 
the inoculated pork sausages (P > 0.05)(Table 16). Cholesterol 
concentration in uninoculated mutton sausages was lower than 
those in mutton sausages inoculated with 0.5 g and 1.0 g of E. 
coprostanoligenes pellet (P < 0.05)(Table 16). Cholesterol 
concentrations observed on dry and wet matter basis in mutton 
sausages were higher than those of the pork sausages (P < 
0.05)(Table 16)(Figure 3). 
Pork sausages inoculated with 2.0 g E. coprostanoligenes 
pellet had the highest coprostanol concentration on dry and 
wet matter basis whereas no coprostanol was detected in the 
uninoculated (control) pork and mutton sausages, pork sausages 
inoculated with the combination of 0.5 g of £. 
coprostanoligenes + 0.05 g of Lactobacillus pellets and with 
0.05 g of Lactobacillus pellet. No differences were observed 
on wet and dry between coprostanol concentrations detected in 
the sausages (P > 0.05)(Table 16)(Figure 4). 
Cholesterol and coprostanol concentrations in fermented 
pork and mutton sausages after 1 month of storage after 
cooking showed that cholesterol was detected in all samples 
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Figure 2. Coprostanol concentrations in meat samples before and after 15 hours of 
fermentation at 37° C, P = pork, M = mutton, Ferm = fermentation, Lact = 
Lactobacillus, E = Eubacterium, Season = seasoning. Values are expressed 
as treatment means ± SEM 
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Table 16. Cholesterol and coprostanol concentrations® in 
fermented pork and mutton sausages after cooking -
Experiment three 
Dry basis (|ig/g) Wet basis (|ig/g) 
Treatments Choi''. Cop®. Choi. Cop. 
Uninoculated 
Pork 
Mutton 
445.0±15.2® NDA"^ 191.6± 5.7® 
1081.8128.2^ NDA 493.5±17.9^ 
NDA 
NDA 
Lactobacillus 
Pellet (0.05 g) - Pork 
Lactobacillus (0.05 g)+ 
E. coprostanoligeixes 
Pellet - Pork 
0.10 g 
0.25 g 
0.50 g 
527.2131.6* 
579.3129.5® 
363.3121.1® 
630.3146.1® 
NDA 
3.3®* 
3.2®* 
NDA® 
228.51 7.8® 
252.3113.0® 
159.71 8.1® 
263.1121.4® 
NDA 
1.4®* 
1.5®* 
NDA 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 
0.50 g 
2.00 g 
Pellet - Mutton 
0.50 g 
1.00 g 
668.6161.3® 
644.0127.1® 
450.0122.5® 
e* 4.0 
6.2® 
8.2®** 
1257.31 15.8Sf 5.0®** 
1853.51179.3^ 7.8®* 
285.6120.3® 
265.7113.6® 
189.01 5.3® 
544.71 9.19 
320.2113.6^ 
2.0®* 
2.6®** 
3.5®** 
2.1®* 
3.2®* 
^Values represent means and standard errors of triplicate 
samples of each treatment except samples treated with 2.0 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. 
''Choi = cholesterol 
®Cop = coprostanol 
^NDA = no detectable amount 
®"'^Means in the same col\amn with the same superscript are not 
different (P < 0.05). 
* = 1 sample positive 
** = 2 samples positive 
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Figure 3. Cholesterol concentrations in fermented sausages after cooking at 68° C for 
25 minutes, P = pork, M = mutton, Ferm = fermentation, Lact = Lactobacillus, 
E = Eubacterium. Values are expressed as treatment means ± SEM 
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Figure 4. Coprostanol concentrations in fermented sausages after cooking at 68° C for 
25 minutes, P = pork, M = mutton, Perm = fermentation, Lact = Lactobacillus, 
E = Eubacterium. Values are expressed as treatment means ± SEM 
147 
but no coprostanol was detected in any pork or mutton sausage 
(data not shown). 
Cholesterol and coprostanol concentrations observed in 
cultures of suspensions from fermented pork and mutton 
sausages after 96 hours incubation in experiment 3 are shown 
in Table 17. Cholesterol concentration detected in cultures 
from uninoculated (control) sausages were lower than those in 
cultures from the other sausages (P < 0.05). Cholesterol 
concentrations observed in cultures from pork sausages 
inoculated with 0.25 g and 0.5 g of E. coprostanoligenes 
pellet and with 0.25 g of E. coprostanoligenes + 0.05 g of 
Lactobacillus pellets and mutton sausages inoculated with 0.5 
g of E. coprostanoligenes pellet were not different from each 
other (P > 0.05), but were higher than those of the other 
treatments (P < 0.05)(Table 17). 
The highest coprostanol concentration was detected in 
cultures from pork sausages inoculated with 2.0 g of E. 
coprostanoligenes pellet whereas no coprostanol was detected 
in cultures from the uninoculated (control) pork and mutton 
sausages, pork sausages inoculated with the combinations of 
0.1 g, 0.25 g and 0.5 g of E. coprostanoligenes + 0.05 g of 
Lactobacillus pellets. The coprostanol concentration detected 
in cultures from pork sausages inoculated with 2.0 g of E. 
coprostanoligenes pellet was higher than those of the other 
treatments (P < 0.05)(Table 17) (Figure 5). The 
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Table 17. Cholesterol and coprostanol concentrations® in 
cultures from pork sausages after fermentation -
96 hours of incubation at 37° C - Experiment three 
(|xg/ml) 
Treatments Choi . Cop®. 
Uninoculated (control) 
Pork 
Mutton 
270.67±34.9"^ 
439.32±72.3® 
NDA"^ 
NDA 
Lactobacillus 
Pellet (0.05 g) - Pork 
465.81+25.2® 1.02+.21®** 
Lactobacillus (0.05 g) + 
E. coprostanoligenes 
Pellet - Pork 
0.10 g 
0.25 g 
0.50 g 
538.74± 46.5® 
538.74±106.6^ 
214.68± 19.2^ 
NDA 
NDA 
NDA 
E. coprostanoligenes 
Pellet - Pork 
0.25 g 
0.50 g 
2.00 g 
547.16±45.3^ 
537.79±51.5^ 
452.93±27.3® 
1.06±.40®** 
1.54±.64®*** 
130.56±.93^** 
Pellet - Mutton 
^ 0.50 g 
r^l.OO g 
576.65±47.5^ 
382.91±52.7® 
2.31±.99®** 
.65®* 
^Values represent means and standard errors of triplicate 
samples of each treatment except sample treated with 2.0 g E. 
coprostanoligenes in duplicate. Treatments were not 
replicated. 
''Choi = cholesterol 
"^Cop = coprostanol 
•^NDA = no detectable amoxint 
®'^Means in the same column with the same superscript are not 
different {P< 0.05). 
* = 1 sample positive 
**= 2 samples positive 
= 3 samples positive 
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coprostanol concentrations detected in the other cultures not 
different from each other (P > 0.05). 
The detection of coprostanol in meat samples and in 
cultures inoculated with suspensions from the fermented 
sausages showed that E. coprostanoligenes remained viable 
while converting cholesterol in pork and mutton during 
fermentation and maintained its ability to reduce cholesterol 
to coprostanol after fermentation when added to media 
containing cholesterol. 
Cholesterol concentration in the fermented sausages and 
cultures showed much variability which could have resulted 
from several factors: the size of the ground meat used in the 
production of the sausages, the amount of cholesterol present 
in the meats, the type of starter culture used and the 
interactions of the bacteria with the condiments added to the 
meats and with the meats themselves and the conditions under 
which the sausages were produced. 
Mutton sausages made from Pediococcus acidilactici H had 
lower (P < 0.05) percent retention of cholesterol during 
processing and storage than those made from Lactacel 75 and 
from Lactobacillus plantarum 27 (Wu et al., 1991). Lipolytic 
microorganisms degrade meat fats by hydrolysis via a lipase 
and/or oxidation by oxidases liberating fatty acids (Bacus, 
1984) . E. coprostanoligenes possesses phospholipase activity 
and requires lecithin for growth. Lecithin was hydrolyzed 
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Figure 5. Coprostanol concentrations in cultures inoculated with suspensions from 
fermented sausages, cultures were incubated for 96 hours at 37° C, P = pork, 
M = mutton, Ferm = fermentation, Lact = Lactobacillus, E = 
Eubacterium. Values are expressed as treatment means ± SEM 
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because free fatty acids were detected in the media, but 
lecithin was not detected (Freier, 1991, Frier et al., 1994). 
E. coprostanoligenes may cause hydrolysis of cholesteryl 
esters in the meat liberating cholesterol and free fatty 
acids. 
Fatty acids liberated by the interactions of the bacteria 
with the meats may be inhibitory to the microorganisms (Bacus, 
1984) and may have affected the ability of the bacteria to 
reduce cholesterol. E. coprostanoligenes did not convert 
cholesterol to coprostanol when fatty acids were added to 
media containing cholesterol and no lecithin (Freier, 1991). 
Cholesterol content was greater (P < 0.05) in high-
temperature- stored products, but no differences (P < 0.05) was 
observed for fresh cooked sausages and 120-day sausages stored 
at 2-4° or 20-22° C (Wu et al., 1991). 
CONCLUSIONS 
The results suggest that addition of Lactobacillus and E. 
coprostanoligenes caused pH to decrease in fermented pork and 
mutton sausages. When combinations of Lactobacillus + E. 
coprostanoligenes were used, lower (P < 0.05) pH values were 
observed when compared with sausages inoculated with 
Lactobacillus. Moisture, total lipid composition and 
cholesterol content were not consistently affected by the 
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bacterial treatments. Small amounts of coprostanol were 
detected in raw ground pork and mutton before fermentation. 
After fermentation no coprostanol was detected in the 
uninoculated (control) pork sausages. The highest 
concentration of coprostanol was detected in pork sausages 
inoculated with 2.0 g of E. coprostanoligenes pellet. Both 
Lactobacillus and E. coprostanoligenes produced coprostanol in 
the pork and mutton during fermentation. 
No coprostanol was detected in cultures from uninoculated 
control) pork and mutton sausages and pork sausages inoculated 
with the various combinations of Lactobacillus + E. 
coprostanoligenes after 96 hours of incubation. Culture from 
sausages inoculated with 2.0 g of E. coprostanoligenes 
produced higher (P < 0.05) concentration of coprostanol after 
96 hours of incubation. The detection of coprostanol in 
cultures from fermented sausages and in cultures from 
fermented sausages confirmed that E. coprostanoligenes will 
remain viable during fermentation of pork and mutton sausages 
while converting cholesterol to coprostanol and will maintain 
its ability to reduce cholesterol to coprostanol during and 
after fermentation. E. coprostanoligenes may be used to 
decrease the cholesterol content of fermented meats. 
Additional studies are needed to determine the 
effectiveness of E. coprostanoligenes to decrease the 
cholesterol content of meats. These studies have identified 
153 
several areas of specific research needs: 
1. Determination of the maximal growth phase of E. 
coprostanoligenes, 
2. Determination of the optimal pH and temperature required 
for growth of the bacteria in meats, 
3. Determination of the most suitable size of ground meat 
needed for adequate growth of the bacteria and reduction 
of cholesterol to coprostanol during fermentation, 
4. Determination of the adequate amount of inoculum of E. 
coprostanoligenes needed for growth of the bacteria in 
meats and conversion of cholesterol to coprostanol 
during fermentation, 
5. Determination of the consistency of the ground meat 
required for adequate growth of the bacteria and 
reduction of cholesterol to coprostanol during 
fermentation, 
7. Determination of the optimal protein, fat and moisture 
content of meat required for adequate growth of the 
bacteria and reduction of cholesterol to coprostanol 
during ferroentation and 
8. Determination of the optimal time required for adequate 
growth of the bacteria in meat and reduction of 
cholesterol to coprostanol during fermentation. 
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GENERAL CONCLUSIONS 
In the first paper of this dissertation, New Zealand White 
adult male rabbits were used to investigate the potential for 
the use of E. coprostanoligenes, a cholesterol-reducing 
bacteria, to decrease plasma cholesterol concentration as a 
model for human hypercholesterolemia. The objectives were; 1) 
To feed a cholesterol-enriched diet to make the rabbits 
hypercholesterolemic and to evaluate the effects of dietary 
administered E. coprostanoligenes on (a) rabbit plasma 
cholesterol concentration (b) rabbit health and (c) fecal 
coprostanol and cholesterol ratios. 
Oral administration of E. coprostanoligenes decreased 
cholesterol concentration in rabbits receiving a 0.1% 
cholesterol diet. Changes in plasma cholesterol concentration 
from day 0-77 were significantly lower (P < 0.01) in rabbits 
fed the 0.1% cholesterol + E. coprostanoligenes in 2% milk 
diet than plasma cholesterol concentration in rabbits fed the 
0.1% cholesterol + boiled E. coprostanoligenes in 2% milk 
diet. 
Several liver enzyme activities and major metabolites in 
plasma evaluated were not influenced by the bacterial 
treatments. The results suggest that incorporation of E. 
coprostanoligenes in milk and feeding to New Zealand White 
adult male rabbits receiving a 0.1% cholesterol-enriched has 
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been shown to be nontoxic and nonpathogenic to rabbits as no 
changes were observed in plasma enzymes GOT, GPT, LDH and ALP 
activities and major metabolites bilirubin, uric acid and 
total protein concentrations during the bacterial feeding when 
compared with the activities and concentrations at the 
initiation of the bacterial feeding. 
The results further suggest that E. coprostanoligenes since 
seemed to be nontoxic and nonpathogenic in rabbits, it may be 
safe for human consumption. Milk may be used as a medixam to 
deliver a cholesterol-reducing microbe to decrease plasma 
cholesterol concentration in humans. The decrease in plasma 
cholesterol concentrations observed in hypercholesterolemic 
rabbits fed E. coprostanoligenes may have important impacts on 
human health and welfare. 
In the second paper the ability of Bubacterium 
coprostanoligenes to decrease cholesterol content of fermented 
pork and mutton sausages was evaluated as a model for 
decreasing the cholesterol content of foods. The viability of 
E. coprostanoligenes in the fermented sausages was evaluated 
by analysis of the concentrations of cholesterol and 
coprostanol in fermented pork and mutton sausages and in 
cultures inoculated with suspensions from the fermented 
sausages. Moisture, total lipid content and cholesterol 
content were not consistently affected by the bacterial 
treatments. The highest concentration of coprostanol was 
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detected in the 100 g pork sausages inoculated with the 2.0 g 
of E. coprostanoligenes pellet. Both Lactobacillus and E. 
coprostanoligenes produced coprostanol in the ground pork 
during fermentation. 
Sausages inoculated with various combinations of 
Lactobacillus + E. coprostanoligenes did not produce 
coprostanol in cultures containing 0.2% cholesterol after 96 
hours of incubation at 37° C. Cultures from fermented sausages 
inoculated with 2.0 g of E. coprostanoligenes also produced 
significantly higher (P < 0.05) concentration of coprostanol 
than all other treatments after 96 hours of incubation at 37° 
C. The detection of coprostanol in cultures from the fermented 
sausages confirmed that E. coprostanoligenes will remain 
viable during fermentation and will maintain its ability to 
reduce cholesterol to coprostanol during and after 
fermentation. E. coprostanoligenes may be used to decrease the 
cholesterol content of fermented meats because coprostanol was 
produced. 
The results obtained from these two studies suggest that 
there are some potential for the development and application 
of technologies to use E. coprostanoligenes to treat hioman 
hypercholesterolemia. There is potential for prevention of 
hypercholesterolemia by utilization of this bacteria and/or 
cholesterol reductase enzyme isolated from this bacteria in 
food processing which should result in the lowering of the 
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cholesterol content in foods. This technology should result in 
the availability of foods with a more favorable cholesterol 
content and maintaining the nutrition, aesthetic, palatability 
and other organoleptic qualities. Informed consiimers who are 
concerned about the composition of their diet and patients 
with hypercholesterolemia could now benefit from this 
technology. 
The potential exist for treatment of hypercholesterolemia 
by utilization of this bacteria and/or cholesterol reductase 
enzyme if research is continued and the results should further 
indicate the safety of the bacteria in humans. 
Hypercholesterolemic human subjects may benefit from ingestion 
of an effective dose of the bacteria and/or enzyme in a 
capsule form which would facilitate passage into the lower 
gastrointestinal tract or consumption of an effective dose of 
the bacteria and/or enzymes in commonly consiimed foods. 
Additional studies are needed to determine the 
effectiveness of E. coprostanoligenes to decrease plasma 
cholesterol concentration of model animals and then hiimans and 
the cholesterol content of meats and other animal-derived 
foods. The following are some future research considerations: 
1. Determination of the minimum effective dose of E. 
coprostanoligenes needed to achieve a decrease in plasma 
cholesterol concentration. 
2. Determination of the by-products of metabolism and evaluate 
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for toxicity. 
3. Isolation and purification of cholesterol reductase enzyme 
produced by E. coprostanoligenes. 
4. Physical and chemical characterization of cholesterol 
reductase. 
5. Determination of the mechanism(s) of cholesterol reductase 
reduction of cholesterol to coprostanol. 
6. Identification and isolation of the gene(s) involved in the 
regulation of cholesterol reductase activity. 
7. Determination of the interaction of E. coprostanoligenes 
with the condiments used in sausage production. 
8. Determination of the most suitable conditions and dose 
needed for E. coprostanoligenes to grow in meats and other 
animal-derived products and to effectively decrease their 
cholesterol content. 
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APPENDIX A BODY WEIGHTS OF RABBITS 
Table 1. Body weight of rabbits fed a commercial chow 
followed by a 0.1% cholesterol-enriched diet and 
Eubacterium coprostanoligenes in 2% fat milk for 21 
days 
Body Weight® (kg) 
Periods of Experiment (days) 
Groups 0 7 14 28 35 42 49 56 63 70 77 
1 3 .8 4 .0 3 .9 4.1 4.0 4.0 4.1 4.0 4.1 4.1 4.0 
± .08 ± .08 ± .08 ±.08 ±.05 ±.08 ±.l ±.03 ±.1 ±.05 ±.l 
2 3 .8 3 .8 3 .9 3.9 3.8 3.9 3.9 3.8 3.9 3.7 3.7 
± .02 ± .02 ± .03 ±.03 ±.03 ±.03 ±.03 ±.05 ±.05 ±.05 ±.03 
3 3 .8 3 .8 3 .8 3.7 3.7 3.8 3.8 3.8 3.8 3.8 3.8 
± .03 ± .03 ± .03 ±.03 ±.03 ±.03 ±.03 ±.03 ±.03 ±.04 ±.05 
^Values represent means and standard errors of body weight per 
group of rabbits corresponding to days of experiment. 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched diet was 
continued until day 77. Groups: 1 = No cholesterol (control), 
N = 4; 2 = 0.1% cholesterol + boiled E. coprostanoligenes in 
2% fat milk, N = 6; 3 = 0.1% cholesterol + E. 
coprostanoligenes in 2% fat milk, N = 8. 
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Table 2. Body weight of rabbits fed a commercial chow 
followed by a 0.1% cholesterol-enriched diet and 
Eubacterium coprostanoligezies in 2% fat milk for 21 
days. 
Body Weight® (kg) 
Days of Experiment 
Groups 108 111 118 125 132 137 
1 4.1 4.0 4.0 4.1 4.1 4.0 
±.05 ±.08 ±.l ±.03 ±.l ±.l 
2 3.9 3.8 3.9 3.8 3.7 3.7 
±.03 ±.03 ±.03 ±.05 ±.05 ±.03 
3 3.7 3.7 3.8 3.8 3.8 3.8 
±.03 ±.03 ±.03 ±.03 ±.03 ±.05 
^Values represent means and standard errors of body weight per 
group of rabbits corresponding to days of experiment. 
Bacterial feeding was initiated on day 28 and terminated on 
day 49. Feeding of the 0.1% cholesterol-enriched diet was 
continued until day 77. Regular chow was fed from day 78 to 
day 108, then followed by 0.1% cholesterol diet from day 109 
to day 137. 
Groups: 1 = No cholesterol (control), N = 4; 2 = 0.1% 
cholesterol + boiled E. coprostanoligenes in 2% fat milk, N = 
6; 3 = 0.1% cholesterol + E. coprostanoligenes in 2% fat milk, 
N = 8. 
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APPENDIX B PLASMA CHOLESTEROL CONCENTRATION IN RABBITS 
Group 1. No cholesterol (control) 
Plasma Cholesterol Concentration (g/100 ml) 
Days of Experiment 
Rabbit No 0 7 14 28 35 42 49 56 63 
2145 16.4 12 .0 10.9 6 .7 9 .6 12 .7 8 .4 12 .4 13 .0 
2149 19.0 22 .0 21.1 14 .6 18 .1 18 .1 16 .1 17 .2 19 .9 
2168 12.6 15 .2 14.0 12 .3 12 .5 14 .7 13 .3 16 .2 14 . 6 
2169 30.8 36 .3 23.5 26 .5 23 .9 20 .4 21 .3 19 .4 28 .4 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 120.3 135 .8 119.8 118 .4 214 .2 247 .4 305 .9 293 .9 275 .1 
2147 42.4 64 . 6 48.7 39 .8 91 .8 96 .7 114 .9 95 .0 90 .2 
2150 180.2 252 .0 194.7 270 .0 258 .7 253 .6 297 .7 345 .5 274 .3 
2153 116.5 137 .5 104.0 162 .8 236 .7 259 .8 309 .3 264 .5 266 .7 
2161 38.0 45 .3 50.8 55 .5 88 .8 75 .2 95 .3 125 .4 91 .8 
2163 82.2 129 .0 138.9 138 .9 137 .4 140 .1 111 .3 103 .7 123 .1 
Group 3. Eubacterium in 2 % fat milk 
2142 85.2 78 .2 85.2 83 .8 109 .2 116 .8 97 .1 84 .3 66 .7 
2148 27.7 31 .4 32.8 20 .8 33 .3 42 .6 58 .1 52 .1 55 .0 
2151 316.8 290 .1 289,9 198 .6 251 .2 264 .6 310 .7 321 .6 280 .5 
2155 162.2 173 .2 166.2 202 .1 257 .4 287 .3 318 .1 273 .0 320 .4 
2156 61.7 57 .3 55.3 55 .7 53 .3 67 .4 74 .1 64 .7 64 .7 
2157 114.4 123 .6 96.1 120 .7 167 .5 175 .9 242 .4 186 .1 213 .9 
2158 323.6 327 .3 296.5 306 .5 330 .8 288 .8 310 .1 288 .9 282 .1 
2164 49.3 59 . 6 44.5 51 .9 64 .9 86 .0 93 .5 72 .2 74 .1 
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Group 1. No cholesterol (control) 
Plasma Cholesterol Concentration (g/100 ml) 
Days of Experiment 
Rabbit No . 70 77 108 111 118 125 132 137 
2145 13.5 11.7 15.9 14.0 18 .6 19. 7 19. 1 16.6 
2149 23.4 23.9 19.1 15.4 20 .5 23. 9 26. 3 32.6 
2168 14.3 15.5 10.9 9.2 16 .6 21. 8 19. 2 14.8 
2169 22.4 16.9 12.7 16.0 27 .5 31. 8 37. 9 25.8 
Group 2. Boiled Eubacterim, 1 in 2% fat milk 
2144 276.4 309.8 80.6 99.6 114 .9 127. 7 128. 7 111.9 
2147 90.7 73.1 13.3 16.8 29 .3 34. 9 59. 1 33.6 
2150 229.1 306.8 241.2 264.1 256 .4 282. 0 291. 3 290.8 
2153 281.3 284.6 71.8 86.8 137 .6 168. 5 169. 3 208.0 
2161 87.0 123.0 7.8 5.9 24 .1 31. 9 21. 4 12.6 
2163 112.8 131.5 238.7 261.7 253 .1 299. 8 290. 1 285.1 
Group 3. Eubacterium in 2 % 1 fat milk 
2142 75.3 83.9 17.3 27.2 45 .2 55. 0 52. 6 34.4 
2148 52.2 60.5 12.2 14.5 26 .5 37. 4 38. 2 20.9 
2151 281.3 309.8 273.7 232.3 171 .2 159. 1 162. 9 158.5 
2155 258.4 283.3 111.1 139.3 209 .9 206. 7 255. 7 265.2 
2156 64.3 55.4 16.8 30.7 44 .6 50. 6 68. 4 28.6 
2157 206.4 222.5 54.1 72.7 115 .3 147. 8 154. 9 132.5 
2158 283.3 310.5 275.2 267.4 252 .5 249. 8 300. 4 297.8 
2164 89.2 76.3 12.2 19.9 44 .6 57. 6 77. 3 41.7 
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APPENDIX C PLASMA ENZYME ACTIVITIES AND MAJOR METABOLITE 
CONCENTRATIONS IN RABBITS 
Group 1. No cholesterol (control) 
Day 28 of Experiment 
GOT GPT LDH ALP Total Bilirubin Uric acid 
Rabbit No. (lU/L) 
irirocein "" 
(g/lOO ml) (mg/100 ml) 
2145 13 14 287 0 5.4 0.1 0.1 
2149 17 45 242 0 5.4 0.1 0.1 
2168 10 24 365 0 5.7 0 0 
2169 7 23 0 0 5.3 0.1 0.2 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 13 22 189 0 1 0 0.3 
2150 12 28 211 2 6.0 3.5 0.9 
2153 9 36 172 4 6.1 0 0.2 
2163 21 34 249 4 5.6 0 0.4 
Group 3. Eubacterium in 2 % fat milk 
2151 9 22 187 5 6.8 0.1 0.5 
2155 0 19 283 2 5.1 0 0.7 
2157 12 22 165 0 6.2 0.3 0 
2158 22 21 223 16 7.5 0 6.5 
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Group 1. No cholesterol (control) 
Day 42 of Experiment 
GOT GPT LDH ALP Total Bilirubin Uric acid 
Rabbit No 
• 
(lU/L) 
• iTjrocein •" 
(g/100 ml) (mg/100 ml) 
2145 3 17 7 0 5.1 0.1 0.2 
2149 10 55 73 0 5.0 0.1 0.2 
2168 12 22 288 0 5.7 0 0.1 
2169 10 24 0 0 5.4 0.1 0.1 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 25 29 287 0 0 0 0.5 
2150 12 26 283 3 0.4 0.1 0.7 
2153 16 29 248 9 7.2 0 1.0 
2163 13 32 167 1 5.3 0.1 0.2 
Group 3. Eubacterium in 2 % fat milk 
2151 17 26 326 7 6.3 0 0.8 
2155 10 25 58 1 5.3 0 1.1 
2157 13 24 321 1 5.7 0 0.3 
2158 13 15 254 2 5.8 0.2 0.9 
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Group 1. No cholesterol (control) 
Day 56 of Experiment 
GOT GPT LDH ALP Total Bilirubin Uric acid 
Protein 
Rabbit No. (lU/L) (g/100 ml) (mg/100 ml) 
2145 8 21 293 1 5.2 0.1 0.1 
2149 20 71 314 0 5.1 0.1 0 
2168 10 21 288 0 4.9 0 0 
2169 0 1 281 0 5.6 0.1 0 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 41 11 47 2 5.7 0 0.4 
2150 13 22 357 3 0 0.3 0.7 
2153 9 28 327 5 6.0 0 0 
2163 17 37 247 0 5.3 0.1 0.1 
Group 3. Eubacterium in 2 % fat milk 
2151 0 1 396 3 5.9 1.2 0.3 
2155 16 28 350 0 0 0.1 0 
2157 16 27 334 0 0 0 0.1 
2158 1 1 305 0 5.4 0 0.2 
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APPENDIX D FECAL STEROLS AND BILE ACID CONCENTRATIONS 
Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 0 of Experiment 
Rabbit No. Cholesterol Coprostanol 
2145 6.23 0 
2149 30.58 0 
2168 0 0 
2169 8.23 0 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 31.67 0 
2147 27.33 0 
2150 25.29 0 
2153 27.33 0 
2161 0 0 
2163 24.55 0 
Group 3. Eubacterium in 2 % fat milk 
2142 43.83 8.99 
2148 10.49 0 
2151 27.50 0 
2155 74.17 4.07 
2156 34.78 0 
2157 16.56 0 
2158 41.30 0 
2164 20.30 0 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 28 of Experiment 
Rabbit No. Cholesterol Coprostanol 
2145 129.5 187.2 
2149 113.6 100.0 
2168 177.2 181.3 
2169 132.6 39.5 
Group 2. Boiled Euhacterium in 2% fat milk 
2144 154.8 170.7 
2147 195.0 179.1 
2150 464.2 274.3 
2153 181.9 138.2 
2161 179.8 274.3 
2163 302.9 128.1 
Group 3. Euhacterium in 2 % fat milk 
2142 172.7 137.7 
2148 368.0 238.7 
2151 163.4 59.6 
2155 351.2 210.3 
2156 124.3 89.3 
2157 154.1 3.7 
2158 273.3 94.3 
2164 256.2 122.8 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 42 of Experiment 
Rabbit No. Cholesterol Coprostanol 
2145 114.9 0 
2149 139.8 0 
2168 67.6 71.2 
2169 95.0 47.5 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 446.6 113.4 
2147 294.9 14.5 
2150 524.2 211.4 
2153 349.7 72.6 
2161 482.5 188.5 
2163 785.7 162.9 
Group 3. Eubacterium in 2 % fat milk 
2142 289.3 0 
2148 506.4 0 
2151 289.4 0 
2155 400.6 56.2 
2156 229.5 63.8 
2157 451.8 108.2 
2158 712.9 31.2 
2164 225.5 49.1 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 56 of E^eriment 
Rabbit No. Cholesterol Coprostanol 
2145 107.7 147.0 
2149 123.2 179.2 
216 87.3 159.3 
2169 150.5 28.3 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 0 0 
2147 109.1 60.7 
2150 172.8 128.5 
2153 155.2 169.3 
2161 130.8 134.9 
2163 271.8 120.0 
Group 3. Eubacterium in 2 % fat milk 
2142 48.5 22.4 
2148 72.4 43.0 
2151 227.2 73.4 
2155 224.6 84.0 
2156 120.9 39.9 
2157 154.1 86.8 
2158 184.3 80.4 
2164 80.3 40.5 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 77 of Experiment 
Rabbit No. Cholesterol Coprostanol 
2145 37.7 0 
2149 27.1 13.8 
2168 27.2 29.0 
2169 140.1 31.2 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 80.5 31.3 
2147 101.0 65.3 
2150 66.1 0 
2153 51.5 15.1 
2161 119.9 88.0 
2163 73.7 23.5 
Group 3. Eubacterium in 2 % fat milk 
2142 156.1 142.8 
2148 101.6 42.3 
2151 434.2 512.6 
2155 99.3 133.9 
2156 33.2 14.6 
2157 80.0 15.6 
2158 349.9 80.1 
2164 126.0 47.5 
Group 1. 
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No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 132 of Experiment 
Rabbit No. Cholesterol Coprostanol 
2145 1810 14.1 
2149 0 0 
2168 0 0 
2169 105.8 57.0 
Group 2. Boiled Exibacteriwn in 2% fat milk 
2144 137.7 25.2 
2147 15.5 66.1 
2150 213.7 222.0 
2153 201.1 28.1 
2161 292.3 216.8 
2163 291.9 328.3 
Group 3. Euhacterivm in 2 % fat milk 
2142 138.4 30.8 
2148 210.5 57.9 
2151 65.0 59.0 
2155 380.8 92.8 
2156 179.1 8.2 
2157 240.4 52.2 
2158 125.3 78.0 
2164 190.4 105.2 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 137 of Experiment 
Rabbit No. Cholesterol Coprostanol 
2145 133.2 94.6 
2149 50.5 0 
2168 56.6 31.2 
2169 65.3 0 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 14.5 16.0 
2147 89.8 63.4 
2150 255.9 219.3 
2153 54.6 10.5 
2161 164.7 106.7 
2163 357.5 428.5 
Group 3. Eubacterium in 2 % fat milk 
2142 145.8 37.2 
2148 110.3 98.5 
2151 139.3 52.5 
2155 139.2 54.2 
2156 59.3 0 
2157 221.9 103.0 
2158 59.8 0 
2164 55.1 5.4 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 0 of Experiment 
Rabbit No. S-sitosterol Deoxycholic acid 
2145 2.0 35.2 
2149 1.1 27.9 
2168 0 36.9 
2169 97.7 27.9 
Group 2. Boiled Eubacteriim in 2% fat milk 
2144 0 47.9 
2147 5.1 41.3 
2150 3.9 24.3 
2153 67.1 24.5 
2161 0 4.8 
2163 323.5 43.8 
Group 3. Eubacterium in 2 % fat milk 
2142 2.4 77.0 
2148 0 20.7 
2151 2.1 23.2 
2155 87.0 77.9 
2156 54.4 47.3 
2157 0 24.6 
2158 124.8 87.0 
2164 4.0 22.5 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 28 of Experiment 
Rabbit No. S-sitosterol Deoxycholic acid 
2145 92.5 7.5 
2149 1625.3 358.3 
2168 1.2 25.3 
2169 2573.7 503.0 
Group 2. Boiled Eubacterivm in 2% fat milk 
2144 9.1 72.9 
2147 1230.4 284.5 
2150 81.7 90.5 
2153 2305.8 301.5 
2161 1309.9 213.6 
2163 3281.5 410.0 
Group 3. Eubacterivm in 2 % fat milk 
2142 1322.0 243.6 
2148 384.0 82.6 
2151 1231.4 269.2 
2155 396.2 82.9 
2156 1227.4 250.7 
2157 1683.2 262.6 
2158 2785.7 453.8 
2164 2930.7 435.6 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 42 of Experiment 
Rabbit No. S-sitosterol Deoxycholic acid 
2145 1770.9 235.6 
2149 2390.8 289.7 
2168 1279.3 208.0 
2169 1313.9 201.2 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 1906.8 250.8 
2147 1593.6 226.6 
2150 2540.7 260.4 
2153 2226.7 228.0 
2161 1719.6 220.6 
2163 3700.0 447.0 
Group 3. Eubacterium in 2 % fat milk 
2142 1548.3 441.4 
2148 2018.0 311.6 
2151 1128.3 183.3 
2155 1884.6 254.6 
2156 1050.5 125.8 
2157 2934.8 340.0 
2158 2307.7 293.1 
2164 1250.3 195.0 
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Group 1. No cholesterol (control) 
Fecal ; Sterol Concentration (ug/g) 
Day 56 of E3cperiment 
Rabbit No. fi-sitosterol Deoxycholic acid 
2145 1928.4 249.7 
2149 2176.0 276.8 
2168 1793.3 275.1 
2169 2278.7 313.6 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 0 0 
2147 863.8 128.8 
2150 2361.5 228.4 
2153 2118.5 231.3 
2161 1385.3 172.1 
2163 2070.6 314.1 
Group 3. Eubacterium in 2 % fat milk 
2142 562.1 75.9 
2148 593.1 123.6 
2151 1635.0 153.4 
2155 2520.0 295.2 
2156 1232.3 172.3 
2157 1505.7 231.9 
2158 1970.2 217.9 
2164 1030.2 102.7 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 77 of Experiment 
Rabbit No. fi-sitosterol Deoxycholic acid 
2145 1907.0 225.6 
2149 1011.5 147.6 
2168 860.2 196.9 
2169 3326.9 356.1 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 934.1 151.1 
2147 1728.3 284.4 
2150 1617.5 177.7 
2153 1239.3 163.3 
2161 2216.6 340.4 
2163 1559.5 221.2 
Group 3. Eubacterium in 2 % fat milk 
2142 4684.6 584.3 
2148 2513.9 400.0 
2151 2954.5 373.8 
2155 2179.2 313.9 
2156 554.6 138.1 
2157 1532.5 298.7 
2158 4772.6 763.6 
2164 3440.8 434.6 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 132 of Experiment 
Rabbit No. S-sitosterol Deoxycholic acid 
2145 0 80.7 
2149 84.0 110.8 
2168 7.0 0 
2169 704.8 404.5 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 540.4 342.0 
2147 623.6 478.1 
2150 506.7 307.0 
2153 881.7 453.9 
2161 731.5 437.6 
2163 873.3 344.0 
Group 3. Eubacterium in 2 % fat milk 
2142 551.2 316.6 
2148 1027.5 540.9 
2151 319.4 156.1 
2155 1693.2 973.4 
2156 902.9 543.8 
2157 1069.3 601.6 
2158 227.7 251.7 
2164 760.0 452.0 
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Group 1. No cholesterol (control) 
Fecal Sterol Concentration (ug/g) 
Day 137 of Experiment 
Rabbit No. IS-sitosterol Deoxycholic acid 
2145 1664.2 535.3 
2149 1566.1 401.8 
2168 1613.7 117.9 
2169 1965.7 481.5 
Group 2. Boiled Eubacterium in 2% fat milk 
2144 103.9 42.6 
2147 495.4 293.5 
2150 1918.2 469.3 
2153 1146.9 151.4 
2161 1372.2 502.8 
2163 1683.9 432.3 
Group 3. Eubacterium in 2 % fat milk 
2142 1597.4 499.9 
2148 534.7 328.8 
2151 917.9 482.1 
2155 830.8 546.2 
2156 425.5 236.4 
2157 1725.9 740.7 
2158 2051.1 232.3 
2164 362.2 177.8 
184 
APPENDIX E DATA FROM MEAT FROM EXPERIMENT ONE 
Table 1. Wet and dry,weight of samples and weight of total 
lipid (g), cholesterol and coprostanol (|ig) in pork 
before and after fermentation samples - Experiment 
one 
Weights® 
(g) (|Lig) 
Treatments Wet Dry Lipid Choi. Cop. 
Before fermentation .501 .1621 .0535 0621 NDA^ 
Raw ground pork ±.00001 ±  .0001 ± .002 ± .  06 
After fermentation 
Uninoculated pork .501 .1759 .0388 1. 297 NDA 
(control) ±.0002 ±  .001 ±  .003 ± .  05 
Lactobacillus .501 .1753 .0599 1. 749 NDA 
Pellet (0.05 g) ±.0002 + .002 ±  .009 ± .  04 
Lactobacillus + 
E. coprostanoligenes .502 • 1757 .0624 1. 281 NDA 
Pellet ±.001 ± .  003 ±  .01 ± .  06 
(0.05 g of each) 
E. coprostanoligenes 
Pellet 
0.05 g .501 1920 .0487 1. 764 NDA 
±.003 ± .  03 ±  .001 ± .  07 
0.10 g .506 • 1743 .0608 1. 683 NDA 
±.0002 ±  •  003 ±  .006 ± .  04 
0.20 g .495 1810 .0620 1. 07 NDA 
±.0002 ± .  002 ±  .02 ± .  03 
Liquid culture 
1.0 ml .503 1713 .0412 1. 624 NDA 
±.002 ± .  001 ±  .007 ± .  06 
2.0 ml .504 1667 .0665 1. 413 NDA 
±.003 ± .  002 ±  .02 ± .  04 
10.0 ml .502 1603 .0529 1. 195 NDA 
±.001 ± .  .003 ±  .009 ± .  02 
^Values represent means and standard errors of triplicate or 
duplicate samples of each treatment. Treatments were not 
replicated. 
^^A = no detectable amount 
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APPENDIX F DATA FROM MEAT FROM EXPERIMENT TWO 
Table 1. Wet and dry weights of samples, and weight of total 
lipid (g), cholesterol and coprostanol ((ig) of raw 
pork before seasoning, after seasoning 
(before fermentation) and pork fermented sausages -
Experiment two 
Sample Weights (g)® 
(g) (^g) 
Treatments Wet Dry Lipid Choi. Cop. 
Before seasoning .504 .1698 .0535 2.02 NDA'' 
Raw ground pork ±0 ±.0 ±.003 ±.003 
Before fermentation 
Raw ground pork .502 .1683 .0551 1.44 NDA 
±.01 ±.01 ±.003 ±.09 
After fermentation 
Uninoculated pork .504 .1780 .0631 1.65 NDA 
(control) ±.003 ±.005 ±.003 ±.03 
Lactobacillus .502 .1836 .0645 1.56 NDA 
Pellet (0.05 g) ±.002 ±.007 ±.003 ±.04 
Lactobacillus + E. copros tanol igenes 
Pellet .503 .1869 .0642 1.48 NDA 
(0.05 of each) ±.005 ±.02 ±.003 ±. 06 
E. coprostanoligenes 
Pellet 
0.05 g .502 .1751 .0714 1.78 NDA 
±.003 ±.003 ±.003 ±.11 
0.10 g .501 .1755 .0791 1.54 NDA 
±.002 ±.01 ±.006 ±.03 
0.50 g .499 .1759 .0690 1.89 NDA 
±.004 ±.004 ±.006 ±.07 
Liquid culture 
1.0 ml .501 .1835 .0553 1.67 NDA 
±.002 ±.007 ±.003 ±.07 
2.0 ml .503 .1742 .0507 1.61 NDA 
±.002 ±.002 ±.0006 ±.02 
10.0 ml .501 .1596 .0564 1.52 NDA 
±.002 ±.01 ±.003 ±.04 
®^Values represent means and standard errors of triplicate 
samples of each treatment except 0.5 g E. coprostanoligenes 
in duplicates. 
'^NDA = no detectable amount 
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Table 2. Wet and dry weights of samples, and weight of total 
lipid (g) , cholesterol and coprostanol ((ig) of 
fermented pork sausages after cooking - Experiment 
two 
Sample Weights (g)^ 
(g) (^.g) 
Treatments Wet Dry Lipid Choi. Cop. 
Uninoculated pork .500 .1768 . 0666 1. 625 NDA^ 
(control) + .003 ±  .001 ±  .003 +. 03 
Lactobacillus .500 .1828 .0810 1. 630 NDA 
Pellet (0.05 g) + .001 ±  .002 ±  .003 ± .  04 
Lactobacillus + 
E. coprostanoligenes .501 .1862 .0842 1. 980 NDA 
Pellet (0.05 g each) ± .003 ±  .006 ±  .006 ± .  14 
E. coprostanoligenes 
Pellet 
0.05 g .500 .1746 .0711 1. 464 NDA 
±  .003 ±  .001 ±  .003 +. 02 
0.10 g .500 .1752 .0768 l'. 40 NDA 
±  .002 ±  .003 ±  .002 ± .  09 
0.50 g .502 .1770 .0666 1. 909 NDA 
+ .0002 ±  .003 + .003 +. 16 
Liquid culture 
1.0 ml .501 .1835 .0687 1. 452 NDA 
+ .00003 + .003 ±  .003 ± .  08 
2.0 ml .504 .1746 .0613 1. 601 NDA 
±  .0003 ±  .0006 ±  .003 ± .  07 
10.0 ml .503 .1602 .0583 1. 412 NDA 
±  .001 ±  . .003 ±  .003 ± .  02 
^Values represent means and standard errors of triplicate 
samples of each treatment except 0.5 g E. coprostanoligenes 
in duplicates. 
= no detectable amount 
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Table 3. Wet and dry weights of samples, and weight of total 
lipid (g) , cholesterol and coprostanol {|ig) of 
fermented pork sausages after 1 month's storage 
after cooking - Experiment two 
Sample Weights^ 
(g) (|J.g) 
Treatments Wet Dry Lipid Choi. Cop. 
Uninoculated pork .503 .1777 .0699 2 .240 NDA^ 
(control) ±.001 ± .002 ± .003 ± .09 
Lactobacillus .502 .1887 .0778 2 .153 NDA 
Pellet (0.05 g) ±.0006 ± .001 ± .003 + .13 
Lactobacillus + 
E. coprostanoligenes .501 .1859 .0793 2 .154 NDA 
Pellet (0.05 g each) ±.003 ± .006 ± .006 ± .28 
E. coprostanoligenes 
Pellet 
0.05 g .502 .1753 .0838 1 .786 NDA 
±.0006 ± .0006 ± .0006 + .06 
0.10 g .502 .1758 .0690 1 .814 NDA 
±.001 ± .003 ± .003 ± .05 
0.50 g .502 .1770 .0732 2 .001 NDA 
±0 ± .003 ± .003 + .02 
Liquid culture 
1.0 ml .503 .1806 .0686 1 .954 NDA 
±.0006 ± .001 ± .003 ± .01 
2.0 ml .502 .1740 .0729 1 .467 NDA 
±.0006 ± .0006 ± .001 ± .14 
10.0 ml .504 .1604 .0597 1 .976 NDA 
±.0006 ± .003 ± .001 + .04 
^Values represent means and standard errors of triplicate 
samples of each treatment except 0.5 g E. coprostanoligenes 
in duplicates. 
= no detectable amount 
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APPENDIX G DATA FROM MEAT FROM EXPERIMENT THREE 
Table 1. Wet and dry weights of samples and weight of total 
lipid (g), cholesterol and coprostanol {|ig) of 
raw ground pork and mutton before fermentation and 
pork and mutton sausages after 15 hours fermentation 
- Experiment three 
Sample Weights® 
(g) ^(|Xg) 
Treatments Wet Dry Lipid Chol°. Cop''. 
Before seasoning (Raw ground) 
Pork .500 .1542 
±0 ±.004 
Mutton .500 .1904 
±0 ±.0006 
Before fermentation (Raw ground) 
Pork .500 .1772 
±0 ±.003 
Mutton .500 .1788 
±0 ±.001 
After fementation 
Uninoculated (control) 
Pork .503 .1867 
±.001 ±.005 
Mutton .503 .2013 
±.0007 ±.002 
Lactobacillus .500 .1838 
Pellet (0.05 g) ±.0003 ±.003 
Pork 
Lactobacillus (0.05 g) + E. coprostanoligenes 
Pellet - Pork 
0.10 g .504 .1802 .0703 1.57 .003® 
±.0003 ±.0001 ±.006 + .08 
0.25 g .507 .1858 .0670 1.61 .006 
±.001 ±.002 ±.002 ±.12 ±.0005 
0.50 g .504 .1864 .0705 1.72 .012 
±.002 ±.003 ±.002 ±.06 ±.002 
E. coprostanoligenes 
Pellet - Pork 
0.25 g .498 .1729 .0585 1.70 .007^ 
±.001 ±.003 ±.002 ±.06 ±.00004 
0.50 g .499 .1815 .0644 1.65 .007^ 
±.0007 ±.002 ±.003 ±.12 ±.002 
2.00 g .502 .1788 .0597 2.09 .019^ 
±.004 ±.003 ±.0001 ±.03 ±.001 
.0629 1.37 .006® 
±.001 ±.07 
.1036 5.03 .005^ 
±,004 ±.08 ±.0003 
.0625 1.75 .004^ 
±.005 ±.08 ±.0003 
.0677 5.27 .005^ 
±.002 ±.08 +.0003 
.0662 1.49 NDA"^ 
±.002 ±.07 
.0957 5.41 .009® 
±.005 ±.43 
.0682 1.59 .003® 
±.002 ±.04 
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Treatments Wet 
-(g)-
Dry 
Sample Weights® 
— (fAg) 
Lipid Choi. Cop. 
Pellet - Mutton 
0.5 g 
1.0 g 
.507 
±.001 
.502 
±.002 
.1897 
± .0008  
.1987 
± . 0 0 2  
.0789 
±.003 
.0911 
±.003 
5.41 
±.14 
5.05 
± . 2 0  
.007^ 
±.003 
.011 
±.0008 
^Values represent means and standard errors of triplicate 
samples of each treatment except 2.0 g E. coprostanoligenes 
which was in duplicate. 
''Choi = cholesterol 
°Cop = coprostanol 
•^NDA = no detectable amount 
® = 1 sample positive 
^ = 2 samples positive 
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Table 2. Wet and dry weights of samples and weight of total 
lipid (g), cholesterol and coprostanol (p,g) of 
fermented pork and mutton sausages after cooking -
Experiment three 
Treatments 
Sample Weights^ 
Wet 
vy / 
Dry Lipid 
(Uc() 
Chop. Cop®. 
Uninoculated (control) 
Pork .501 .2176 .0603 1.44 NDA"^  
±.001 ±.002 ±.006 ±.04 
Mutton .503 .2296 .0945 3.71 NDA 
±.002 ±.006 ±.004 ±.13 
Lactobacillus .500 .2194 .0691 1.55 NDA 
Pellet (0.05 g) ±.001 ±.008 ±.004 ±.06 
Pork 
Lactobacillus (0 .05 g) + E. coprostanoligenes 
Pellet - Pork 
0.10 g .500 .2177 .0611 1.82 .0101' 
±.001 ±.0009 ±.004 ±.09 
0.25 g .502 .2265 .0765 1.52 .0143' 
±.001 ±.004 ±.007 ±.08 
0.50 g .501 .2086 .0744 1.33 NDA 
±.002 ±.001 ±.003 ±.11 
E. coprostanoligenes 
Pellet - Pork 
0.25 g .503 .2052 .0840 1.40 .0096' 
±.002 ±.006 ±.01 ±.10 
0.50 g .504 .2056 .0714 1.38 .0135 
±.001 ±.002 ±.002 ±.07 ± .005 
2.00 g .507 .2141 .0965 1.14 .0208 
±.0003 ±.004 ±.01 ±. 03 ± .002 
Pellet - Mutton 
0.5 g .502 .2172 .0968 3.82 .0145 
±.001 ±.004 ±.007 ±.07 ± .006 
1.0 g .503 .2143 .0904 3.76 .0154 
±.001 ±.003 ±.003 ±.31 
^Values represent means and standard errors of triplicate 
samples of each treatment except 2.0 g E. coprostanoligenes 
which was in duplicate. 
^Chol = cholesterol 
'^ Cop = coprostanol 
"^ NDA = no detectable amount 
® = 1 sample positive 
^ = 2 samples positive 
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Table 3. Wet and dry weights of samples and weight of total 
lipid (g), cholesterol and coprostanol (Jig) of 
fermented pork and mutton sausages after 1 month's 
storage after cooking - Experiment three 
Sample Weights (g)^ 
Treatments Wet Dry Lipid 
Uninoculated (control) 
Pork .503 .2104 .0704 
±.001 ±.0008 ±.001 
Mutton .504 .2193 .0836 
±.0007 ±.002 ±.003 
Lactobacillus .504 .2164 .0663 
Pellet (0.05 g) ±.0003 ±.005 ±.002 
Pork 
Lactobacillus (0.05 g) + E. coprostanoligenes 
Pellet - Pork 
0.10 g .502 .2134 .0583 
±.001 ±.003 ±.003 
0.25 g .501 .2416 .0854 
±.001 ±.002 ±.004 
0.50 g .506 .2168 .0813 
±.0007 ±.006 ±.003 
E. coprostanoligenes 
Pellet - Pork 
0 .25 g .504 .2033 .0660 
±.0003 ±.003 ±.0008 
0.50 g .503 .1924 .0709 
±.0007 ±.004 ±.003 
2 .00 g .502 .2081 .0724 
±.001 ±.00007 ±.002 
Pellet - Mutton 
0.5 g .504 .2204 .0785 
±.0007 ±.001 ±.01 
1.0 g .504 .2214 .0866 
±.001 ±.003 ±.001 
^Values represent means and standard errors of triplicate 
samples of each treatment except 2.0 g E. coprostanoligenes 
which was in duplicate. 
